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The N-end rule pathway is a proteolytic system in which single N-terminal amino acids of proteins 
act as a class of degrons (N-degrons) that determine the half-lives of proteins. We have previously 
identified a family of mammals N-recognins whose conserved UBR boxes bind N-degrons to 
facilitate substrate ubiquitination, leading to proteolysis via the ubiquitin proteasome system or 
autophagy. Amongst these N-recognins, UBR4 binds to both type-1 and type-2 residues without 
known ubiquitylation domain. N-terminal Arg is one of the principal degrons that it can be 
generated through post-translational conjugation of L-Arg from Arg-tRNAArg to N-terminal Asp 
or Glu, which is mediated by ATE1-encoded Arg-tRNA transferases. In this dissertation study, we 
addressed the roles of UBR4 in mammalian development and ATE1 in innate immune response, 
respectively. 
First, we generated UBR4-deficient mice in which the UBR box of UBR4 was deleted and 
characterized the null phenotypes. UBR4-deficient mice exhibit severe embryonic lethality and 
pleiotropic abnormalities, including accumulated autophagic vacuoles in the yolk sac endoderm. 
UBR4 also modulates early endosomal maturation and the trafficking through the interaction with 
Ca2+-bound calmodulin. UBR4-/- embryos have multiple developmental defects including 
neurogenesis and cardiovascular system, which is at least in part attributed to the impairment in 
cell adhesion and depletion of cell surface proteins. Collectively, these data reveal that the N-
recognin UBR4 plays important roles in multiple developmental processes associated with 
angiogenesis, neurogenesis and cardiovascular system. The developmental processes are most 
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 v 
commonly involved in non-proteolytic processes such as endosomal maturation, trafficking and 
cellular adhesion. 
We show that cytosolic foreign DNA induces N-terminal arginylation of ER chaperons, 
which is required for host defense system for IFN-β mediated gene induction and IRF3 
phosphorylation. Cytosolic dsDNA facilitates relocation of ATE1 to the ER, on which ATE1 is 
colocalized with STING. Interference of Nt-arginylation that is important for host defense induces 
the production of virion. Our results suggest that N-terminal arginylation is essential for cellular 
immune response against foreign DNA and viral infections. 
This work provides meaningful evidences demonstrating that the N-end rule pathway plays 
a pivotal role in mammalian development and innate immunity beside proteolytic function.  
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1.1 THE N-END RULE PATHWAY 
A substantial fraction of newly synthesized proteins (30%) is continuously being degraded to 
amino acids within minutes of synthesis [1]. Enough capacity to degrade non-functional, damaged, 
or toxic proteins is vital for cell survival and maintaining homeostasis. To ensure the rapid turnover 
and degradation, cells remain the remarkably high abundance of proteasome (constituting 1% of 
total cellular protein). In addition, approximately 600 genes encoding proteases or protease-like 
proteins have been identified in human, and proteases are estimated to comprise 1.7% of the human 
genome, which is one of the largest human enzyme families [2]. Many polypeptides expose new 
N-terminal residues during their life cycles through proteolytic cleavages, yet their functions and 
mechanisms have received little attention in various biological fields relative to internal residues. 
Recent studies reveal an emerging role of the protein N-termini in proteolysis. The relationship 
between the identity of the proteins N-termini and their half-life is defined by a rule, called the N-
end rule [3, 4].  
In mammals, the substrates of N-recognins include positively charged (Arg, Lys, and His; 
type 1) and bulky hydrophobic (Phe, Tyr, Trp, Leu, and Ile; type-2) residues (Figure 1A) [5-8]. 
They can be exposed when polypeptides are cleaved at the N-terminal Met (Nt-Met) residue by 
Met amino peptidases or at the internal residues by endopeptidases, such as caspases, separases, 
and signal peptide peptidases [9, 10]. N-terminal Arg (Nt-Arg) is one of the principal degrons that 
can be conditionally generated through post-translational conjugation of L-Arg from Arg-tRNAArg 
to Nt-Asp or Nt-Glu. This tRNA-dependent post-translational modification (PTM) is mediated by 
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Figure 1: The mammalian N-end rule pathway in the UPS and autophagy.  
(A) In the UPS, the tertiary destabilizing Nt-Asn and Gln are deamidated by two distinct enzymes, NTAN1 and 
WDYHV1/NTAQ1 into Asp and Glu, respectively. The secondary destabilizing N-terminal residues Asp and Glu are 
arginylated by ATE1 R-transferase isoforms produced through alternative splicing of ATE1. The destabilizing activity 
of Nt-Cys requires its oxidation prior to arginylation by ATE1. C* denotes the oxidized Nt-Cys residue, either Cys-
sulfinic acid [CysO2(H)] or Cys-sulfonic acid [CysO3(H)]. Nt-Arg together with other type 1 and type 2 residues are 
directly bound by a set of N-recognins characterized by the UBR box, including UBR1, UBR2, UBR4, and UBR5. 
UBR box proteins can target substrates through the recognition of internal degrons as well as N-degrons (B) In 
autophagic proteolysis, the formation of cytosolic misfolded proteins triggers Nt-arginylation and cytosolic 
relocalization of ER-residing chaperones including BiP and PDI. Among Nt-arginylated ER proteins, R-BiP binds to 
the autophagic receptor p62 and is degraded through lysosomal degradation. In this proteolytic system, Nt-Arg acts 
as a cis-acting degron for Nt-arginylated proteins themselves and a trans-acting degron for associated cargoes, such 
as cytosolic misfolded proteins [11]. 
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ATE1-encoded Arg-tRNA transferases (R-transferases; EC 2.3.2) [12-15]. The arginylation-
permissive Nt-Asp and Nt-Glu residues can be exposed by endoproteolytic cleavage or newly 
generated through deamidation of Nt-Asn and Nt-Gln by the amidases NTAN1 and NTAQ1, 
respectively [16]. In the mammalian N-end rule pathway, Nt-Cys is oxidized into Cys-sulfinic acid 
(CysO2(H)) or Cys-sulfonic acid (CysO3(H)), which is arginylated to generate Nt-Arg [12, 15]. In 
addition to the classical N-end rule pathway, Nt-Met and acetylated N-terminal residues, found at 
80% of human proteins, can also function as N-degrons, resulting proteolysis  through the N-end 
rule pathway [17, 18].  
In the N-end rule proteolytic pathway, single N-terminal amino acids can modulate proteins’ 
half-lives through their recognition and binding by specific recognition components, called N-
recognins [4, 19]. In eukaryotic cells, these N-recognins induce proteolysis through the recognition 
of specific N-terminal amino acids that function as degradation determinant (N-degrons). Rare 
examples of N-recognins, which can bind proteolysis-inducing N-terminal residues, include a 
family of UBR box-containing proteins (e.g., UBR1, UBR2, UBR4, and UBR5) and the 
autophagic adaptor p62/SQSTM-1/Sequestosome-1 (Figure 1B) [4, 20]. Following the recognition 
by N-recognins, N-terminal amino acids can act as cis-degrons that induce proteolysis of substrates 
themselves (Figure 1A). If substrates (e.g., chaperones) are associated with cargoes (e.g., 
misfolded proteins), the same degron can induce proteolysis of protein complexes or aggregates 
in a trans-mode (Figure 1B) [11, 20]. In principle, N-degrons can induce the degradation of non-
proteolytic materials, such as endosomes and other membraneneous constituents, if the degrons 
are exposed on the surface of such subcellular structures. 
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1.2 MODULATION OF AUTOPHAGY BY THE N-TERMINAL ARGINYLATION 
In eukaryotes, ATE1-encoded Arg-tRNA transferases (R-transferases; EC 2.3.2) transfer L-
arginine (L-Arg) of Arg-tRNAArg to the N-terminal Asp (Nt-Asp) and Glu (Nt-Glu) of substrates 
including misfolded proteins and endoplasmic reticulum (ER)-residing chaperones [14, 20, 21]. 
Additionally, the Nt-Arg can be generated by endoproteolytic cleavages or enzymatically through 
the modification of Nt-Asn, Nt-Gln, Nt-Cys, Nt-Asp, and Nt-Glu [10]. The resulting N-terminal 
Arg (Nt-Arg) residue is recognized by N-recognins like UBR1, UBR2, UBR4/p600, UBR5/EDD, 
and p62/SQSTM1/Sequestosome-1, acting as a bimodal degradational signal to either (UPS) or 
macroautophagy (hereafter referred to as autophagy; Figure 1) [8, 9, 20]. Among numerous 
substrates, we found that various cellular stresses facilitate relocation of ER-residing proteins or 
nuclear proteins to the cytoplasm and induce their Nt-arginylation by ATE1 [9, 20]. The Nt-
arginylation of ER chaperones like binding-immunoglobulin protein (BiP/GRP78/HSPA5), 
calreticulin/CRT/CALR, and protein disulfide isomerase (PDI) is induced by cytosolic double-
stranded DNA (dsDNA), a strong activator of the innate immune response [20]. The dsDNA-
mediated immune response promotes the accumulation of Nt-arginylated of BiP (R-BiP) in the 
cytosol, which binds the selective autophagy receptor p62 through its binding of the ZZ domain 
of p62, resulting its self-oligomerization [20]. However, the physiological meanings of Nt-
arginylation of BiP and the induced interaction of R-BiP with SQSTM1 in the innate immune 
system are poorly defined.  
Among numerous substrates, we found that various cellular stresses facilitate relocation of 
ER-residing proteins or nuclear proteins to the cytoplasm and induce their Nt-arginylation by 
 6 
ATE1 [9, 20]. When misfolded cytosolic substrates excessively accumulate beyond the UPS’s 
capacity or under unresolvable ER stress conditions, Ub-conjugated cargoes are redirected to 
macroautophagy and segregated by autophagosomes for lysosomal degradation [20, 22]. The 
accumulated cargoes, such as misfolded proteins, signals to ATE1-dependent N-terminal 
arginylation of endoplasmic reticulum (ER)-residing molecular chaperones including BiP/GRP78, 
calreticulin/CRT/CALR, and PDI [20]. Nt-arginylated ER proteins relocate to the cytosol where 
they get associated with cytosolic misfolded proteins and bind the N-recognin p62 through the 
specific interaction of their N-terminal Arg with p62 ZZ domain [20]. Upon binding, N-terminal 
Arg acts as an activating ligand that induces p62 self-oligomerization and interaction with LC3 on 
the surface of autophagosomal membranes, facilitating autophagic degradation for aggregated 
proteins. Under the specific cellular conditions including aggregated misfolded proteins, ER stress, 
proteasomal inhibition, and cytosolic double-stranded DNA (dsDNA) exposure, Nt-arginylation 
by ATE1 can contributes to reprograming global proteolytic flux to relieve cellular stress via 
autophagic degradation. 
1.3 THE NONCANONICAL N-RECOGNIN UBR4 
N-recognins directly bind to N-terminal destabilizing residues of substrates and induce 
polyubiquitination and subsequent degradation of the substrates through the 26S proteasome 
complex [5, 7]. We have shown that four mammalian proteins, UBR1, UBR2, UBR4/p600, and 
UBR5/EDD, can bind type-1 or type-2 destabilizing N-terminal residues (Figure 2) [5, 6, 8]. These 
N-recognins share the UBR box, which is a ~70-residue zinc finger domain that acts as a substrate 
recognition domain, to bind type-1 residues, including Nt-Arg [23]. The canonical N-recognins 
 7 
UBR1 and UBR2 also contain the N-domain as type-2 binding site and have been characterized in 
various mammalian processes. However, the non-canonical N-recognin UBR4 can bind to both 
type 1 and type 2 residues with no known ubiquitylation domain. While the function and 
mechanism of the noncanonical N-recognins UBR4 in the N-end rule pathway remains poorly 
understood, studies by us and others have shown that the cooperative activities of N-recognins 
mediate the selective proteolysis of cytosolic short-lived proteins, including RGS4 and caspase-
generated C-terminal fragments exposing N-terminal degrons (Sriram et al., 2011; Tasaki et al., 
2012).  
Figure 2: The UBR box N-recognin family of the mammalian N-end rule pathway.  
AI, autoinhibitory domain; CRD, cysteine-rich domain; Fbox, F-box; HECT, homologous to the E6-AP carboxyl 
terminus; N, N-domain; PABC, poly(A) binding protein C-terminal domain; PHD, plant homeodomain finger; RING, 
RING finger; UBA, ubiquitin association domain; UBR, UBR box [24]. 
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Human UBR4 is a microtubule-associated protein with a size of 570 kDa [8, 24-26]. Beside 
its huge size, UBR4 is abundant and one of top 15% in human whole organism [27]. UBR4 is 
ubiquitously expressed in all tissues at variable levels, but analysis of human brain cDNA libraries 
identified UBR4 as a putative large protein enriched in the central nervous system [28]. In addition, 
UBR4 is a major protein and candidate protein marker for microvesicles and ecotosomes [29, 30]. 
UBR4 promotes ubiquitination of ATP-citrate lyase (ACLY), a key regulator of fatty acid 
biogenesis, suggesting that UBR4 has a role in tumor progression and lipid synthesis [31]. 
In neuronal system, UBR4 is a marker whose mRNA and protein levels are strikingly 
decreased in the synaptic regions of neurodegenerative brains in mice, sheep, and Drosophila 
melanogaster [32, 33]. The mutations in human UBR4 has been correlated to early-onset dementia 
as well as developmental regression, brain atrophy, and ataxia [34]. UBR4 is required for optimal 
degradation of a model N-end rule substrate as well as ubiquitination of huntingtin (HTT) proteins 
such as 73 poly-glutamine repeat-bearing mutant HTT (73Q-HTT) and 175Q-HTT [35]. UBR4 
and UBR5 are key regulators that synthesize K11/K48-branched heterotypic ubiquitin chains, 
which are induced and destined for proteasomal degradation during proteotoxic stress [35]. 
The host UBR4 is essential for replication and pathogenesis of various viruses. UBR4 is 
required for influenza A virus budding and viral infection through its association with the viral M2 
protein, which promotes apical transport of viral proteins [36]. UBR4-M2 interaction initiates in 
the ER and the UBR4-M2 complex moves to the plasma membrane at the late stages of infection. 
UBR4-loss disrupts that the apical (from the perinuclear ER to the plasma membrane) transport of 
viral progenies during the last stage of infection as well as the affection of neighboring cells during 
the pathogenesis [36]. UBR4 is required for dengue virus and Zika virus infection and replication 
through its binding to nonstructural protein 5 (NS5) viral protein, which inhibits IFN-I signaling 
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via IFN-regulated transcriptional activator STAT2 (signal transducer and activator of transcription 
2) degradation [37, 38]. In addition, the interaction between UBR4 and viral protein E7 is highly 
conserved across 17 human papillomavirus types (HPV) including HPV-16, 6b, and 11 as well as 
bovine papillomavirus. It regulates E7-mediated cellular immortalization and transformation 
activities [39-42]. The UBR4 interaction with HPV E7 is required for the proteasomal degradation 
of PTPN14 (protein tyrosine phosphatase non-receptor Type 14), a tyrosine phosphatase and tumor 
suppressor protein [43, 44].  
UBR4 regulates homeostasis of podocin/MEC-2 and its multimeric complex, which is a 
PHB-domain protein and constructs the renal filtration barrier, through helping its ubiquitination 
at the residues K301 and K307 [45]. UBR4 is a component of a triple E2-E3 complex with a E2 
conjugating enzyme RAD6 (Radiation sensitivity protein 6) and a E3 ligase KCMF1 (potassium 
channel modulatory factor 1). Disruption of the complex leads to misregulation of late endosomal-
lysosomal vesicle trafficking and can be related with a downregulated neuronal development in X-
linked intellectual disability (XLID) patients [46]. Calossin/Pushover, the D. melanogaster of 
UBR4 orthology, plays a role in synaptic transmission in photoreceptor cells and perineurial glial 
growth [47, 48]. It plays a role in cell proliferation and differentiation through regulating MAPK 
for proteasomal degradation in RAS-MAPK signaling [49]. Consistently, UBR4 has been 
implicated in cell adhesion and integrin-mediated processes, including the formation of ruffled 
membranes and apoptotic regulation [50]. In Arabidopsis, UBR4/BIG has been shown to mediate 
the vesicular transport of auxin, a master hormone [51]. 
Overall, these results suggest that UBR4 plays an important role in various biological 
processes, including protein degradation, viral infection, axonal integrity, neurodegeneration, and 
synaptic plasticity.  
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1.4 DISSERTATION OUTLINE 
The contents of the dissertation included: 
Chapter I. Introduction is a brief description of the research background about the N-end 
rule pathway, the autophagic modulation by N-terminal arginylation, and the N-recognin UBR4.  
Chapter II. The Role of UBR4 in Autophagic Modulation in the Yolk Sac is a full 
research paper that contains the research background, materials, methods, experimental results, 
discussion, and conclusion. It suggests that UBR4 plays an important role in mammalian 
development, in part through regulation of bulk degradation by lysosomal hydrolases in the YS.  
Chapter III. The Role of the N-recognin UBR4 in the Biogenesis of the Early 
Endosome is a full research paper that contains the research background, materials, methods, 
experimental results, discussion, and conclusion. It shows that UBR4 modulates endosome 
maturation and the trafficking and proteolysis of internalized cargoes.  
Chapter IV. The Function of UBR4 in Neurogenesis and Plasma Membrane Proteins 
is a full research paper that contains the research background, materials, methods, experimental 
results, discussion, and conclusion. It proposes that UBR4 plays a role in neurogenesis and the 
homeostasis of cell surface proteins as well as cell adhesion molecules. 
Chapter V. The Function of N-terminal Arginylation by ATE1 in Innate Immunity is 
a full research paper that contains the research background, materials, methods, experimental 
results, discussion, and conclusion. It suggests that ATE1-mediated Nt-arginylation is essential for 
sustain innate immunity against foreign DNA and viral infections.  
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2.1 RESEARCH BACKGROUND 
Substrates of the classical N-end rule pathway include cytosolic short-lived proteins carrying type-
1 (Arg, Lys, and His; positively charged) and type-2 (Phe, Tyr, Trp, Leu, and Ile; bulky 
hydrophobic) N-degrons [5-8]. In addition, N-terminal Met excision or proteolytic cleavage can 
also expose N-degrons. Among these N-degrons, the principal degron Arg can also be generated 
through post-translational arginylation of Nt-Asp and Nt-Glu by ATE1 R-transferases [12-15]. In 
addition, deamidation of the secondary pro-N-degrons Asn and Glu by NTAN1 and NTAQ1 can 
generate the arginylation-permissive pro-N-degrons Asp and Glu [16]. In addition to type-1 and 
type-2 N-degrons, Nt-Met and acetylated N-terminal residues, can act as N-degrons [17, 18]. The 
cellular functions of the N-end rule pathway in degradation of short-lived proteins carrying N-
degrons have been characterized in various processes [4, 10].  
Our previous studies identified the mammalian N-recognin family consisting of UBR1, 
UBR2, UBR4/p600, and UBR5, which share the UBR box, a ~70 residue-zinc finger domain that 
acts as a substrate recognition domain [5, 6, 8, 23]. While the canonical N-recognins UBR1 and 
UBR2 have been characterized in various mammalian processes, the physiological functions of 
the noncanonical N-recognins UBR4 in the N-end rule pathway remain unclear. Unlike the other 
canonical N-recognins, UBR4 does not contain a known ubiquitylation domain [8].  Thus, we can 
expect that the action mechanism of UBR4 in the N-end rule pathway could be different from those 
of canonical N-recognins.  
Autophagy mediates bulk lysosomal degradation of cytoplasmic constituents such as 
proteins and damaged cellular organelles. Various cellular stresses including amino acid starvation 
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induce autophagy to promote lysosomal digestion of non-essential cellular materials, providing 
amino acids and maintaining essential cellular processes[52]. Autophagic cargoes are sequestered 
and delivered into double-membrane vesicles (autophagosomes) whose fusion with lysosomes, 
generating autolysosomes wherein the content is degraded by lysosomal hydrolases[53]. The 
formation of autophagosomes involves ATG12 recruitment to phagophores, which is conjugated 
to its substrate, ATG5. The ATG5-ATG12-ATG16L1 complex promotes ligation of the ubiquitin-
like protein LC3-I with phospholipid phosphatidylethanolamine (PE) to generate LC3-II whose 
PE moiety is anchored to phagophore membranes[53, 54].  
During early embryogenesis, yolk sac (YS) is a major supplier of amino acids for 
embryonic survival (till ~E9.5 in mice) and that these amino acids are generated through lysosomal 
digestion of endocytosed maternal lipids and proteins in YS endoderm [55, 56]. As illustrated in 
Figure 3, YS can be divided into two developmentally distinct layers. The inner mesodermal layer 
is a circulation organ in which vitelline vessels are developed through intercellular signaling of 
endothelial cells with vascular smooth muscle cells (SMCs) and surrounding mesenchymal cells. 
The outer endodermal layer contains a specialized proteolytic system for degradation of 
extracellular maternal proteins and lipids, which are internalized via endocytosis (Figure 3) [57]. 
Cargo-loaded endosomal vesicles are fused with autophagosomes which are finally digested by 
hydrolases of lysosomal vacuoles of the YS endoderm. The resulting lysosome-derived amino 
acids are essential for protein translation during vascular development and embryonic survival at 
early embryonic developmental stage. At E9.5, the embryo relies on lysosome-generated amino 
acids from the YS endoderm, because the placenta is not functional at this stage. Therefore, the 
YS endoderm has a tissue-specific autophagic system that mediates constitutive degradation of 
extracellular maternal proteins as a major type of cargoes. 
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Figure 3: The structure and function of the visceral YS of murine embryos.  
(A) A cross-section of a mouse embryo at E9.5 with the YS intact. (B) An enlarged view of a dotted rectangle in A. 
the visceral YS of early mouse embryos at E9.5 is composed of two developmentally distinct layers: an outer layer 
derived from the endoderm and an underlying layer derived from the mesoderm. the YS at E9.5 contains a constitutive, 
bulk protein degradation system that absorbs maternal proteins from the YS cavity and digests these foreign materials 
using lysosomal hydrolases. the model illustrates that endocytosed maternal proteins are delivered to and digested by 
the lysosome through early endosomes (EEs) and late endosomes (LEs). Lysosome-derived amino acids in the YS 
endoderm are supplied to the embryo via the vitelline circulation or used to synthesize paracrine that control vascular 
development in the mesodermal layer. Ap, autophagosome; Amph, amphisome; En, endothelial cells; Ly, lysosome; 
nu, nucleus; me, mesenchymal cell; he, hematopoietic cell [26]. 
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In this chapter, we observe that UBR4 is required for the developmental processes during 
murine embryogenesis, in part through its function in heterophagy, a specialized autophagy 
targeting exogenous materials. Our previous and current studies together reveal a dual function of 
UBR4 in selective proteolysis by the proteasome and autophagic degradation by the lysosome. 
2.2 MATERIALS AND METHODS 
2.2.1 Construction of mice lacking UBR4 
We cloned the UBR4 gene from a bacterial artificial chromosome (BAC) library (CITB, Invitrogen, 
CA) derived from the mouse embryonic stem (ES) cell line CJ7 using a mouse UBR4 cDNA 
fragment (nt 4231-5430) as a probe. The IRES-tau-lacZ-pA-ACNF plasmid, derived from the 
IRES-tau-lacZ-pA cassette [58] and the ACNF cassette [59], is a gift from Dr. Peter Mombaerts 
at the Rockefeller University. The targeting vector pUBR4KO-tauLacZ was constructed using 
gene recombineering (recombination-mediated genetic engineering) as described [60, 61], 
linearized with FseI, and electroporated into E14 ES cells (a gift from Dr. Mombaerts). Targeted 
ES cell clones were analyzed using Southern blotting and PCR analysis. The clone 2F12 ES cells 
were injected into C57/BL6J blastocysts to generate chimeric mice which, in turn, were used to 
obtain germline transmission of the UBR4- mutant allele.  
2.2.2 Antibodies 
Rabbit polyclonal anti-human UBR4 antibody (1:400), raised against residues 3755–4160 [62], 
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was used for immunostaining of the YS. Rabbit polyclonal anti-UBR4 antibody (1:500, IHC-
00640, Bethyl laboratories, Montgomery, TX) was used for immunostaining of cultured cells. 
Other primary antibodies are rabbit polyclonal anti-V5 (1:500, V8137, Sigma, St. Louis, MO), 
goat polyclonal anti-ATG12 (1:100, SC-70128, Santa Cruz Biotechnology, Santa Cruz, CA), goat 
polyclonal anti-ATG5 (1:200, SC-8666, Santa Cruz Biotechnology), and goat polyclonal anti-LC3 
(1:100, SC-16755, Santa Cruz Biotechnology). The following secondary antibodies were from 
Invitrogen (Eugene, OR): Alexa Fluor 488 goat anti-rabbit IgG (1:200, A11034), Alexa Fluor 555 
donkey anti-goat IgG (1:200, A21432), Alexa Fluor 555 goat anti-mouse IgG (1:200, A21424), 
and anti-rat IgG-HRP (1: 500, Jackson ImmunoResearch).  
2.2.3 Cell culture 
HEK293 cell was purchased from the American Type Culture Collection (ATCC). All the cell 
lines were determined to be negative in a mycoplasma test using a MycoAlert detection kit (Lonza, 
LT07-118). HEK293 cell was cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; 
Gibco,10566016). The media was supplemented with 10% FBS and 100 units/mL 
penicillin/streptomycin. All the culture plates and the cell lines were maintained at 37°C and 5% 
CO2 in a humidified incubator. 
2.2.4 Immunohistochemistry 
For immunohistochemistry of animal tissues, paraffin-embedded slides were treated with xylene, 
followed by gradual dehydration in EtOH (100%, 90%, 80% and 70%; 6 min each) and rehydration 
in water for 20 min. The slides were treated with blocking solution (1% BSA and 0.2% Triton X-
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100 in PBS) for 1 h and incubated with primary antibodies and subsequently secondary antibodies. 
The slides were counter-stained with 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI; 
Sigma, D8417) and mounted with Vectashield antifade mounting medium (Vector lab, H1000). 
Confocal images were taken by Fluoview FV1000 confocal laser scanning microscope equipped 
with Olympus Plan-Apo 60X (1.42 NA) oil immersion lens and analyzed using Fluoview software 
(Olympus, Shinjuku-ku, Japan). Two ImageJ (1) plugins, colocalization finder (by Christophe 
Laummonerie and Jerome Mutterer) and JACoP (Just Another Co-localization Plugin, 2), were 
used to evaluate colocalization of fluorescent images.  
2.2.5 Immunocytochemistry of cultured cells 
Coverslips were coated with diluted poly-L-lysine (1:10 in sterile deionized water) for 30 min at 
room temperature. After washing, the coverslip was exposed under a UV radiation lamp overnight 
in a hood. Cells were cultured on the coated coverslips and fixed in 4% paraformaldehyde (PFA) 
in PBS (pH 7.4) for 0.5 h at room temperature. After washing twice with PBS, the slide was treated 
with blocking solution (5% FBS and 0.3% Triton X-100 in PBS) for 1 h, followed by incubation 
with primary and secondary antibodies, subsequently. 
2.2.6 Immunoelectron microscopy 
HEK293-UBR4V5 cells were fixed in 2% PFA in PBS (pH 7.4) for 1 h and washed with PBS. 
Fixed cells were collected by scraping and resuspended in 3% gelatin. The gelatin was solidified 
on ice, and cells embedded in gelatin were fixed again with 2% PFA for 15 min. After 
cryoprotected with 2.3 M sucrose with PVP solution overnight, samples were frozen in liquid 
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nitrogen and were trimmed into 0.5 mm cubes. The frozen cell blocks were sectioned by 
cryomicrotome (Leica EM Crion) in 70 nm sections and collected on 200 mesh grids. Primary 
antibodies were diluted in PBS with 0.5% BSA and 0.15% glycine. Donkey anti-rabbit 12 nm gold 
and donkey anti-goat 18 nm gold beads were diluted to 1:25 before use. After immunostaining, 
sections were incubated with 2.5% glutaraldehyde for 10 min and with 2% Neutral UA acetate for 
7 min. Sections were further processed with 4% uranyl acetate and methyl cellulose for contrasting 
and drying, respectively. After drying, samples were recorded using JEOL JEM1011 TEM with 
high resolution AMT digital camera (Peabody, MA).  
2.2.7 Establishment of UBR4-/- MEFs 
Primary MEFs were established from E8.5 UBR4-/- embryos and their +/+ littermates. The embryos 
were minced by pipetting in Iscove’s Modified Dulbecco’s Medium (IMDM) (Invitrogen, #31980-
022), 15% FBS (Hyclone), 0.1 mM non-essential amino acids (Invitrogen), 0.1 mM β-
mercaptoethanol, and 100 U/ml penicillin/streptomycin (Invitrogen). The cells were seeded on the 
gelatinized 35 mm culture dish. Permanent cell lines were established from primary MEFs through 
crisis-mediated immortalization over 10 passages.   
2.2.8 Proximity ligation assay 
The proximity ligation assay (PLA) was used to visualize protein-protein interactions in UBR4V5 
stable HEK293 cells using reagent kit (Olink Bioscience, Uppsala, Sweden). The cells were fixed 
with 4% PFA for 0.5 h and blocked for 1 h in 10% goat serum (Invitrogen, Camarillo, CA), 
followed by incubation with UBR4 and test antibodies (ATG12 or LC3) in antibody solution (0.3% 
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Triton X-100 and 5% bovine serum albumin in PBS) overnight at 4 °C. The cells were incubated 
with two oligonucleotide-tagged probe antibodies to primary antibodies. Annealing of the probes 
occurs when the target proteins are within 400 Å from each other, which initiates the amplification 
of Green fluorophore. Following 1 h incubation with the PLA probes, the cells were subject to 
hybridization, ligation, and DNA amplification in accordance with the manufacturer’s instruction. 
A z-stack image of the green PLA signals was collected by 20 sampling the specimen at different 
focal planes (0.53 µm /slice) using confocal microscope (Olympus, FV1000).  
2.3 EXPERIMENTAL RESULTS 
2.3.1 Mice lacking UBR4 die during early embryogenesis. 
To determine the role of UBR4 in mammalian development, we constructed mice lacking UBR4. 
As the UBR box is a general substrate recognition domain for destabilizing N-terminal residues, a 
UBR box-containing region spanning exons 36 through 42 was replaced with IRES (internal 
ribosome entry site)-translated tau-lacZ and a floxed tACE-Cre-Neo cassette in embryonic stem 
(ES) cells (Figure 4). The selection marker Neo flanked by loxP sites was removed by the Cre-
recombinase expressed from the tACE (angiotensin-converting enzyme) promoter in 
spermatogonia of germline-transmitted F1 pups (Figure 4). Genotyping F2 C57BL/6J:129/Ola 
hybrid offspring from heterozygous parents yielded no viable UBR4-/- mice (Table 1), indicating 
that UBR4-/- mice die as embryos or neonates. By E9.0-9.5, UBR4-/- embryos were retrieved at 
Mendelian ratios but growth-arrested at the 14- to 18- somite stage, some of which were found 
dead (Table 1). No live mutants were retrieved at E11.5 and afterwards. Thus, mouse UBR4 is  
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Figure 4: Targeting strategy of the UBR4 gene using recombineering.  
(A) Restriction map of the ∼7.5-kb 5′-proximal region of the ∼108-kb mouse UBR4 gene spanning exons 27 through 53. (B) Targeting vector. (C) Targeted 
UBR4− allele in ES cells. (D) Targeted UBR4− allele in F1 pups. Exons are denoted by solid vertical rectangles. Directions of transcription of the neomycin (neo) 
and the thymidine kinase (tk) genes are indicated. Homologous recombination resulted in the replacement of the UBR4 exons 36–42 with the neo cassette. Exons 
36 and 37, marked by an asterisk, contain Gly and Asp that are conserved in the UBR box N-recognin family and are essential for binding to type-1 destabilizing 
N-terminal residues in Saccharomyces cerevisiae Ubr1. Primers used for PCR genotyping are indicated by solid rectangles [24].  
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Table 1: Litter size of embryos from UBR4+/- intercrosses. 
Stage +/+ +/- -/- ND # litter Ave. litter size 
E8.5 27 39 22  10 8.8 
E9.0 13 23 12a  5 9.6 
E9.5 43 107 40 a 3 23 8.4 
E10.5 7 17 6 a 3 4 8.3 
E11.5 6 8, 2b 3 b  2 6.0 
E12.5 3 5 0  1 8.0 
E15.5 1 2 0  1 3.0 
P21 65 138 0  35 5.8 
Footnote: a, morphologically abnormal; b, found dead; ND, not determined [24].  
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indispensable for survival during embryogenesis. 
2.3.2 UBR4 is highly expressed in the YS endoderm. 
This prompted us to examine UBR4 expression on the cross section of the YS comprising two 
developmentally distinct layers, the outer layer derived from the endoderm and the inner layer 
from the mesoderm (Figure 5A). Instead, the staining of UBR4 was largely restricted to autophagy-
enriched endodermal cell layer that coordinates differentiation of mesoderm-derived vascular cells  
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Figure 5: Expression of UBR4 in the YS endoderm. 
(A) Immunostaining of UBR4 on cross-sections of +/+ and UBR4−/− YS at E9.5 (scale bar, 10 μm). Enlarged views 
of areas indicated by rectangles (scale bar, 5 μm). *, lysosomal vacuole. (B) TUNEL assay of +/+ and UBR4−/− YS at 
E9.5. DNase 1 was treated on UBR4−/− YS as a positive control for TUNEL+ cells. ee, extraembryonic endoderm; mes, 
mesodermal layer [24]. 
and supplies lysosome-produced amino acids during early embryogenesis. UBR4−/− YS showed a 
comparable level to +/+ in apoptosis as determined by terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) assay (Fig. 5B).  
2.3.3 UBR4 is associated with autophagosome in the YS endoderm. 
To determine the function of UBR4 in the YS endoderm, we immunostained endogenous UBR4 
on YS cross sections at E9.5. In contrast to typical cytosolic proteins of the UPS that would appear 
to be diffusive, the staining appeared as cytosolic punctate signals (Figure 6A). Although 
morphologically heterogeneous, some had round shape with diameters of 0.1-0.3 or ~1.0 µm and 
distributed with lysosomal vacuoles in a cytosolic compartment between the microvilli and nucleus 
(Figure 6A). A significant portion of UBR4 puncta were at least partially associated with puncta 
positive for LC3, a hallmark of double membrane structures (Figure 6A). Despite colocalization, 
the shapes and sizes of UBR4 puncta were distinct from those of LC3 puncta. In addition, a 
confocal distance measurement indicated that the center of UBR4 puncta was separated from that 
of LC3 puncta by approximately 0.15 µm (Figure 6B-D). These results suggest that UBR4 is not 
a constitutive component of autophagic machinery but associated with autophagic cargoes. Next, 
we asked whether UBR4-loss affects autophagic activity. Immunostaining of LC3 on YS cross 
sections from +/+ and UBR4-/- embryos at E9.5 indicated that UBR4-/- YS contained a markedly 
increased level of LC3 puncta in number and signal intensity (Figure 6E), without significant 
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changes in cell  death (Figure 5B). ATG12 puncta, a hallmark of phagophores, were also 
significantly induced in UBR4-/- YS, though less striking compared with LC3 (Figure 6E). Given 
that MVBs carrying maternal proteins from the YS cavity are major autophagic cargoes in the YS 
endoderm, we asked whether UBR4 is associated with the MVB using the transmission electron 
microscopy (EM). The EM of UBR4 and LC3 in HEK293-UBR4V5 cells identified one or a few 
UBR4 dots (not as a cluster of aggregates) within the MVB or in the proximity of endosome-like 
Figure 6: UBR4 is associated with autophagosome of the YS endoderm. 
(A) Immunohistochemistry assay for UBR4 and LC3 in cross-sections of the +/+ and UBR4-/- YS. *, lysosome (scale 
bar, 10 μm). Enlarged views of area indicated by rectangles (scale bar, 2 μm). (B-D) Distances between UBR4+ and 
LC3+ puncta. (E) Immunohistochemistry assay for LC3 and ATG12 in cross-sections of the +/+ and UBR4-/- YS (scale 
bar, 10 μm). *, lysosome.(F) Electron microscopy analysis of HEK293–UBR4V5 stably overexpressed cells labeled 
for UBR4 (12 nm) and LC3 (18 nm) (scale bar, 200 nm) [24]. 
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cellular materials and LC3 at the ‘entrance’ of the MVB (Figure 6F). These results suggest that 
UBR4 plays a role in a tissue-specific constitutive autophagic pathway of the YS endoderm, 
through its association with autophagic cargoes.  
2.3.4 UBR4 plays a role in delivery of autophagic cargoes to phagophores. 
To test whether UBR4 has a general function in autophagy, we immunostained UBR4 in HEK293 
cells expressing 570 kDa-UBR4 with C-terminal V5 tag (UBR4V5). The immunostaining analysis 
revealed cytosolic punctate signals with diameters of 0.1-0.3 or ~1.0 µm, typical for phagophores 
and autophagosomes, respectively (Figure 7A). Most UBR4 puncta colocalized at least partially 
with LC3 puncta (Figure 7A), a hallmark of phagophores and autophagosomes. UBR4 puncta with 
sizes of 0.1-0.3 µm also showed similar colocalization with ATG12 and ATG5 that mark 
phagophores (Figure 7A). However, UBR4 puncta had shapes and sizes distinct from those of 
ATG12, ATG5, and LC3. To directly determine the association of UBR4 with autophagic vacuoles, 
we performed the EM of UBR4V5 in HEK293-UBR4V5 cells (Figure 7B). The analysis identified 
one or a few individual UBR4V5 dots (not as a cluster of aggregates) in association with cargo-
like materials with a diameter of approximately 0.1 µm and in the proximity of ATG12 on the 
surface or lumen of autophagic vacuoles (Figure 7B). These results collectively suggest that UBR4 
can be associated with  cellular materials to form UBR4-cargo complexes which, in turn, are 
delivered to LC3-positive autophagic vacuoles. However, we do not exclude the possibility that a 
fraction of overexpressed UBR4 molecules are misfolded and, thus, deposited to autophagic 
vacuoles. 
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Figure 7: UBR4 plays a role in delivery of autophagic cargoes to phagophores and autophagosome. 
(A) Immunostaining of UBR4 in comparison with LC3, ATG5, and ATG12 in HEK293–UBR4V5 stably expression 
cells. Enlarged views of areas indicated by rectangles. (B) Immunoelectron microscopy of HEK293–UBR4V5 cells 
labeled for UBR4 (12 nm) and ATG12 (18 nm) (scale bar, 100 nm). Enlarged views of areas indicated by rectangles 
[24]. 
2.3.5 Amino acid starvation facilitates UBR4 association with autophagic core 
machineries. 
To examine whether nutrient deprivation promotes UBR4 association with autophagic core 
machinery, we employed proximity ligation assay (PLA) which visualizes two proteins located in 
the proximity (< 400 Å) based on the ability of antibody-conjugated oligonucleotides to hybridize 
with each other. The PLA of UBR4V5 and LC3 in HEK293-UBR4V5 cells revealed punctate 
signals with diameters of ~1.0 µm (2.76 ± 0.28 per cell, N=148), indicating multiple UBR4-LC3 
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PLA interactions within autophagosomes (Figure 8). UBR4V5 showed similar PLA interactions 
with its upstream components, ATG12 (1.47 ± 0.33, N= 51) and ATG5 (3.36 ± 0.31, N= 77). 
Nutrient deprivation for 1 h caused a significantly increased correlation between UBR4 and LC3 
(7.96 ± 0.39,  N= 101; *** p = 0.001) and, to a less degree, ATG12 (3.2 ± 0.37, N= 27; ** p = 
0.002) and ATG5 (5.04 ± 0.34, N= 111; *** p = 0.0007) as well. These results together suggest 
that nutrient deprivation promotes the association of UBR4 with autophagic cargoes, leading to its 
degradation by autophagy.  
Figure 8: PLA assay of UBR4 in comparison with LC3, ATG12, and ATG5 in HEK293–UBR4V5 cells. 
(A) PLA of UBR4 with LC3, ATG12, and ATG5 in control and amino acid starved HEK293-UBR4V5 cells (scale 
bar, 5 μm). (B) Quantification of A, representing the number of PLA+ puncta per cell. Data are presented as mean 
percentage ± SEM of Mock. Statistical significance was determined using two-tailed t-test. 
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2.3.6 UBR4-loss results in misregulation of autophagic induction and flux. 
Given the enhanced formation of LC3 and ATG12 cytosolic puncta in UBR4-/- YS (Figure 6E), we 
examined autophagic induction and flux in +/+ and UBR4-/- MEFs. Both of Immunostaining and 
immunoblotting analyses showed that UBR4-/- MEF contained a higher level of LC3 compared 
with +/+ cells (Figure 9A and B; 9C, lane 1 vs. 3). Cytosolic form LC3-I is accumulated in UBR4−/− 
MEFs even in normal growth media. Transient over-expression of UBR4V5 in UBR4−/− MEFs 
only marginally reduces the synthesis of LC3-I and the formation of LC3 foci. This marginal effect 
provides a possibility that autophagic induction in UBR4-/- cells is caused by cellular stress and/or 
impairment of organelles that cannot be readily rescued by transient supplement of UBR4.  
Immunoblotting analysis confirmed that UBR4-/- MEFs contained significantly increased 
basal levels for LC3-I and LC3-II (Figure 10A) as well as GABARAP-I and GABARAP-II (Figure 
10B, lanes 2 vs. 1), which are the other homologs of LC3 in mammalian system. Transient over-
expression of Green Fluorescence Protein (GFP)-associated LC3 (GFP-LC3) confirmed that 
formation of cytosolic punctate structures was activated in UBR4-/- MEFs growing in normal as 
well as starvation media (Figure 10C). These results suggest that UBR4 deficiency can induce 
autophagic pathway. To further characterize the role of UBR4 in autophagy, we transiently 
transfected HEK293 cells with small interfering RNA (siRNA) against human UBR4. Transiently 
silencing of human UBR4 markedly induced the formation of LC3 puncta in HEK293 cells (Figure 
11A). Moreover, transient re-expression of recombinant UBR4V5 in human UBR4-knockdown 
HEK293 cells reverted those induced LC3 puncta back to the basal level (Figure 11). These results 
indicate that UBR4 plays an active role in autophagic flux.  
 29 
 
Figure 9: UBR4-/- MEF contained a higher level of LC3. 
(A) Expression and conversion of LC3 in +/+ and UBR4-/- MEFs transiently expressing UBR4V5. Immunofluorescent 
analysis of V5 (UBR4V5) and LC3 in +/+ and UBR4-/- MEFs transiently transfected with a plasmid encoding UBR4V5. 
+/+ and UBR4-/- MEFs were transfected with a plasmid (1.0 μg) encoding UBR4V5 (scale bar, 20 μm). (B) Enlarged 
views of the cellular areas indicated by a–d. a; non-transfected +/+ cell; b, transfected wild-type cell; c, non-transfected 
UBR4-/- MEF; d, transfected UBR4-/- MEF cell (scale bar, 4 μm). (C) Immunoblotting analysis of V5 (UBR4V5) and 
LC3 in +/+ and UBR4-/- MEFs transiently transfected with the indicated amounts of a plasmid encoding UBR4V5 [24]. 
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Figure 10: UBR4 loss leads to multiple misregulations of autophagic induction and flux.  
(A) Immunoblotting of +/+ and UBR4-/- MEFs. (B) Immunoblotting of +/+ and UBR4-/- MEFs growing in normal or 
starvation medium for 90 min in the presence or absence of 0.2 μM bafilomycin A1 or 10 mM 3-methyladenine (3MA). 
(C) Immunostaining of transiently expressed GFP-LC3 and endogenous ATG12 in +/+ and UBR4-/- MEFs.  Panels A 
and B were conducted by Takafumi Tasaki [24]. 
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Figure 11: Knockdown of UBR4 induces the formation of LC3 puncta in HEK293 cells.  
(A) HEK293 cells were transfected with control or siUBR4 siRNA. After 48 h post-siRNA transfection, the cells were 
transfected with 1 μg UBR4V5 plasmid. After 24 h from the transfection, cells were subjected to 
immunocytochemistry of V5 (UBR4V5) and LC3 (scale bar, 5 μm). (B) Immunoblotting analysis of HEK293 cells 
that had been treated with siUBR4 for 48 h, followed by transient transfection of the plasmid UBR4V5. Note that 
overexpression of UBR4V5 in UBR4 knockdown cells results in disappearance of endogenous human UBR4 and 
accumulation of recombinant human UBR4V5 [24]. 
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2.4 DISCUSSION AND CONCLUSION 
The results presented in the study suggest that UBR4 subpopulation in the YS endoderm is 
specifically associated with cellular cargoes to form UBR4-cargo complexes destined to 
autophagosomes and lysosomal vacuoles. Given that embryo requires lysosome-derived amino 
acids digested from the YS endoderm, it is likely that misregulation of autophagic pathways in the 
UBR4-/- YS endoderm significantly contributes to embryonic lethality with multiple developmental 
defects.  
In this study we demonstrate that mice lacking UBR4, a newly identified N-recognin, die 
during early embryogenesis associated with induced autophagy pathway in YS endoderm. The YS 
endoderm is a specialized digestive organ wherein maternal proteins from the YS cavity are 
endocytosed and digested into amino acids through the MVB-autophagosome-lysosome pathway 
[57]. What is the function and mechanism of UBR4 in the autophagic and MVB pathway, as the 
N-recognin of the N-end rule pathway? The N-end rule pathway has been characterized as a 
proteolytic system that controls the half-lives of cytosolic short-lived proteins through selective 
proteolysis by the 26S proteasome. N-recognin, known to bind to substrates of selective 
proteasomal degradation, is also associated with substrates of bulk lysosomal degradation. UBR4 
does not have a known ubiquitylation domain but does contain the UBR box which is conserved 
in the UBR N-recognin family and binds to type-1 destabilizing N-terminal residues, including the 
primary degron Arg. Therefore, it is natural to speculate that UBR4 is associated with (unknown) 
cellular cargoes through binding of the UBR box to the N-terminal Arg exposed from the substrates 
(Fig 12).  
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UBR4 has a putative LC3 interacting region (LIR), which is predicted by iLIR database 
(https://ilir.warwick.ac.uk) (Fig. 12) [63]. Through the interaction with LC3, UBR4 can bind 
proteasomal and/or autophgic cargoes, exposing the primary degron, and deliver them to 
phagophore/autophagosome pathway for selective degradation under cellular stresses. Our results 
show that UBR4-/- YS and MEFs contain an increased level of LC3+ puncta as compared with 
controls. This suggests that multiple misregulations of autophagy and other UBR4-dependent 
processes in UBR4-/- cells result in cellular stress (e.g., nutrient insufficiency, and/or accumulation 
of damaged organelles) which, in turn, stimulates the formation of autophagic vacuoles.  
Further investigation is needed to understand the mechanism by which UBR4 plays a dual 
role in selective degradation of short-lived proteins via the proteasome and bulk degradation of 
cellular materials via the lysosome. 
Figure 12: UBR4 domains and protein binding regions. 
UBR4 contains UBR box that binds to type-1 destabilizing N-degrons, including the primary degron Arg. It has an 
atypical calmodulin (CaM)-binding domain. The C-terminal of UBR4 contains a large microtubule-binding region, 
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which overlaps with Ndel1-binding region. It includes two ER-associated domains and a putative LC3 interacting 
region (LIR). 
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3.0  THE ROLE OF THE N-RECOGNIN UBR4 IN THE BIOGENESIS OF THE 
EARLY ENDOSOME 
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3.1 RESEARCH BACKGROUND 
In eukaryotes, cellular proteins are mainly degraded by the UPS, autophagy, and/or endosomal 
system. In the UPS, proteasomal proteases degrade Ub-tagged short-lived and misfolded/damaged 
substrates into short-peptides [21, 64-66]. Autophagy uses lysosomal hydrolases to degrade 
various long-lived and insoluble misfolded proteins into amino acids [67]. By contrast, plasma 
membrane-associated and extracellular proteins are endocytosed and sequestered in endosomes 
and degraded by endosomal hydrolases into short peptides and truncated proteins [68-72]. Studies 
have shown that approximately 50% of the plasma membrane and 5-30% of cellular volumes are 
internalized in every hour [73, 74]. As such, the plasma membrane and associated proteins can be 
almost entirely replaced by new materials in just one hour [73, 74]. Although the majority of cell 
surface proteins are short-lived substrates of endosomal proteolysis, the key regulators underlying 
endosomal processes remain incompletely understood. 
The substrates of endosomal proteolysis are endocytosed and sequestered within endocytic 
vesicles [74-78] (Figure 13). Endocytic vesicles can be recycled back to the membrane [79] or 
homotypically fused with each other to form early endosome (pH 5.8-6.3) [72, 80], in which the 
cargoes are digested by endosomal hydrolases into short peptides or truncated fragments [72, 73, 
81-83]. The partially digested cargoes are further degraded as early endosomes undergo maturation 
into late endosomes (pH 5.4-5.8) containing approximately 50 hydrolases [71, 84-86] (Figure 13). 
The proteolytic products in late endosomes are released into the cytosol and further digested by 
the proteasome and aminopeptidases [71, 87]. Together, approximately 80% of endosomal cargoes 
destined for degradation are digested within early endosomes or late endosomes which occurs 
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Figure 13. Endosomal maturation and proteolysis. 
External contents and surface proteins are endocytosed via primary endocytic vesicles and accumulated in early 
endosomes (pH 5.8-6.3) through homotypic fusion. Within 10 min, early endosomes recycle their cargoes to the 
plasma membrane or partially digests the cargoes by endosomal hydrolases into short peptides. Through early-to-late 
endosome conversion, the undigested fragments are exposed to more acidic pH, which is optimal for the enzymatic 
activity of hydrolases in late endosomes (pH 5.4-5.8). A portion of early endosomes and late endosomes are fused to 
MVBs along with autophagosomes, which generates amphisomes. Eventually, multiple cargoes originated from 
various sources including extracellular contents, plasma membrane, and autophagosomes are digested by endosome-
derived hydrolases in lysosomes (pH 4.5-5.0) into amino acids. 
independent of lysosomes and, thus, are mechanistically distinct from the UPS and autophagy [70, 
88]. The undigested cargoes in late endosomes are delivered to lysosomes (pH 5.0) and degraded 
into amino acids by lysosomal hydrolases [71]. Endosomes also mediate lysosome-independent 
degradation of autophagic cargoes sequestered in hydrolases-free autophagosomes. Specifically, a 
portion of early endosomes and late endosomes are fused with autophagosomes to form 
amphisomes and initiates the degradation of autophagic cargoes using their endosomal hydrolases 
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[71, 89] (Figure 13). In addition, some early endosomes and late endosomes are co-deposited to 
multivesicular bodies (MVBs) along with autophagosomes and their cargoes (Figure 13), wherein 
autophagic cargoes are degraded by endosomal hydrolases, independent of lysosomes [90]. The 
undigested and partially digested cargoes in amphisomes and MVBs are eventually digested by 
endosome-derived hydrolases in lysosomes into amino acids (Figure 13). Overall, the amounts of 
cargoes degraded in early endosomes, late endosomes, MVBs, and amphisomes, prior to lysosomal 
targeting, may rival or even exceed those by lysosomes, especially in normally growing cells. 
The endocytic vesicles containing endosomal cargoes mature into early endosomes and 
subsequently late endosomes through a series of homotypic fusion. During this process, GTP-
bound RAB5 is associated with endocytic vesicles and induces the formation of 
phosphatidylinositol 3-phosphate (PI3P) on endocytic vesicles [72] (Figure 13). The PI3P moieties 
on endocytic vesicles subsequently recruit EEA1 (early endosome antigen 1). PI3P-bound EEA1 
is maximally ~240 nm long and tethers two endocytic vesicles through the interaction of its two 
ends with two RAB5 molecules, each of which on an endocytic vesicle [72, 91, 92]. The tethering 
of two endocytic vesicles by EEA1 is facilitated by Ca2+-bound calmodulin that binds EEA1 and 
its conformational change from 70 nm to 240 nm long [93-95] (Figure 13). The cooperation 
amongst RAB5, EEA1, and calmodulin is critical for homotypic fusion of endocytic vesicles into 
early endosomes (Figure 13). The resulting early endosomes can be fused with endocytic vesicles 
or early endosomes in the course of maturation to an late endosome [72]. During the conversion 
of early endosomes to late endosomes, RAB5 is dissociated from early endosomes and replaced 
with the G-protein RAB7 [96]. To date, little is known about the peripheral components that 
modulate endosomal maturation and proteolysis.  
The N-end rule pathway is a proteolytic system, in which single N-terminal amino acids 
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function as a determinant of degradation signals (degrons), called N-degrons [3, 4, 10]. The 
degradation determinants include positively charged (Arg, Lys, and His; type 1) and bulky 
hydrophobic (Phe, Tyr, Trp, Leu, and Ile; type-2) residues on the protein N-termini [5, 97, 98]. 
Amongst these, the Arg N-degron can be generated by the conjugation of the amino acid L-Arg 
by ATE1-encoded R-transferases (EC 2.3.2) [15, 16, 97, 99]. The N-terminal Arg (Nt-Arg) of 
arginylated proteins can induce proteolysis by the N-end rule pathway via either the UPS or 
autophagy [11, 20, 100]. We have previously identified a family of N-recognins UBR1, UBR2, 
UBR4, and UBR5 [6, 101]. The E3 ligases UBR1 and UBR2 are RING finger proteins that mediate 
ubiquitination of short-lived and misfolded proteins in the cytosol and nucleus [6, 101]. Compared 
with UBR1 and UBR2, the biochemical mechanisms and physiological functions of UBR4 and 
UBR5 as N-recognins remain poorly understood.  
Our earlier work has identified UBR4 as an N-recognin that can bind type-1 and type-2 N-
degrons including Nt-Arg [8]. We and others have constructed knockout mice lacking UBR4 [24, 
102]. Our mutant animals, in which a DNA region encoding the UBR box was deleted, die during 
embryogenesis at midgestation (~E9.5-10.5) associated with vascular defects and multiple 
misregulation of autophagic induction in the yolk sac (YS) [24, 26]. 
In this chapter, we show that UBR4 modulates the biogenesis of endosomes and the 
formation and functionality of endosome-related cellular structures. UBR4 loss impacts the 
trafficking and proteolysis of endocytosed protein cargoes. Our results suggest that UBR4 is a key 
regulator in the endosome-lysosome system, providing the mechanisms underlying the aforesaid 
observations with UBR4. 
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3.2 MATERIALS AND METHODS 
3.2.1 Antibodies 
Rabbit polyclonal anti-UBR4 antibody (Bethyl Laboratories, IHC-00640, 1:300) was used for 
immunohistochemical analysis of YS and embryos and immunocytochemical analysis of cultured 
cells. Other antibodies are as follows: rabbit polyclonal anti-EEA1 (Cell Signaling, 2411, 1:100), 
mouse monoclonal anti-EGFR (Santa Cruz, SC-374607, 1:200), rabbit polyclonal anti-RAB5 (Cell 
Signaling, 3547, 1:400), mouse monoclonal anti-RAB7 (Sigma, R8779, 1:1,300), rabbit 
polyclonal anti-V5 (Sigma, V8137, 1:500). For immunoblotting analysis, mouse monoclonal anti-
β actin (Sigma, A1978, 1:10,000), rabbit polyclonal anti-UBR4 (Abcam, AB86738, 1:100), and 
mouse monoclonal anti-GAPDH (Sigma, G8795, 1:20,000) were used. The following secondary 
antibodies are from Invitrogen: Alexa Fluor 488 goat anti-rabbit IgG (A11034, 1:200), and Alexa 
Fluor 555 goat anti-mouse IgG (A21424, 1:200). 
3.2.2 Plasmids and other reagents 
mRFP-RAB5 and EGFP-calmodulin were kindly gifted from Ari Helenius (Addgene plasmid # 
14437) and Emanuel Strehler (Addgene plasmid # 47602), respectively. EGFP-EEA1 and 
TagRFP-EEA1 were kindly gifted from Silvia Corvera (Addgene plasmid # 42307 and #42635, 
respectively. GFP and V5 tagged UBR4 plasmids were prepared as described in the previous 
studies[8, 24]. These plasmids were transiently transfected with Lipofectamine 3000 reagent 
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following the manufacturer's instructions (Invitrogen). Normal goat serum (ab7481) was obtained 
from Abcam. Hoechst 33342 (H21492) was obtained from Invitrogen. 4′,6-Diamidino-2-
phenylindole dihydrochloride (DAPI; D8417) and nocodazole (M1404) were obtained from Sigma. 
W-7 (681629) and latrunculin A (428021) were obtained from Calbiochem. Synthetic TAT-FITC 
peptide was purchased from Anygen (Kwangju, South Korea). The sequence was FITC-
GGGGYGRKKRRQRRR-NH2. Vectashield antifade mounting medium (H1000) was from 
Vector lab. All other chemicals were reagent grades from Sigma or Merck. 
3.2.3 UBR4 knockout mice  
We have previously constructed UBR4-knockout mice, in which the UBR box, a substrate 
recognition domain for destabilizing N-terminal residues, was replaced with IRES (internal 
ribosome entry site)-translated tau-lacZ [24]. Animal studies were conducted according to the 
protocols (SNU130604-2-10) approved by the Institutional Animal Care and Use Committee at 
Seoul National University. 
3.2.4 Cell culture 
We previously established primary mouse embryonic fibroblasts (MEFs) from +/+ and UBR4-/- 
embryos at E8.5 [24]. Immortalized cell lines were established from primary MEFs through crisis-
mediated immortalization over 10 passages [24]. MEF cells were cultured in Iscove’s modified 
Dulbecco’s medium (IMDM) (31980–022; Invitrogen), 15% FBS (HyClone), 0.1 mM non-
essential amino acids (Invitrogen), 0.1 mM β-mercaptoethanol, and 100 units/mL 
penicillin/streptomycin (Invitrogen). CCL2 HeLa and HEK293 cell were purchased from the 
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American Type Culture Collection (ATCC). All the cell lines were determined to be negative in a 
mycoplasma test using a MycoAlert detection kit (Lonza, LT07-118). HeLa and HEK293 cell were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco,10566016). The media was 
supplemented with 10% FBS and 100 units/mL penicillin/streptomycin. All the culture plates and 
the cell lines were maintained at 37°C and 5% CO2 in a humidified incubator. 
3.2.5 RNA interference assay 
Reagents for siRNA silencing were purchased from Life Technologies. Transfection was 
performed according to the manufacture’s protocol. Briefly, Cells were transfected with either 
siControl (Invitrogen, cat. #4390843), EEA1 siRNA (Origene, cat#SR30003), or UBR4 siRNA 
(Invitrogen, cat. #4392420, ID #23628) at a final concentration of 10 nM using Lipofectamine 
RNAiMAX reagent (Invitrogen, 13778150). Approximately 48 h after siRNA silencing, cells were 
harvested for immunoblotting and immunocytochemical analyses. The sequences of UBR4 
siRNAs are 5’-GCCUGUUCGAAAGCGCAAA (sense) and 5’-UUUGCGCUUUCGAACAGGC 
(antisense). 
3.2.6 Immunoblotting analysis 
Cells were washed with ice-cold PBS and lysed using RIPA buffer (50 mM Tris-HCl, 150 mM 
NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) containing freshly prepared protease 
inhibitor cocktail (Sigma, P8340). Lysates were centrifuged at 14,000 rpm for 20 min at 4°C, and 
the supernatants were used for immunoblotting. Protein concentrations were measured using the 
BCA protein assay kit (Pierce, 23225). The samples were diluted with 2X Laemmli sample buffer 
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(65.8 mM Tris-HCl, pH 6.8, 26.3% (w/v) glycerol, 2.1% SDS, 0.01% bromophenol blue, Bio-Rad, 
161-0737) or in Lithium dodecyl sulfate (LDS) sample buffer (Invitrogen, NP0007) with a 
reducing reagent, followed by heating for 10 min at 70°C. Whole cell lysates were separated by 
sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred to 
polyvinylidene difluoride membranes (PVDF; Millipore, IPVH00010). Blocking was done using 
TBS-T (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% (v/v) Tween 20) containing 1% BSA 
for 1 h at room temperature, and the membrane was incubated with antibodies diluted with the 
blocking solution for overnight at 4°C.  
3.2.7 Histology and immunohistochemistry 
Immunohistochemistry analysis was performed as described in the previous study [24]. Briefly, 
for histological analysis, embryos were fixed overnight at 4°C in 4% PFA in PBS, pH 7.4. Fixed 
embryos were gradually dehydrated with 70%, 90%, and 100% EtOH, followed by immersion in 
Neo-Clear (Millipore, 65351). Tissues were embedded in paraffin wax at 58°C and sectioned 
transversely or sagittally with 7 μm thickness. Paraffin-embedded slides were freshly treated with 
Neo-Clear twice for 10 min each, followed by gradual rehydration in EtOH (100%, 90%, 80%, 
and 70%; 6 min each) and water for 20 min. The slides were treated with blocking solution (5% 
normal goat serum and 0.2% Triton X-100 in PBS) for 1 h and incubated with primary antibodies 
and subsequently secondary antibodies.  
3.2.8 Immunocytochemistry of cultured cells 
Immunocytochemistry analysis was performed as described in the previous study [24]. Three 22 
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mm2 coverslips per well were placed in 6-well plates, followed by incubation of diluted poly-L-
lysine (1:10 in sterile deionized water; Sigma, P8920) for 30 min at room temperature. After 
washing once, the plate was exposed under UV radiation lamp overnight in a fume hood. Cells 
were cultured in the plate for further experiments. Cells were fixed in 4% PFA in PBS, for 30 min 
at room temperature. After washing twice with PBS, the cells were incubated for 1 h in blocking 
solution (5% normal goat serum and 0.3% Triton X-100 in 0.1 M PBS). After blocking, the 
samples were incubated with primary antibodies and subsequently secondary antibodies. Confocal 
images were taken with a Zeiss LSM 700 laser scanning confocal microscope equipped with Zeiss 
C-Apochromat 60x (1.2 NA) and 40x (1.2 NA) water immersion lens and analyzed using ZEN 
(black edition) 2012 SP5 software (Zeiss). Using the ZEN software, z-stacks of images covering 
the entire cell thickness were acquired and projected maximally. Image processing and annotation 
was done with Adobe Photoshop, Adobe Illustrator and Fiji software [103]. N-SIM images were 
taken with a Nikon Eclipse Ti inverted microscope (Nikon, Tokyo, Japan) equipped with a Nikon 
Apo TIRF 100x (1.49 NA) oil-immersion lens. The SIM images were reconstructed from the raw 
images through the Nikon NIS-element (ver. 3.22.10.).  
3.2.9 TAT-FITC peptide internalization assay. 
TAT Peptide incubation was performed as previously described with minor modification [104]. 
Cells were washed twice with PBS and preincubated in Opti-MEM (Gibco, 31985070) for 30 min, 
followed by TAT-FITC peptide treatment for the indicated times. Cells were fixed with 4% PFA 
for further experiments. Immunocytochemical processes were conducted as described above. 
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3.2.10 Horseradish peroxidase (HRP) uptake analysis.  
HRP uptake analysis was performed as previously described with minor modification [105-107]. 
After washing cells with prewarmed culture media, cells were incubated in IMDM containing 5 
mg/ml HRP and 1% BSA for 30 min. The uptake was stopped by washing cells five times with 
ice-cold PBS containing 0.1% BSA. After the final wash, cells were scraped into 1 ml of ice-cold 
PBS and pelleted at 800 x g for 3 min at 4°C. Cell pellet was lysed in 400 μl of ice-cold PBS 
containing 0.1% Triton X-100. The lysate was assayed for horseradish peroxidase activity. The 
enzyme assay was conducted in a 96-well microplate using 1-Step™ Ultra TMB-ELISA substrate 
solution as the chromogenic substrate. The reaction was started by adding 1 μl of the lysate to 100 
μl of 1-Step™ Ultra TMB-ELISA substrate solution (Thermo Scientific, 34029). The reaction was 
conducted at room temperature for 20 min and stopped by adding 100 μl of 2 M H2SO4. Quantified 
by measuring OD425nm in a Tecan microplate reader (Tecan, Sunrise™). Protein content was 
determined by the Pierce BCA assay (Thermo, 23227) according to the manufacturer’s instructions. 
3.2.11 Immunoelectron microscopy 
Immunoelectron microscopy analysis was performed as described in the previous study [24]. 
Briefly, cells were fixed in 2% PFA in PBS, pH 7.4, for 1 h and washed with PBS. Fixed cells 
were collected by scraping and resuspended in 3% gelatin. Cells embedded in gelatin were fixed 
again with 2% PFA for 15 min. After cryoprotected with 2.3 M sucrose with PVP solution 
overnight, samples were frozen in liquid nitrogen and were trimmed into 0.5 mm cubes. The frozen 
cell blocks were sectioned by cryo-microtome (Leica EM Crion) in 70 nm sections and collected 
 46 
on 200 mesh grids. The primary antibody was diluted in 0.1 M PBS with 0.5% BSA, 0.15% glycine 
according to the established condition for immunohistochemistry. A secondary antibody labelled 
with 12 nm gold beads (Jackson ImmunoResearch) was diluted to 1:25 before use. After 
immunostaining, sections were incubated with 2.5% glutaraldehyde for 10 min and with 2% 
Neutral UA acetate for 7 min. Sections were further processed with 4% uranyl acetate and methyl 
cellulose for contrasting and drying, respectively. After drying, samples were recorded using JEOL 
JEM1011 TEM with high resolution AMT digital camera (Peabody, MA).  
3.2.12 Fractionation of proteins 
Crude extracts were prepared by homogenizing +/+ and UBR4-/- MEFs in a hypotonic solution. 
Cellular proteins were separated into cytosolic (S150) and microsomal (P150) fractions using 
differential centrifugations and solubilization [24]. Cell were harvested from 5 of 15 cm dishes by 
trypsin-EDTA solution, followed by three-time of wash with PBS. Cell pellets were washed once 
with 5-packed cell volume (pcv) of hypotonic buffer (10 mM HEPES, pH7.9; 1.5 mM MgCl2; 10 
mM KCl) supplemented with protease inhibitor cocktail (Sigma), 20 mM NaF, 10 mM sodium 
orthovanadate, and 1 mM DTT. Cells were suspended with 2-pcv of hypotonic buffer with 
supplements was added and cells were incubated for 10 min on ice. The expanded cells were 
homogenated by dounce homogenizer and a soluble fraction was collected after a centrifugation 
at 15,000 x g for 5 min. The pelleted fraction including nucleus, mitochondria, and plasma 
membranes, was solubilized with RIPA buffer (10 mM Tris-HCl, pH 7.4, 1% NP-40, 0.1% sodium 
deoxycholate, 0.1% SDS, 0.15 M NaCl, and 1 mM EDTA) to yield a soluble fraction (P15S) and 
an insoluble fraction (P15I). The soluble fraction after dounce homogenization and a centrifugation 
was further fractionated by an ultra-centrifugation at 150,000 x g for 1 h. The supernatant 
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represents a cytosol (S150) and the pelleted membranes represent microsomes including ER 
(P150). Protein concentration was quantified, using the BCA protein assay and each fraction was 
kept frozen at -80°C until a use for SDS-PAGE.  
3.2.13 EGFP-EEA1 and mRFP-RAB5 puncta analysis  
HeLa cells were transiently transfected with either 1 µg/ml of EGFP-EEA1 or mRFP-RAB5 
plasmids using Lipofectamine 3000 reagent (Invitrogen). Following the transfection, cells were 
cultured for 24 h and trypsinized for replating on coated slides. 24 h after replating, cells were 
treated with picolinic acid and fixed with 4% PFA for further experiments at the indicated times. 
After PBS washing, immunocytochemical processes were conducted as described above. 
3.2.14 Pull-down assay of UBR4 and calmodulin 
Pulldown assay was performed as previously described with minor modification [8]. HEK293 
Cells were transfected with UBR4-GFP and GUS-GFP (GUS, β-glucuronidase) plasmids using 
Lipofectamine LTX and Plus reagent (Invitrogen) and harvested 48 h after transfection. GUS-GFP 
was used as a transfection control. Cells were lysed in 1% Nonidet-P40 (NP-40), 0.15 M NaCl, 1 
mM EDTA, 10 mM Tris-HCl (pH 7.5). The lysates were incubated with anti-GFP biotin 
conjugated antibody in binding buffer A (0.1% Nonidet P-40, 10% glycerol, 0.15 M KCl, and 20 
mM HEPES, pH 7.9) and mixed with streptavidin-sepharose beads (Amersham Bioscience). The 
beads were pelleted by centrifugation at 2,400 x g for 30 s, washed three times with binding buffer 
A and resuspended in SDS-PAGE sample buffer, and heated and analyzed by immunoblotting 
with anti-calmodulin antibody.  
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3.2.15 Synthesis of biotinylation of picolinic acid 
Picolinic acid was biotin-conjugated using EZ-link pentylamine-Biotin (Thermo, 21345). 0.18 
mM picolinic acid was added to the mixture including 0.22 mM N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (EDCI.HCl), 6.2 mM hydroxybenzotriazole (HOBt), 0.54 mM 
N,N-diisopropylethylamine (DIPEA), and 2 ml DMF. After 10 min, 0.15 mM 5-
(biotinamido)pentylamine was added to the mixture with continued stirring. The reaction was 
quenched by the addition of water and then ethyl acetate was added. It was washed with saturated 
citric acid to eliminate unreacted amine derivatives followed by sequential washing with sodium 
bicarbonate to remove unreacted acid derivative and with brine. The combined organic layers were 
dried over anhydrous Na2SO4 and concentrated under vacuum. The crude residue was purified 
using silica gel column chromatography (methanol/dichloro methane = 1:9) to yield the 
biotinylated picolinic acid as white solid. The structure of the product biotinylated picolinic acid 
was confirmed with LC-MS (Figure 14). Its mass spectrum revealed a molecular ion peak at 434.32 
[M+H]+ corresponding to the molecular formula C21H31N5O3S confirms the structure of 
biotinylated picolinic acid. 
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Figure 14: Synthesis of biotinylated picolinic acid.  
(A) Schematic illustration for synthesis of biotinylated picolinic acid. (B) Verification of picolinic acid biotinylation 
using LC-MS. Synthesis was conducted by Srinivasrao Ganipisetti. 
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3.2.16 X-peptide and biotinylated picolinic acid pull-down assay 
The X-peptide and biotinylated picolinic acid pull-down assays were carried out as previously 
described with minor modification [6]. We used a set of 12-mer X-nsP4 peptides (X-
IFSTIEGRTYK–biotin) bearing N-terminal Arg (type 1), Phe (type 2), and Gly (stabilizing control) 
residues, which is known as a N-end rule substrate. For cross-linking with resin, the biotin-
conjugated picolinic acid and peptides were mixed with high capacity streptavidin agarose resin 
(Thermo, 20361) with a ratio of 0.5 mg peptide per 1 ml settled resin and incubated on rotator at 
4°C for overnight. After washing 5 times with PBS, the peptide-beads conjugates were diluted 
with PBS at 1:1 ratio. To prepare protein extracts, cells were collected by centrifugation and lysed 
by freezing and thawing at least ten times in hypotonic buffer (10 mM KCl, 1.5 mM MgCl2, and 
10 mM HEPES, pH 7.9) with a protease inhibitor mix (Sigma, P8340). After spinning down with 
centrifugation in 12,000 rpm at 4°C for 15 min, proteins were quantified using BCA protein assay 
kit (23227, Thermo). Total proteins (300 μg) diluted in 250 μl binding buffer (0.05% Tween-20, 
10% glycerol, 0.2 M KCl, and 20 mM HEPES, pH 7.9) were mixed with 50 μl peptide-bead resin 
and incubated at 4°C for overnight on a rotator. The protein-bound beads were collected by 
centrifugation at 5,000 rpm for 1 min and washed five times with binding buffer. The beads were 
resuspended in 25 μl SDS sample buffer, heated at 70°C for 10 min, and subjected to SDS-PAGE 
and immunoblotting. 
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3.2.17 Labeling of epidermal growth factor (EGF) and transferrin with fluorescence 
Labeling with EGF and transferrin were performed as previously described with minor 
modification [108]. Cells were serum-starved for 1 h and stimulated with 1 μg/ml EGF conjugated 
with Alexa Fluor 555 (Invitrogen, E35350) or 0.5 μg/ml transferrin with Alexa Fluor 488 
(Invitrogen, T13342) in DMEM-HEPES buffer containing 1% BSA on ice for 1 h and washed 
with cold PBS. The samples were incubated in pre-warmed media for indicated times, followed 
by 4% PFA fixation at the appropriate time point. After fixation, we followed the same procedures 
as we mentioned above in immunocytochemistry.  
3.2.18 EGF-biotin pulldown assay 
Labeling with EGF was performed as previously described with minor modification [108]. Cells 
were serum-starved for 1 h and stimulated with 1 μg/ml EGF conjugated with biotin (Invitrogen, 
E3477) in DMEM-HEPES buffer containing 1% BSA on ice for 1 h and washed with cold PBS. 
The samples were incubated in pre-warmed media for indicated times, followed by lysis. The 
internalized EGF-biotin was analyzed by dot blotting. For dot blot experiments, isolated EGF-
biotin samples were spotted onto a nitrocellulose membrane and incubated with the anti-biotin 
HRP conjugated secondary antibody.   
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3.2.19 Statistical analysis 
All numerical data are presented as means ± SEM or mean percentages ± SEM. Western blots 
shown are representative of three or more independent experiments. Comparisons among 
treatment groups were performed with one-way analysis of variance (ANOVA) and Tukey test or 
Dunnet’s multiple comparison as a post hoc comparison. Instances involving only two 
comparisons were evaluated with two-tailed t-test. Statistical significance was accepted if the null 
hypothesis was rejected with p < 0.05. All statistical analyses were determined using Prism 7.0a 
software (GraphPad, La Jolla, CA). 
3.3 EXPERIMENTAL RESULTS 
3.3.1 The EEA1+ early endosome is impaired in the YS and embryos lacking mouse 
UBR4.  
We have previously found that UBR4-/- mouse embryos die at E9.5-10.5 associated with vascular 
defects in the YS [24]. At this stage, embryos cannot synthesize amino acids de novo and, thus, 
obtain amino acids by breaking down endocytosed proteins in the YS (Figure 15A) [109]. These 
extracellular protein cargoes (e.g., albumins), provided by pregnant mothers, are endocytosed by 
the YS and sequestered and degraded by EEA1+ early endosomes [71, 110]. The cargoes within 
early endosomes are further degraded as early endosomes are fused with autophagosomes to 
generate amphisomes and, subsequently, by lysosomal hydrolases [109]. To determine the role of 
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UBR4 in endosomal pathways in animals, we examined the localization of UBR4 on the cross 
sections of E9.5 +/+ and UBR4-/- YSs and embryonic bodies. Immunostaining analysis showed 
that UBR4 is prominently expressed in the YS endoderm, a specialized tissue enriched in 
endosomal proteolysis (Figure 15B and C). UBR4 signals formed cytosolic puncta that colocalized 
with EEA1+ early endosomes (Figure 15C). UBR4+EEA1+ punctate signals were more prominent 
in the YS endoderm as compared with the YS mesoderm (Figure 15C). Within the YS endoderm, 
both UBR4 and EEA1 signals were enriched in the cytosol’s apical side and near lysosomal 
vacuoles. A significant portion of UBR4+EEA1+ puncta distributed along the axis from the plasma 
membrane to apical vacuoles (Figure 15C). Moreover, the EEA1 staining was significantly 
reduced in the YS of UBR4-/- at E9.5 (Figure 15D).   
To further validate these results in embryonic tissues, we immunostained EEA1 on the cross 
sections of +/+ and UBR4-/- mouse embryonic bodies at E9.5. Whereas EEA1 was detected as 
punctate structures in various tissues of +/+ embryos, such signals were markedly down-regulated 
and disorganized in various tissues of UBR4-/- embryos, including the neural tube and paraximal 
mesoderm of neuronal tissues (Figure 15E). These results collectively suggest that UBR4 plays a 
role in the biogenesis of early endosomes in YS and various tissues of mouse embryos. 
 
 
 
 
 
 
 
 54 
Figure 15: UBR4 regulates endosomal pathways in mouse YS and embryos.  
(A) Schematic illustration of the structure and function of the visceral YS of murine embryos. The visceral YS of 
mouse embryos at E9.5 is composed of two developmentally distinct layers, visceral endoderm (Ed) and mesoderm 
(Md). AP, autophagosome; AV, apical vacuole; EE, early endosome; LE, late endosome; MVB, multivesicular body; 
PP; phagophore; TJ, tight junction. (B) Immunostaining analysis of UBR4 on cross sections of +/+ and UBR4-/- YS 
at E9.5. The dotted line represents two distinct layers of the visceral YS (scale bar = 10 μm). Enlarged views show 
the area indicated by rectangles (scale bar = 1 μm). Ed, endodermal layer; Md, mesodermal layer. (C) Immunostaining 
analysis of UBR4 and EEA1 on the cross sections of +/+ YS at E9.5 (scale bar = 10 μm). Enlarged views show the 
areas indicated by rectangles (scale bar = 1 μm). Ed, endodermal layer; Md, mesodermal layer. (D) Immunostaining 
analysis of EEA1 on the cross sections of +/+ and UBR4-/- YS at E9.5. UBR4 is required for the formation of EEA1+ 
early endosomes in YS (scale bar = 10 μm). (E) Immunostaining of EEA1 on +/+ and UBR4-/- embryonic tissues, 
including neural tube and paraximal mesoderm (scale bar = 20 μm).  
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3.3.2 UBR4 is dispensible for the internalization of extracellular ligands.  
To characterize the rle of UBR4 in endosomal pathways, we compared the internalization of 
extracellular ligands in +/+ and UBR4-/- MEFs by measuring the uptake of horseradish peroxidase 
(HRP), a fluid-phase marker for bulk endocytosis [105-107]. Quantitation analyses showed that 
UBR4-/- MEFs contained a comparable amount of internalized HRP relative to +/+ MEFs (Figure 
16A). As an alternative way to monitor the endocytosis and visualize early endosomes containing 
endocytosed external cargoes, we treated FITC conjugated-TAT peptide, which is derived from 
the transactivator of transcription (TAT) of human immunodeficiency virus (HIV). TAT peptide 
binds to various cellular receptors and internalized through endosomal pathway. Upon 
internalization, TAT crosses the endosomal membrane to enter the cytosol [104, 111, 112]. 
Fluorescence assay showed that TAT-FITC was endocytosed and made punctate structures in +/+ 
MEFs and both number and size were gradually increased in timely manner (2 fold and 1.5 fold 
of +/+ 10 min, respectively; Figure 16B-D). Contrary to +/+ MEFs, the size of TAT+ endosomal 
vesicles in UBR4-/- MEFs had remained arrested as 50% of +/+ at 20 min (*** p < 0.001; Figure 
16B and C). Even though UBR4-/- MEF had smaller TAT+ endosomes, it contained an excessive 
number of TAT+ puncta, compared to that of +/+ MEFs (6 fold of +/+ 20 min, *** p < 0.001; 
Figure 16D). The result suggests that comparable amount of TAT was endocytosed in UBR4-/- 
MEFs. Collectively, these results show that UBR4 is largely dispensible for the internalization of 
extracellular ligands but plays a role in early endosomal maturation.   
 56 
Figure 16: UBR4 is dispensible for the internalization of external cargoes.  
(A) HRP uptake analysis in +/+ and UBR4-/- MEF cells. Cells were treated with prewarmed serum-free IMDM 
containing 5 mg/ml HRP and 1% BSA. Normalized OD425nm measurements by the protein amount determined by the 
BCA assay. n.s., not significant. Representative of three biological replicates. Statistical significance was determined 
using two-tailed t-test. (B) Immunofluorescence analysis of +/+ and UBR4-/- MEFs treated with the endosomal 
substrate FITC conjugated TAT (sacle bar = 10 μm) during the indicated times. (C and D) Quantification of B, 
representing the diameter and number of TAT-FITC+ vesicles, respectively. ***p < 0.001 compared to +/+ MEF cells 
(n = 4-8 in each group). Data are presented as mean percentage ± SEM of +/+ at 10 min. Statistical significance was 
determined using one-way analysis of variance (ANOVA) and Sidak test as a post hoc comparison. 
3.3.3 UBR4 modulates the biogenesis of early endosomes.  
To determine the function of UBR4 in endosomal proteolysis and endocytosis, we further 
examined the biogenesis of early endosomes in +/+ and UBR4-/- MEFs. Immunostaining analysis 
visualized EEA1+ puncta with diameters of 200-500 nm throughout the cytosol of +/+ MEFs 
(Figure 17A and B). In contrast, UBR4 deficiency UBR4-/- MEFs contained a significantly reduced 
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number of large early endosomes (Figure 17A). We systematically clarified the descriptions of 
endosomes based on other studies as well as our own additional quantitation analyses (Figure 17C). 
Early endosome is heterogenous in terms of size and morphology because it constitutes of thin 
tubular extensions (∼60 nm diameter) and large vesicles (∼400 nm diameter) [113]. Thus, we 
separated three categories and defined a large vesicle that is greater than 500 nm as a matured 
endosome (Figure 17C). Quantitative analysis showed that UBR4 deficiency decreased the number  
Figure 17: Down-regulated EEA1+ endosomal biogenesis by UBR4 deficiency.  
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(A) Immunostaining of EEA1 on +/+ and UBR4-/- MEFs. White dotted lines delineate the cell boundary (scale bar = 
15 μm). Enlarged views shows arears indicated by yellow rectangles (scale bar = 2 μm). (B) Quantification of A, 
showing the mean areas of EEA1+ puncta (μm2). ***p < 0.0001 compared to +/+ MEF cells (n = 3,057 and n = 3,455 
for +/+ and UBR4-/- MEFs, respectively). Data are presented as mean ± SEM. Statistical significance was determined 
using two-tailed t-test. (C) Classification of EEA1+ puncta within three divisions depends on their diameters from B. 
(D) Immunostaining of EEA1 on siCtrl- and siUBR4-treated +/+ and UBR4-/- MEFs. The number of EEA1+ EE puncta 
was significantly down-regulated in UBR4 knockdown as well as knockout MEFs (scale bar = 15 μm). Enlarged views 
show the areas indicated by yellow rectangles. White dotted lines delineate the cell boundary (scale bar = 1 μm). (E) 
Quantification of D, showing the mean intensity of EEA1+ puncta (% of siCtrl). n.s., not significant; ***p < 0.0001 
compared to siCtrl-treated +/+ MEF cells (n = 4 for each group). Data are presented as mean percentage ± SEM of 
siCtrl-treated +/+ MEF cells. Statistical significance was determined using one-way ANOVA and Tukey test as a post 
hoc comparison. (F) Immunoblotting of EEA1 and RAB5, and UBR4 in +/+ and UBR4-/- MEFs. β-Actin was probed 
for loading control. (G and H) Quantification of F, showing the ratio of EEA1 and RAB5 amounts relative to β-actin 
amounts, respectively. n.s., not significant. Representative of three biological replicates. Statistical significance was 
determined using two-tailed t-test. Panels F-H were conducted by Yoon Jee Lee. 
of matured EEA1+ endosomes to 38% relative to +/+ MEF cell (Figure 17C). Such a down- 
regulation of EEA1+ early endosomes was readily reproduced by transiently depleting UBR4 using 
siRNA (Figure 17D and E). Despite the down-regulation of EEA1+ puncta maturation, UBR4-/- 
MEFs contained a normal level of EEA1 as determined by immunoblotting analyses (Figure 17F-
H). 
Moreover, the overexpression of EEA1 in UBR4-/- MEFs did not restore the defect, 
suggesting that the failure to form EEA1+ endosomes is not caused by EEA1 insufficiency (Figure 
18A). To further characterize the role of UBR4 in early endosomal formation, we performed 
immunostaining analyses using RAB5 which is associated with endocytic vesicles and early 
endosomes and replaced with RAB7 in late endosomes [114]. Consistent with the results with 
EEA1, UBR4-/- MEFs were notably impaired in the formation of RAB5+ early endosomes (Figure 
18B). 
Next, we asked whether exogenous expression of UBR4 would rescue the reduced size of 
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EEA1+ and RAB5+ early endosomes in UBR4-/- MEFs. The overexpression of UBR4-GFP restored 
the ability of UBR4-/- MEFs to form EEA1+ puncta (Figure 18C and D). Similar to the restored 
EEA1 puncta formation, transiently overexpressed UBR4-GFP in UBR4-/- MEFs readily rescued 
the biogenesis of RAB5+ early endosomes (Figure 18E and F). Collectively, these data suggest  
that UBR4-loss impairs the biogenesis of early endosomes.  
We have previous identified a set of N-recognins (UBR1, UBR2, UBR4, and UBR5) 
characterized by the UBR box [8]. Amongst these, UBR1 and UBR2 have been implicated in the 
UPS-linked N-end rule pathway [10, 98]. To determine whether the aforesaid role in endosomal 
pathways is confined to UBR4 amongst N-recognins, we performed immunostaining analyses. 
UBR1-/-UBR2-/-  MEFs normally contained EEA1+ as well as RAB5+ early endosomes as compared 
with +/+ MEFs (Figure 19). These results suggest that UBR4 may be a designated N-recognin that 
controls endosomal proteolysis. 
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Figure 18: UBR4 is required for the biogenesis of the EEs. 
 61 
(A) +/+ and UBR4-/- MEFs were transiently transfected with EGFP-EEA1 for 48 h and fixed with 4% PFA for further 
analysis. White and yellow dotted lines delineate the cell boundary (scale bar = 10 μm). Enlarged views show the 
areas indicated by yellow rectangles (scale bar = 1 μm). (B) Immunostaining of RAB5 on +/+ and UBR4-/- MEFs. The 
number of RAB5+ early endosomal puncta was notably decreased in UBR4-/- MEFs (scale bar = 10 μm). Enlarged 
views show the area indicated by yellow rectangles. White dotted lines delineate the cell boundary (scale bar = 1.5 
μm). (C) Immunostaining analysis of EEA1 on +/+ and UBR4−/− MEFs transiently transfected with plasmids encoding 
EGFP or UBR4-GFP (1.0 μg/ml). After 24 h from transfection, cells were fixed with 4% PFA for further process 
(scale bar = 5 μm). Transfected cells were indicated by an asterisk (*). (D) Quantification of C, showing the relative 
mean area of EEA1+ puncta (% of +/+). The formation of EEA1+ puncta was rescued by transient supplement of UBR4 
for 24 h. ***p < 0.001 compared to +/+ MEF cell (n = 15-35 in each group). Data are presented as mean percentage 
± SEM of +/+ MEF cell. Statistical significance was determined using one-way ANOVA and Tukey test as a post hoc 
comparison. (E) Immunostaining analysis of RAB5 on +/+ and UBR4−/− MEFs transiently transfected with plasmids 
encoding EGFP or UBR4-GFP (1.0 μg/ml). At 24 h after transfection, cells were fixed with 4% PFA for further process 
(scale bar = 5 μm). Transfected cells were indicated by an asterisk (*). (F) Quantification of E, showing the relative 
mean area of RAB5+ puncta (% of +/+). The formation of RAB5+ puncta was rescued by transient supplement of 
UBR4 for 24 h. ***p < 0.001 compared to +/+ MEF cells and **p = 0.008 compared to EGFP-transfected UBR4−/−/ 
MEF cells (n = 16-25 in each group). Data are presented as mean percentage ± SEM of +/+ MEF cells. Statistical 
significance was determined using one-way ANOVA and Tukey test as a post hoc comparison.  
Figure 19: The normal formation of EEA1+ and RAB5+ early endosomes in UBR1-/-UBR2-/- MEF cell.  
Immunostaining of EEA1 and RAB5 on +/+ and UBR1-/-UBR2-/- MEFs. There were no significant differences on the 
intensities of EEA1 and RAB5 in UBR1-/-UBR2-/- MEF as compared with those of +/+ MEF (scale bar = 10 μm). 
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3.3.4 UBR4 is associated with the EEA1+ early endosome through its interaction with 
Ca2+-calmodulin.  
We examined the intracellular localization of UBR4 in comparison with endosomal markers. 
Immunostaining analysis using super-resolution confocal microscope (N-SIM) with a resolution 
of 100 nm showed that UBR4 stainings formed punctate structures with sizes of 150 x 300 nm 
(Figure 20A). Some UBR4+ signals were juxtaposed to RAB5+ endosomes in a way that tethers  
Figure 20: UBR4 is recruited to endosomal vesicles. 
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(A) Representative images captured by an N-SIM super-resolution microscope showing immunostaining for the 
subcellular localization of UBR4 and RAB5 in HeLa cells. White dotted line delineates the cell boundary (scale bar = 
1.5 μm). Enlarged views show the areas ‘a’ and ‘b’ indicated by yellow rectangles (scale bar = 400 nm). (B) A 
magnified micrograph corresponding to the box within the region ‘a’, which is indicated by an asterisk (*). (C) 
Schematic illustration of UBR4+RAB5+ punctate structure corresponding to B. UBR4 is located between RAB5+ 
primary endocytic vesicles. (D) Transmission electron microscopy (TEM) using a 12 nm immunogold labelled 
secondary antibody against V5 in HEK293 stably expressing UBR4V5. White line delineates the plasma membrane, 
and yellow dotted line represents the UBR4V5+ vesicular structure. Red dotted line shows two distinct endocytic 
vesicles (scale bar = 100 nm). (E) Schematic diagram of cell fraction assay. (F) Cell fraction assays using +/+ and 
UBR4-/- MEFs retrieved UBR4 mainly from plasma membrane-associated and cytosolic vesicular fractions. Cellular 
proteins were separated into cytosolic and microsomal fractions using differential centrifugations and solubilization. 
Panel F was conducted by Takafumi Tasaki. 
two RAB5+ endosomes (Figure 20B and C). As an alternative method to determine the localization 
of UBR4 on endosomal vesicles, we performed immunoelectron microscopy using UBR4V5 
stably expressing HEK293 cells. Immunogold labeled UBR4 molecules also were attached with 
two endosomal vesicles (Figure 20D). Given that UBR4 is partially associated with two endosomal 
vesicles, UBR4 can be mediate the process of early endosomal maturation. To further support this 
speculation, we separated +/+ and UBR4-/- MEFs into the soluble cytosol (S150), cells membranes 
(P15S), and cytosolic vesicles (P150) using differential centrifugation (Figure 20E). UBR4 was 
mainly retrieved from the soluble cytosol as well as cytosolic vesicles. These results suggest that 
some part of UBR4 is associated with endosomal membranes (Figure 20F).  
Next, we searched for the proteins that link UBR4 to endocytic vesicles. During the 
maturation of endocytic vesicles, Ca2+-bound calmodulin (CaM) is associated with the endocytic 
vesicles and induces the conformational change of EEA1, facilitating the homotypic fusion of two 
primary endocytic vesicles into a matured early endosome [115, 116]. To date, little is known 
about how CaM activity is regulated during endosome biogenesis. Given the association of UBR4 
with endosomes, we paid attention to a previous study in which UBR4 was identified as a CaM-
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binding protein, although its meaning remains unknown [50]. To validate this finding, we 
performed in vitro interaction assays using UBR4-GFP stably expressed in HEK293 cells. The 
results showed that UBR4 indeed bound calmodulin and that their interaction was disrupted when 
Ca2+ was chelated (Figure 21A). We therefore examined the colocalization of UBR4 and CaM on 
Figure 21: UBR4 is recruited to EEA1+ EEs through interaction with Ca2+-bound calmodulin. 
(A) Calcium-dependent binding of calmodulin (CaM) to UBR4. HEK293 cells were transiently transfected with 
UBR4-GFP and GUS-GFP plasmids and lysed for the pull-down assay. Western blot analysis was used to determine 
the presence of calmodulin in the complexes. GUS-GFP plasmid was used as a transfection control.(B) 
Immunofluorescence assay of UBR4 in comparison with calmodulin and EEA1. HeLa cells transiently expressing 
calmodulin-EGFP and EEA1-TagRFP were treated with the CaM inhibitor W7 for 15 min (scale bar = 3 μm). Enlarged 
views show the areas indicated by yellow rectangles (scale bar = 1 μm). (C) Quantification of B, showing the relative 
colocalization frequency between UBR4+- and EEA1+-puncta (% of control). **p = 0.0013 compared to DMSO-
treated HeLa cells (n = 4 for control and n = 5 for W7-treated group). Data are presented as mean percentage ± SEM 
of DMSO-treated HeLa cells. Statistical significance was determined using two-tailed t-test. Panel A was conducted 
by Takafumi Tasaki. 
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the early endosomes in HeLa cells transiently expressing CaM-EGFP and EEA1-TagRFP. Co-
immunostaining analyses showed that virtually most of CaM+EEA1+ puncta were also positive for 
UBR4 (Figure 21B). When cells were treated with W7, a CaM inhibitor, for 15 min, UBR4 as well 
as CaM were dissociated from EEA1+ puncta (Figure 21B and C). These results suggest that UBR4 
is associated with early endosomes in part through its interaction with Ca2+-CaM. 
3.3.5 UBR4 regulates endosomal trafficking.  
To determine the role of UBR4 in endosomal trafficking, we treated +/+ and UBR4-/- MEFs with 
Alexa Fluor 555-conjugated EGF (epidermal growth factor) and monitored the intracellular 
trafficking of the EGF-EGFR complex using co-immunofluorescence analyses. By 10 min, 
EGF+EGFR+ endosomes in +/+ MEFs were distributed across the cytosol, from the plasma 
membrane to the peri-nuclear region (Figure 22B). By 20 min, most EGF+EGFR+ endosomes 
migrated to the peri-nuclear region, indicative of endosomal trafficking. By sharp contrast, UBR4-
/- MEFs contained a markedly decreased number of EGF+EGFR+ signals which appeared to be 
arrested at endocytic vesicles based on their morphology and sizes (Figure 22B). As an alternative 
assay, we quantified the intracellular localization of EGF+EGFR+ endosomes along the plasma 
membrane-nucleus axis at 10 min and 20 min (Figure 22C). Whereas most of the EGF+EGFR+ 
endosomes in +/+ MEFs migrated to the peri-nuclear region, those in UBR4-/- MEFs stayed near 
the plasma membrane (Figure 22C-E). Despite impaired endosomal trafficking, UBR4-/- MEFs 
retained the cytoskeleton structures as determined by immunostaining analyses of actin filaments 
and microtubules (Figure 23). These results suggest that UBR4 is required for endosomal 
trafficking of ligand-receptor complexes internalized from the plasma membrane.  
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Figure 22: UBR4 loss impairs the trafficking of endocytosed protein cargoes.  
(A) Schematic diagram of fluorescence-labeled EGF+ vesicles trafficking. X and Y represent peripheral and 
perinuclear cellular regions, respectively. (B) Immunostaining of Alexa Fluor 555-labelled EGF and EGFR on +/+ 
and UBR4-/- MEFs. Cells were incubated with serum-free medium for 1 h, followed by 1 μg/ml EGF treatment during 
the indicated time. White dotted line delineates cell boundary (scale bar = 10 μm). (C) Schematic diagram of 
quantitative analysis of internalized EGF-EGFR complex. Upper panel shows a confocal image of Alexa Fluor 555-
labelled EGF and EGFR on +/+ MEF. Each of the confocal image was manually segmented based on distance from 
the plasma membrane (down panel). Each band has a width of 1 μm. (D)  Segmented band-based quantitative analysis 
of subcellular EGF-EGFR complex distribution. Plot showing the subcellular distribution of EGF-EGFR complex 
from the plasma membrane during EGF treatment for 10 min. *p = 0.0157 for 1 μm, ***p < 0.0001 for 2 μm, and  
***p = 0.0096 for < 10 μm compared to +/+ MEF cells, respectively (n = 3 in +/+ and 5 in UBR4-/-). Data are presented 
as percentage ± SEM. Statistical significance was determined using two-way ANOVA and Sidak’s test as a post hoc 
comparison. (E) Plot showing the subcellular distribution of EGF-EGFR complex from the plasma membrane during 
EGF treatment for 20 min. *p = 0.0221 for 2 μm and ***p = 0.0005 for < 10 μm compared to +/+ MEF cells, 
respectively (n = 7 in +/+ and 5 in UBR4-/-). Data are presented as percentage ± SEM. Statistical significance was 
determined using two-way ANOVA and Sidak test as a post hoc comparison.  
 67 
Figure 23: UBR4 depletion does not destabilize cytoskeletal filaments and microtubules.  
(A) Immunostaining analysis of actin filaments and microtubules on +/+ and UBR4-/- MEFs. All images are displayed 
as z-stack maximum projections (scale bar = 10 μm). (B) Immunostaining analysis of actin filaments and microtubules 
on +/+ MEF cells. Cells were treated with latrunculin A and nocodazole for 6 h as actin- and microtubule-destabilizing 
agents, respectively. Cells were also treated with picolinic acid for 24 h and W7 for 30 min, respectively (scale bar = 
10 µm). All images are displayed as z-stack maximum projections. 
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3.3.6 Defective endosomal proteolysis in UBR4-deficient MEFs.  
One important function of endosomes is the turnover of plasma membrane-associated and 
extracellular proteins. To characterize the role of UBR4 in endosomal proteolysis, we treated +/+ 
and UBR4-/- MEFs with an endocytic cargo DQ-BSA, which generates fluorescence upon 
endosomal proteolysis [117]. Fluorescence analysis showed that in +/+ MEFs, DQ-BSA was 
normally endocytosed and degraded by endosomal hydrolases (Figure 24A and B). In sharp 
contrast, the degradation of DQ-BSA was markedly impaired in UBR4-/- MEFs as compared with 
+/+ cells (Figure 24A and B). Such an inhibition of DQ-BSA degradation was reproduced when 
UBR4 was transiently silenced using siRNA (Figure 24A and B). These results suggest that the 
misregulated biogenesis of early endosome reduces degradation of endosomal protein cargoes, 
implicating the significance of UBR4 in endosomal proteolysis. 
Figure 24: UBR4 is required for proteolysis of endosomal cargoes. 
(A) Immunofluorescence analysis of +/+ and UBR4-/- MEFs treated with the model substrate DQ-BSA of endosomal 
proteolysis for 40 min (scale bar = 10 μm). +/+ MEFs were transiently transfected with negative control siRNA (siCtrl) 
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and UBR4 siRNA (siUBR4) for 48 h. UBR4 loss disrupts endosomal proteolysis. (B) Quantification of A, representing 
the relative cellular area of DQ-BSA+ puncta. * p = 0.0375 and ***p < 0.0001 compared to siCtrl-treated +/+ MEF 
cells (n = 30 in each group). Data are presented as mean percentage ± SEM of siCtrl-treated +/+ MEF cells. Statistical 
significance was determined using one-way analysis of variance (ANOVA) and Tukey test as a post hoc comparison. 
3.3.7 Development of a UBR4 ligand and its use to reversibly inhibit endosomal processes.  
To develop a pharmaceutical reagent targeting UBR4, we screeened 11,679 drugs through 
DrugBank 5.0 database, a bioinformatics and cheminformatics resource containing drugs and their 
(putative) targets [118]. This screening identified picolinic acid as a putative ligand to the zinc 
finger of UBR4. Picolinic acid is a pyridine carboxylate metabolite of the type-2 amino acid 
tryptophan of the N-end rule pathway [118] (Figure 25A). To determine whether picolinic acid 
binds UBR4, we assessed the ability of picolinic acid to pulldown full-length 570 kDa UBR4 from 
HEK293 cell extracts. In comparison, we performed analogous assay using biotin-conjugated 11-
mer peptides bearing Nt-Arg (type 1), Nt-Phe (type 2), and Nt-Gly (stabilizing). UBR4 was pulled 
down by picolinic acid, Arg-peptide and Phe-peptide but not by Gly-peptide (Figure 25B and C). 
Although we do not exclude the possibility of off-target effects, these results suggest that picolinic 
acid binds UBR4. Next, to assess the efficacy of picolinic acid, we treated this compound on HeLa 
cells transiently expressing EEA1-EGFP and RAB5-mRFP. This treatment markedly down-
regulated the formation of EEA1+ as well as RAB5+ early endosomes (Figure 25D and E). The 
inhibitory effect of picolinic acid on endosomal maturation was reversible (Figure 25F-I). 
Specifically, although transfected EGFP signals was not affected by picolinic acid (Figure 25F), 
EEA1+ and RAB5+ puncta became smaller in a time-dependent manner and were readily restored  
when picolinic acid was removed (Figure 25G-I). These results provide a means to modulate 
endosomal processes by targeting UBR4. 
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Figure 25:  Development of a UBR4 inhibitor and its use to inhibit early endosomal biogenesis. 
(A) The chemical structures of picolinic acid. (B) The chemical structure of biotinylated picolinic acid. (C) The 
pulldown assay of UBR4 using biotin-conjugated picolinic acid (PA) which is immobilized on streptavidin-beads. 
Also shown is the X-peptide pulldown assay in which UBR4 was captured using biotin-conjugated 11-mer X-nsP4 
peptides (X= Arg, Phe, or Gly) which are immobilized on streptavidin-beads. (D and E) Fluorescence analysis of 
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EGFP-EEA1 and mRFP-RAB5. Picolinic acid perturbed the formation of early endosomes in HeLa. HeLa cells were 
transiently transfected with EGFP-EEA1 and mRFP-RAB5 for 48 h, respectively, followed by the treatment of 3 mM 
picolinic acid for 24 h. White dotted line delineates cell boundary (scale bar = 10 μm). (F) HeLa cells were transfected 
with EGFP and measured its intensity during picolinic acid treatment and after the washout. Control assay for G and 
H. (G and H) The inhibitory effects of picolinic acid on endosomal biogenesis was reversible. After PA treatment, we 
measured the average puncta sizes of transiently transfected EGFP-EEA1+ and mRFP-RAB5+ before and after PBS 
washing in a timely manner. *p < 0.05, **p < 0.001, ***p < 0.0001 (n = 25 for EEA1 and n = 10 for RAB5). Data 
are presented as mean percentage ± SEM of untreated control. Statistical significance was determined using one-way 
ANOVA and Dunnet’s multiple comparison test as a post hoc comparison. (I) PA reversably inhibits the maturation 
of endogenous RAB5+ endosomes in HeLa cells (n = 18 in each group). Shown are the time-course measurement of 
relative areas of endogenous RAB5+ puncta. Note that HeLa cells normally generate RAB5+ endosomes after picolinic 
acid is washed out. **p < 0.001, ***p < 0.0001. Data are presented as mean percentage ± SEM of untreated control. 
Statistical significance was determined using one-way ANOVA and Dunnet’s multiple comparison test as a post hoc 
comparison. Panel C was conducted by Suran Mun.  
To determine the function of picolinic acid in endosomal trafficking, we treated DMSO 
and picolinic acid in HeLa cells with Alexa Fluor 555-conjugated EGF and monitored the 
intracellular trafficking of the EGF+EGFR+ complex using co-immunofluorescence assay. By 10 
min, most EGF+EGFR+ endosomes migrated from the plasma membrane to the peri-nuclear region 
in control group (Figure 26A). However, picolinic acid arrested the migration of EGF+EGFR+ 
complex. As alternative assay, we monitored the intracellular trafficking of Alexa Fluor 488-
conjugated transferrin. Fluorescence analysis showed that trafficking of transferrin was also 
similarly impaired by picolinic acid (Figure 26B). These results suggest that picolinic acid inhibits 
endosomal processes such as early endosomal maturation and trafficking of ligand-receptor 
complexes internalized from the plasma membrane. 
Next, we tested whether picolinic acid treatment effects on the protein level of UBR4. 
Immunoblotting analyses showed that the treatment of picolinic acid did not change the total 
cellular level of UBR4 (Figure 26C and D). Even though the inhibited endosomal maturation and 
trafficking by picolinic acid, the decreases are not due to the reduction of UBR4 level. 
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Figure 26: Picolinic acid impairs endosomal trafficking.  
(A) Immunostaining of Alexa Fluor 555-labelled EGF and EGFR on HeLa cells. Cells were incubated with starvation 
medium for 1 h, followed by 1 μg/ml EGF treatment for 10 min. White dotted line delineates cell boundary. (B) 
Fluorescence analysis of Alexa Fluor 488-labelled Transferrin on HeLa cells. Cells were incubated with starvation 
medium for 1 h, followed by 500 ng/ml transferrin treatment for 40 min. Picolinic acid that binds to UBR box of 
UBR4 hampers endosomal trafficking. White dotted line delineates cell boundary. (C) Immunoblotting of UBR4 in 
DMSO- and picolinic acid-treated HeLa cells. β-Actin was probed for loading control. (D) Quantification of C, 
showing the ratio of UBR4 amounts relative to β-actin amounts. n.s., not significant. Representative of three biological 
replicates. Statistical significance was determined using two-tailed t-test. Panels C and D were conducted by Yoon 
Jee Lee. 
3.4 DISCUSSION AND CONCLUSION 
We have previously identified two classes of N-recognins that can recognize the Nt-Arg residues 
of arginylated proteins using the UBR box (UBR1, UBR1, UBR4, and UBR5) or the ZZ domain 
(p62) [8, 20]. Studies by us and others have shown that UBR1 and UBR2 mediate the 
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ubiquitination of short-lived regulators carrying N-degrons as well as soluble misfolded proteins, 
leading to proteasomal degradation into short-peptides [8, 15, 23, 119]. More recently, we have 
shown that the autophagic receptor p62 binds the Nt-Arg of arginylated ER-derived proteins and 
mediates their lysosomal degradation along with misfolded proteins [20]. Compared with other N-
recognins, little is known about UBR4 and UBR5. In this study, we characterized the functions 
and mechanisms of UBR4. We show that UBR4 is associated with the endocytic vesicles in part 
through the binding to calmodulin (Figure 21B and 27A). Functionally, UBR4 is not critical for 
endocytosis, i.e., the internalization of extracellular materials such as HRP and TAT-FITC (Figure 
16). However, the majority of EEA1+ and RAB5+ early endosome is arrested in terms of size, 
possibly during homotypic fusion with each other (Figure 27B). Overall, our results indicate that 
UBR4 is required for the biosynthesis of early endosomes (Figure 27B). This conclusion is 
supported by several lines of evidence: (1) UBR4-/- MEFs contained a significantly reduced number 
of matured EEA1+ and RAB5+ early endosomes (Figure 17A-E) (2) the treatment of an UBR4 
inhibitor markedly down-regulated the formation of EEA1+ as well as RAB5+ early endosomes 
(Figure 25D-I), and (3) UBR4 is required for ligand-mediated endosomal trafficking from the 
plasma membrane (Figure 22D and E). Additionally, these disrupted endosomal maturation and 
trafficking observed in UBR4 deficiency MEF cells were not caused by destabilization of actin 
filaments and microtubules (Figure 23A). Either of picolinic acid and W7 also did not damage 
these cytoskeletal components (Figure 23B).  
Given that UBR4 is an N-recognin, it is tantalizing to speculate that the function of UBR4 
may be modulated by the Nt-Arg residues of arginylated proteins on early endosomal membranes.  
The majority of cell surface proteins and various extracellular materials are endocytosed and 
degraded by endosomal hydrolases in the early endosomes, late endosomes, MVBs, and amphi- 
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Figure 27: Schematic diagrams showing the process of endosomal maturation.  
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(A) A model illustrating the function of UBR4 in the endosomal fusion. Ca2+-bound CaM is associated with the 
endocytic vesicles and induces the conformational change of EEA1, facilitating the homotypic fusion of two endocytic 
vesicles into an early endosome. Our results suggest that UBR4 is recruited to maturing endosomes through the 
interaction with Ca2+-bound CaM. C2H2-ZF, Cys2-His2 zinc finger; CaM, calmodulin; FYVE-ZF, FYVE zinc finger; 
IQ, IQ calmodulin-binding motif; PI3P, phosphatidylinositol 3-phosphate; R5BD, RAB5-binding domain. (B) A 
diagram showing that two endocytic vesicles are fused with each other to form a single early endosoome. This process 
is impaired in UBR4-deficient cells, resulting in the accumulation of premature, abnormal endosomes. 
somes [71]. Several isolated studies suggest that the overall amounts of cargoes that are digested 
by endosomal hydrolases may match or even exceed those by lysosomal hydrolases in normal 
conditions [71, 73-76, 81, 82]. Despite the importance of the endosomal proteolytic system, little 
attention has been paid to its functions and mechanisms, for example, in the turnover of cell surface 
proteins. In principle, internalized cell surface proteins carried in the endocytic vesicles are 
recycled back to the plasma membrane or move forward to the degradative endosomal pathway. 
Although the relative portion and rate depend on cell types and physiological states, it is estimated 
that approximately 50% of the plasma membrane-associated proteins and 5-30% of cellular 
volumes are be internalized in every hour [73, 74]. In this study, we show that UBR4 plays a role 
in endosomal proteolytic flux. This conclusion is supported by the findings that (1) UBR4 marks 
and is required for endosomal proteolysis in the YS of mouse embryos (Figure 15), (2) the 
degradation of the model substrate DQ-BSA is markedly impaired in UBR4-/- MEFs as compared 
with +/+ cells (Figure 24A and B), and (3) UBR4 is required for the biogenesis of early endosomes 
(Figure 17). 
Our earlier work has shown that UBR4 knockout mice die at E9.5-E10.5 with vascular 
defects in the visceral YS [24]. Vascular development in UBR4-lacking YS was arrested during 
angiogenic remodeling of primary capillary plexus. To date, the mechanisms underlying the YS 
null phenotypes remain unknown. In this study, we show that UBR4 is prominently expressed in 
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the YS endoderm, a specialized tissue enriched in endosomal proteolysis (Figure 15B and C). In 
the YS, UBR4 marks EEA1+ early endosomes that carry internalized extracellular proteins 
provided by the mother. The cargoes are partially degraded within early endosomes and 
amphisomes and eventually converted to amino acids [26]. Notably, our immunostaining analyses 
on the sections of embryonic tissues show that EEA1+ early endosomes are markedly 
downregulated in the YS of UBR4-/- embryos (Figure 15D). Given that the resulting amino acids 
are the major source for protein translation during embryogenesis, defective endosomal proteolysis 
in the YS may contribute to developmental abnormalities and arrest. 
 
  
 77 
 
4.0  THE ROLE OF UBR4 IN NEUROGENESIS AND HOMEOSTASIS OF CELL 
SURFACE PROTEINS 
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recognin UBR4 of the N-end rule pathway is required for  neurogenesis and homeostasis of cell 
surface proteins. PLOS ONE. 2018. Under review.] 
  
 78 
 
4.1 RESEARCH BACKGROUND 
During the development of the nervous system, cell-cell adhesion regulates the differentiation, 
proliferation, and migration of neural stem/progenitor cells [120, 121]. Cell adhesion is mediated 
by membrane-associated proteins such as cadherins, by which cells bind the extracellular matrix 
or interact with other cells. Of classical cadherins, neural or N-cadherin (Cadherin-2), enriched in 
the neural system, is a component of adherens junction, in which it interacts with delta-catenin 
(p120), beta-catenin, and gamma-catenin [121, 122]. N-cadherin is also broadly expressed in non-
neuronal tissues such as the cardiac system [121, 123]. Mice lacking N-cadherin exhibit embryonic 
lethality at E10 due to impaired cell adhesion in the primitive heart and YS [121, 123]. Similar 
developmental defects in cell adhesion are observed in mice lacking other adhesion proteins that 
interact with N-cadherin [121].  
We have previously constructed UBR4-knockout mice in which a UBR box-containing 
region, spanning exons 36 through 42, was replaced with IRES (internal ribosome entry site)-
translated tau-lacZ [24]. The mutant mice die during embryogenesis from E9.5 through E10.5. 
UBR4-deficient mouse embryos exhibit vascular defects in the yolk sac (YS) [24, 26]. The 
development of blood vessels in the UBR4-/- YS advances via vasculogenesis but is arrested during 
angiogenic remodeling of primary capillary plexus [24]. In the YS, UBR4 marks endoderm-
originated, autophagy-specialized cells that support angiogenic remodeling of mesoderm-derived 
vascular cells and supply autophagy-produced amino acids during early embryogenesis [24, 26]. 
In cultured cells, UBR4 is a substrate of autophagy, and UBR4 loss results in the induction of 
autophagy and its flux, implicating UBR4 in autophagy modulation [24].  
 79 
In this chapter, we further characterized the null phenotypes of UBR4-deficient mouse 
embryos. Our results show that UBR4-/- embryos develop multiple developmental defects 
including neurogenesis. Various types of cells in UBR4-deficient embryos lose directionality and 
are morphologically abnormal, which is at least in part attributed to the impairment in cell adhesion. 
UBR4-loss induces the depletion of cell surface proteins associated with the inability to generate 
MVBs. Our results reveal an essential role of UBR4 in non-proteolytic processes such as the 
homeostasis of cell surface proteins and, thus, cell adhesion and integrity. 
4.2 MATERIALS AND METHODS 
4.2.1 Chemicals and antibodies 
Rabbit polyclonal anti-UBR4 antibody (Bethyl Laboratories, IHC-00640, 1:500) was used for 
immunostaining of mouse tissues and cultured cells. Other antibodies were as follows: rat 
monoclonal anti-CD63 (R&D, MAB5417, 1:200), mouse monoclonal anti-EGFR (Santa Cruz, SC-
374607, 1:200), rabbit monoclonal anti-PDGFR-β (Cell Signaling, 3169, 1:100), mouse 
monoclonal anti-VTI1A (BD Biosciences, 611220, 1:200), Alexa Fluor 488-conjugated phalloidin 
(Invitrogen, A12379, 1:100), rabbit polyclonal anti-SLC7A1 (Proteintech, 14195-1-AP, 1:100), 
mouse monoclonal anti-tubulin (Millipore, 05-661, 1:600), goat polyclonal anti-VAT1 (Santa 
Cruz, SC-107348, 1:100). For immunoblotting analysis, mouse monoclonal anti-β-actin (Sigma, 
A1978, 1:10,000), rabbit polyclonal anti-UBR4 (Abcam, AB86738, 1:100), and mouse 
monoclonal anti-GAPDH (Sigma, G8795, 1:20,000) were used. The following secondary 
antibodies were obtained from Invitrogen: Alexa Fluor 488 goat anti-rabbit IgG (A11034, 1:200), 
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and Alexa Fluor 555 goat anti-mouse IgG (A21424, 1:200). Normal goat serum (ab7481) was 
obtained from Abcam. Hoechst 33342 (H21492) was obtained from Invitrogen. 4′,6-Diamidino-
2-phenylindole dihydrochloride (DAPI; D8417) was obtained from Sigma. Vectashield antifade 
mounting medium (H1000) was from Vector lab. All other chemicals were reagent grades from 
Sigma or Merck. 
4.2.2 UBR4 knockout mice.  
We have previously constructed UBR4-knockout mice, in which the UBR box, a substrate 
recognition domain for destabilizing N-terminal residues, was replaced with IRES (internal 
ribosome entry site)-translated tau-lacZ [24]. Animal studies were conducted according to the 
Guide for the Care and Use of Laboratory Animals published by the protocols (SNU130604-2-10) 
approved by the Institutional Animal Care and Use Committee at Seoul National University. 
4.2.3 Cell culture 
We previously established immortalized primary MEFs from +/+ and UBR4-/- embryos at E8.5 
[24]. MEF cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM) (31980–022; 
Invitrogen), 15% FBS (HyClone), 0.1 mM non-essential amino acids (Invitrogen), 0.1 mM β-
mercaptoethanol, and 100 units/mL penicillin/streptomycin (Invitrogen). CCL2 HeLa and 
HEK293 cell were purchased from the American Type Culture Collection (ATCC) and cultured 
in Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco,10566016), supplemented with 10% 
FBS and 100 units/mL penicillin/streptomycin. SH-SY5Y cells were provided by Prof. Onyou 
Hwang (University of Ulsan College of Medicine, Seoul, Republic of Korea). SH-SY5Y cells were 
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cultured in DMEM/F-12 (Gibco, 10565-042), supplemented with 10% FBS and 100 units/mL 
penicillin/streptomycin. All the cell lines were determined to be negative in a mycoplasma test 
using a MycoAlert detection kit (Lonza, LT07-118). All the culture plates and the cell lines were 
maintained at 37°C and 5% CO2 in a humidified incubator. 
4.2.4 RNA interference assay 
Reagents for siRNA silencing were purchased from Life Technologies. Transfection was 
performed according to the manufacture’s protocol. Briefly, HEK293 and SH-SY5Y cells were 
transfected with either siControl (cat. #4390843) or UBR4 siRNA (cat. #4392420, ID #23628) at 
a final concentration of 10 nM using Lipofectamine RNAiMAX reagent (Invitrogen, 13778150). 
Approximately 48 h after siRNA silencing, cells were harvested for immunoblotting and 
immunocytochemical analyses. The sequences of UBR4 siRNAs are 5’-
GCCUGUUCGAAAGCGCAAA (sense) and 5’-UUUGCGCUUUCGAACAGGC (antisense). 
4.2.5 Immunoblotting analysis 
 Cells were washed with ice-cold PBS and lysed using RIPA buffer (50 mM Tris-HCl, 150 mM 
NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) containing freshly prepared protease 
inhibitor cocktail (Sigma, P8340). Lysates were centrifuged at 14,000 rpm for 20 min at 4°C, and 
the supernatants were used for immunoblotting. Protein concentrations were measured using the 
BCA protein assay kit (Pierce, 23225). The samples were diluted with 2X Laemmli sample buffer 
(65.8 mM Tris-HCl, pH 6.8, 26.3% (w/v) glycerol, 2.1% SDS, 0.01% bromophenol blue, Bio-Rad, 
161-0737) or in Lithium dodecyl sulfate (LDS) sample buffer (Invitrogen, NP0007) with a 
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reducing reagent, followed by heating for 10 min at 70°C. Whole cell lysates were separated by 
sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred to PVDF 
membranes (Millipore, IPVH00010). Blocking was done using TBS-T (20 mM Tris-HCl, pH 7.5, 
150 mM NaCl, and 0.05% (v/v) Tween 20) containing 1% BSA for 1 h at room temperature, and 
the membrane was incubated with antibodies diluted with the blocking solution for overnight at 
4°C.  
4.2.6 Histology and immunohistochemistry 
Immunohistochemistry analysis was performed as described in the previous study [24]. Briefly, 
for histological analysis, embryos were fixed overnight at 4°C in 4% PFA in PBS, pH 7.4. Fixed 
embryos were gradually dehydrated with 70%, 90%, and 100% EtOH, followed by immersion in 
Neo-Clear (Millipore, 65351), followed by paraffin embedding at 58°C. The samples were 
sectioned transversely or sagittally with 7 μm thickness. Paraffin-embedded slides were gradually 
rehydrated through the serial incubation with Neo-clear, EtOH (100%, 90%, 80%, and 70%; 6 min 
each) and water for 20 min. The slides were treated with blocking solution (5% normal goat serum 
and 0.2% Triton X-100 in PBS) for 1 h and incubated with primary antibodies and subsequently 
secondary antibodies.  
4.2.7 Immunocytochemistry of cultured cells 
Immunocytochemistry analysis was performed as described in the previous study [24]. Briefly, 22 
mm2 coverslips per well were incubated with diluted poly-L-lysine (1:10 in sterile deionized water; 
Sigma, P8920) for 30 min. After washing once, the plate was exposed under UV radiation lamp 
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overnight in a fume hood. Cells were cultured in the plate for further experiments. Cells were fixed 
in 4% PFA in PBS, for 30 min and washed with PBS three times. After 1 h blocking (5% normal 
goat serum and 0.3% Triton X-100 in 0.1 M PBS), the samples were incubated with primary 
antibodies and subsequently secondary antibodies. Confocal images were taken with a Zeiss LSM 
700 laser scanning confocal microscope equipped with Zeiss C-Apochromat 60x (1.2 NA) and 40x 
(1.2 NA) water immersion lens and analyzed using ZEN (black edition) 2012 SP5 software (Zeiss). 
Using the ZEN software, z-stacks of images covering the entire cell thickness were acquired and 
projected maximally. Image processing and annotation was done with Adobe Photoshop, Adobe 
Illustrator and Fiji software [103].  
4.2.8 Biotinylation and affinity purification of cell surface proteins 
Cells (107) were washed three times with cold PBS and biotinylated for 15 min at room temperature 
using 0.5 mg/ml sulfo-NHS-SS-biotin (Thermo Fisher, 21331), and then washed with 50 mM Tris-
HCl (pH 7.5). Cells were harvested by centrifugation (500 × g, 5 min, 4°C) with a buffer containing 
0.5 mM oxidized glutathione (Sigma) in PBS. The cell pellet was resuspended in PBS containing 
2% NP-40, 0.2% SDS, 0.1 mM oxidized glutathion, and protease inhibitor cocktail (Roche 
Diagnostics). Cells were then lysed by sonication on ice. Protein concentrations were measured 
using the Micro BCA Protein Assay Kit (Thermo, 23235) [124, 125]. Protein mixtures were diluted 
to a concentration of 0.6 mg/mL using PBS and biotinylated proteins were isolated using a 
Streptavidin Sepharose High Performance column (GE Healthcare) following the manufacturer’s 
protocol [126]. Purified proteins were precipitated with acetone, resuspended with 0.1% SDS in 
100 mM ammonium bicarbonate, and protein concentration was determined by the BCA protein 
assay. 
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4.2.9 SDS-PAGE fractionation and in-gel digestion 
Fifty micrograms of protein samples were fractionated on 4–12% Bis-Tris gel (Invitrogen) and 
stained with Coomassie Brilliant Blue (Sigma). Each gel lane was cut into eight pieces and 
subjected to in-gel tryptic digestion following the general protocol [127]. Briefly, protein bands 
were excised, destained, and washed. Proteins were reduced with 20 mM dithiothreitol and 
alkylated with 55 mM iodoacetamide. After dehydration, the proteins were digested with 12.5 
ng/µL sequencing grade modified porcine trypsin (Promega) in 50 mM ammonium bicarbonate 
overnight at 37°C. Peptides were extracted from the gel pieces with 50% (v/v) acetonitrile in 5% 
(v/v) formic acid and dried under vacuum. 
4.2.10 Mass spectrometry analysis and relative protein quantification 
Peptides were resuspended in Solvent A (0.1% formic acid in water) and loaded onto an in-house 
packed 75 µm (inner diameter micro-capillary) x 10 cm C18 column and separated with a linear 
gradient of 5–32% Solvent B (0.1% formic acid in acetonitrile) for 70 min at a flow rate 300 
nL/min. MS spectra were recorded on Q-Exactive (Thermo Fisher) interfaced with a nano-UPLC 
system (Easy nLC, Thermo Fisher). The Q-Exactive was operated in data-dependent mode with 
one survey MS scan at 400–1600 m/z followed by ten MS/MS scans by normalized collision 
energy of 30 eV, and the duration time of dynamic exclusion was 30 s. Collected MS/MS data 
were converted into mzXML files through the Trans Proteomic pipeline (TPP) (version 4.5) and 
searched against the decoy IPI Mouse database (version 3.87, 119072 entries) for the estimation 
of false discovery rate (FDR) with the SEQUEST® (Thermo Fisher Scientific; version v.27, rev. 
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11) in SORCERERTM (Sage-N Research, version 3.5) search platform. Precursor and fragment ion 
tolerance were set to 50 ppm and 0.5 Da, respectively. Trypsin was chosen as the enzyme and up 
to two missed cleavages were allowed. Carbamidomethyl of cysteine was considered as the fixed 
modification, and methionine oxidation as variable modification. Scaffold software (version 3.4.9, 
Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein 
identifications. Peptide and protein identifications were accepted if they could be established at 
greater than 95% and 99% probability respectively, as specified by the Peptide and Protein Prophet 
algorithm, and protein identification contained at least two identified peptides [128, 129]. Relative 
protein quantitation was accomplished using the spectral counting. The MS/MS data were 
normalized to compare abundances of proteins between samples using Scaffold software. The 
normalized spectral counts from duplicate measurements of the +/+ and UBR4-/- MEFs cells were 
compared using the R program with PLGEM software (http://www.bioconductor.org) in order to 
identify statistically significant protein changes between the two cell lines [130]. The subcellular 
localization of the identified proteins was classified using Ingenuity Pathway Analysis (IPA) 
(Ingenuity® Systems, www.ingenuity.com). 
4.2.11 Immunogold labelling for transmission electron microscopy. 
Immunoelectron microscopy experiment was performed as previously described [24]. UBR4V5 
stably expressing HEK293 cells were fixed in 2% PFA in PBS for 1 h, followed by PBS washing. 
The fixed cells were collected by scraping and resuspended in 3% gelatin. Solidified gelatin on ice 
was fixed again with 2% PFA for 15 min. After sequential cryoprotections with 2.3 M sucrose and 
PVP solution overnight, samples were frozen in liquid nitrogen and were trimmed into 0.5 mm 
cubes, which were sectioned by cryo-microtome (Leica EM Crion) in 70 nm sections. The primary 
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antibody against V5 was diluted in 0.1 M PBS, supplemented with 0.5% bovine serum albumin 
(BSA), 0.15% glycine. Secondary antibody, 12nm gold beads labelled donkey anti-rabbit IgG 
(Jackson ImmunoResearch), was diluted to 1:25. Sections were incubated with 2.5% 
glutaraldehyde for 10 min and with 2% Neutral UA acetate for 7 min, followed by incubation in 
4% uranyl acetate and methyl cellulose for contrasting and drying. After drying, samples were 
recorded using JEOL JEM1011 TEM with high resolution AMT digital camera (Peabody, MA). 
4.2.12 Statistical analysis 
All numerical data are presented as means ± SEM or mean percentages ± SEM. Western blots 
shown are representative of three or more independent experiments. Comparisons among 
treatment groups were performed with one-way ANOVA and Tukey test or Dunnett’s multiple 
comparison as a post hoc comparison. Instances involving only two comparisons were evaluated 
with unpaired t-test or two-tailed Mann-Whitney test for non-parametric test. Statistical 
significance was accepted if the null hypothesis was rejected with p < 0.05. All statistical analyses 
were determined using Prism 7.0c software (GraphPad, La Jolla, CA). 
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4.3 EXPERIMENTAL RESULTS 
4.3.1 Mouse embryos lacking UBR4 die associated with multiple developmental 
abnormalities.  
We have previously constructed UBR4 knockout mice, in which a 4.1 kb-DNA fragment encoding 
the UBR box was deleted [24]. The mutant mouse embryos died at midgestation (~E9.5-10.5) 
associated with vascular defects in the YS (Table 1) [24]. In this study, we characterized the null 
phenotypes of the mutant embryos proper. When gross phenotypes were examined, UBR4-/- 
embryos began to show growth retardation at E8.5, resulting in developmental arrest at E9.5 
(Figure 28A). By E10.5, most homozygous mutants were close to death or found dead (Table 1). 
No live mutants were retrieved at and beyond E11.5. These results suggest that UBR4 is 
indispensable for embryonic development at midgestation. 
One distinct developmental defect was that the majority of UBR4-/- embryos between E8.5 
and E9.5 had smaller and malformed pharyngeal arches as compared to control embryos (Figure 
28A). The abnormalities were more prominent in the second pharyngeal arch, which is derived 
from pharyngeal epithelium and mesenchymal cells (Figure 28A and B, blue line). It is known that 
mesoderm cells in the first arch migrate to the developing heart tube, contributing to right 
ventricular myocardium at E7.5-E8.0 (Figure 28B). By E9.5-E10, mesodermal cells in the second 
arch also migrate to contribute to outflow tract myocardium [131]. Consistent with these 
developmental fates, UBR4-/- embryos almost invariably exhibited defects in cardiovascular 
development characterized by thin myocardium and loosely associated cardiac fibroblasts (Figure  
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Figure 28: Mouse embryos lacking UBR4 die at midgestation associated with multiple developmental 
abnormalities. 
(A) Gross morphology of +/+ and UBR4-/- mouse littermates at E8.5-E9.5. UBR4 mutants exhibit embryonic growth 
retardation and malformed pharyngeal arches. The red and blue lines represent the first pharyngeal arch and second 
pharyngeal arch, respectively (scale bar = 1 mm). (B) Anatomical illustration of the pharyngeal arch (PA) and heart 
of the mouse embryo at E9.0. First pharyngeal arch mesodermal cells (red) move to the developing heart tube for the 
right ventricular myocardium at E7.5-8.0, while second pharyngeal arches mesodermal cells (blue) migrate to the 
outflow tract (oft) of the myocardium at around E9.5-E10. (C) Hematoxylin and eosin (H&E) staining on cross 
sections of +/+ and UBR4-/- embryos at E9.5. nt, neural tube; at, atrium; vt, ventricles; 4th, fourth ventricle (scale bar 
= 100 μm). (D) H&E staining of the placenta of +/+ and UBR4-/- mouse littermates at E9.5 (scale bar = 500 μm). 
Panels C and D were conducted by Takafumi Tasaki. 
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28C). Despite such pleiotropic abnormalities, the placenta of UBR4-/- embryos at E9.5 did not show 
severe morphological and histological abnormalities in the spongiotrophoblast and labyrinthine 
layer (Figure 28D), indicating that these null phenotypes observed in UBR4-/- embryos are not 
secondary to the YS vascular defects. These results suggest that UBR4 is required for embryonic 
development at and beyond E8.0. 
4.3.2 UBR4 is required for embryonic neurogenesis.  
To further characterize the in vivo role of UBR4 in embryonic development, we histologically 
examined the cross sections of +/+ and UBR4-/- mouse embryos at E8.5 through E10.5. One 
prominent histological phenotype was noticed in neurogenesis (Figures 28C and 29A). The neural 
tube of UBR4-/- embryos at E9.5 was thinner and rough on the surface of the neuroepithelium as 
compared with littermate controls (Figures 28C and 29A). The fourth ventricle in UBR4-/- embryos 
was morphologically abnormal, shrunken, and almost closed as compared with control embryos 
(Figure 28C). The areas between mesencephalic ventricles and cephalic mesenchyme tissues were 
significantly reduced (Figure 29A). The cells located in cephalic mesenchyme tissues were 
sparsely found and did not show directionality (Figure 29A). These results suggest that UBR4 is 
required for neurogenesis. 
We next determined whether the  developmental defects are secondary to cell proliferation 
and death. TUNEL assays on cross sections of +/+ and UBR4-/- embryos showed that the severity 
of null phenotypes correlated to the degree of apoptotic induction (Figure 29B). However, the 
overall levels of apoptotic cells were not significantly influenced by UBR4 knockout. We therefore 
examined cellular senescence by monitoring the activity of β-galactosidase, an indicator of sene- 
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Figure 29: The null phenotypes of UBR4-/- embryos are not due to cell death or misregulation in cell cycle or 
proliferation.  
(A) H&E staining of the midbrain of +/+ and UBR4-/- mouse embryos at E9.5. Insets: magnified image of area enclosed 
by lined boxes. cm, cephalic mesenchyme tissue; mv, mesencephalic vesicle; ne, neuroepithelium of midbrain region 
(scale bar = 200 μm). (B) TUNEL assay of +/+ and UBR4-/- embryos at E9.5 (scale bar = 150 μm). (C) Cytochemical 
staining of senescence-associated β-galactosidase (SA-βgal) activity in +/+ and UBR4-/- MEFs. For a positive control, 
UBR4-/- MEF were treated with 50 nM doxorubicin for 7 days. White dotted line delineates the cell boundary (scale 
bar = 30 and 15 μm, respectively). N, nucleus. (D) BrdU incorporation assay of +/+ and UBR4-/- embryos at E9.5. S-
phase indices were determined to be 39.3% and 33.4% for +/+ and UBR4-/- embryos, respectively. nt, neural tube; ht, 
heart (scale bar = 150 μm). (E) Immunostaining of F-actin (filamentous actin) and Ki67 in +/+ and UBR4-/- MEFs. For 
a negative control (G0 phage), UBR4-/- MEF were treated with 50 nM doxorubicin for 7 days. (scale bar = 15 μm). (F) 
Quantitative of Ki67-positive signals in  +/+ and UBR4-/- MEFs. Statistically no significant difference was noted 
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between +/+ and UBR4-/- MEFs (n.s., not significant; p = 0.8591). Data are presented as mean percentage ± SEM. 
Statistical significance was determined using one-way ANOVA and Tukey test as a post hoc comparison. Panels A, 
B, and D were conducted by Takafumi Tasaki.  
scence (Figure 29C). UBR4-/- MEFs did not contain a comparable level of β-galactosidase activity 
and, thus, had the capacity to undergo cell cycle. To determine whether UBR4 loss affects cell  
proliferation, we measured the S-phase index of UBR4-/- embryos. We injected bromodeoxyuridine 
(BrdU) into pregnant females, harvested embryos, and examined the incorporation of BrdU into 
S-phase DNA. Anti-BrdU immunostaining analyses on the cross sections of +/+ and UBR4-/- 
embryos at E9.5 showed that the S-phase index of UBR4-/- embryos was largely comparable to that 
of +/+ embryos (Figure 29D). Consistently, immunostaining analyses of Ki67, a marker of 
proliferating cells, showed that UBR4-/- MEFs were mitotically active as compared to +/+ cells 
(Figure 29E and F). These results suggest that the developmental abnormalities of UBR4-/- embryos 
are not subsidiary to reduced cell proliferation or increased cell death.  
To determine the cell-autonomous function of UBR4 in neuronal cells, human 
neuroblastoma-derived SH-SY5Y cells were differentiated into the neuronal lineage by treating 
retinoic acid for 5 days. Immunostaining analyses showed that UBR4 was expressed in neuronal 
cells as cytosolic puncta throughout the cell body as well as the axon (Figure 30A). Next, we 
silenced UBR4 in differentiated SH-SY5Y cells and examined their axonal growth. 
Immunostaining and immunoblotting analyses confirmed that UBR4 was properly knocked down 
(Figures 30A, B, and 32D). Microscopic inspection revealed that UBR4-knockdown acutely 
induced the recession of axons as determined by axonal length without any changes in neurite 
diameter (Figure 30C and D). These results suggest that UBR4 is required to maintain axonal 
integrity of neuronal cells.  
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Figure 30: UBR4 depletion causes neurite shortening in differentiated SH-SY5Y cells. 
(A) Immunostaining analyses of UBR4 in differentiated SH-SY5Y cells treated with siCtrl (siControl)- and siUBR4. 
SH-SY5Y cells were differentiated by retinoic acid treatment for 5 d, followed by siRNA treatment for 48 h. White 
dotted lines delineate the cell boundary. Enlarged views show the areas indicated by yellow rectangles (scale bar = 30 
μm). (B) Quantification of A. Total 25 control and 18 UBR4 knockdown SH-SY5Y cells were observed. ***p < 
0.0001. Data are presented as mean ± SEM. Statistical significance was determined using unpaired t-test. (C) Average 
neurite diameters (in μm) of control and UBR4 knockdown SH-SY5Y cells. Linear regression (solid line) was applied 
to this data. The slope indicates that the immunofluorescence intensity of UBR has no relationship with the neurite 
diameter. n.s., not significant. (D) Average neurite length (in μm) of control and UBR4 knockdown SH-SY5Y cells. 
Linear regression (solid line) was applied to this data. The slope indicates that the immunofluorescence intensity of 
UBR4 had a correlation with neurite length. 
 93 
 
4.3.3 UBR4 plays a role in cell adhesion. 
In UBR4-/- embryos at E9.5, migratory mesenchymal cells were more separated from each other 
as compared with +/+ embryos (Figure 29A). Although to a less degree, the extracellular space of 
various cells, including neuronal cells of the neural tube, was also invariably expanded than +/+ 
embryos (Figure 31A and B). Quantitative analyses showed that the extracellular space of neural 
tube in UBR4-/- embryos were about 1.5-fold (**p = 0.004) larger than that of +/+ embryos (Figure 
31B). In addition, the cells in UBR4-/- embryos exhibited morphological abnormalities. 
Specifically, in +/+ embryos, mesenchymal cells were in a fibrillar shape toward the direction of 
migration and paracrine signaling. In sharp contrast, the same kinds of cells in UBR4-/- embryos 
lost fibrillar shapes and remained arrested as globular shapes (Figures 29A and 31A). These 
cellular defects were similarly observed in UBR4-/- MEFs which were morphologically different 
from +/+ fibroblasts, lacking elongated lamellipodia and filopodia (Figure 31C, arrowheads). 
Instead, the cytosolic surface areas of UBR4-/- MEFs were about 5-fold larger than +/+ MEFs 
(Figure 31D). Despite the increased surface area, UBR4-/- MEFs retained the cytoskeleton 
structures as determined by immunostaining analyses of actin filaments and microtubules (Figures 
23A and 31E). Overall, these results suggest that UBR4 may be required for cell-to-cell adhesion. 
 We therefore asked whether UBR4 plays a role in cell adhesion by immunostaining N-
cadherin, a type-1 transmembrane protein involved in adhesion [132, 133]. The cytoplasmic 
domain of N-cadherin linked to actin cytoskeleton filaments through interaction with delta-catenin, 
beta-catenin and gamma-catenin [122]. Immunostaining analyses of +/+ embryos revealed N-
cadherin stainings as thin lines along the plasma membrane (Figure 31F). Such expression pattern 
was markedly downregulated and disorganized in UBR4-/- embryos (Figure 31F). Notably,  
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Figure 31: UBR4-/- embryos are impaired in neurogenesis and cell adhesion.  
(A) H&E staining images of the neural tube of +/+ and UBR4-/- mouse embryos at E9.5 (scale bar = 10 μm). (B) 
Quantification of the extracellular space between neuronal cells in E9.5 +/+ and UBR4-/- neural tubes (% of +/+). 
Extracellular space of UBR4-/- is larger than that of +/+ (149 ± 7% of +/+, **p = 0.0040 , n = 4 and n = 8 for +/+ and 
UBR4-/- embryos, respectively). Data are presented as mean ± SEM. Statistical significance was determined using 
two-tailed Mann-Whitney test for non-parametric test. (C) The long-term deficiency of UBR4 caused morphological 
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transformation in MEFs. UBR4-/- MEFs show an increased surface area and lack extended lamellipodia and filopodia. 
White arrowheads mark extended filopodia (scale bar = 20 μm). Insets: magnified image of area enclosed by yellow 
lined boxes. (D) Quantification of cellular surface (x1000 μm2). ***p < 0.0001 (n = 201 and n = 212 for +/+ and 
UBR4-/- MEF, respectively). Data are presented as mean area ± SEM. Statistical significance was determined using 
two-tailed Mann-Whitney test for non-parametric test. (E) Immunostaining analysis of F-actin and β-tubulin on +/+ 
and UBR4-/- MEFs. All images are displayed as z-stack maximum projections (scale bar = 10 μm). (F) Immunostaining 
of N-cadherin on cross-sections of +/+ and UBR4-/- YS and embryos at E9.5. Dotted line represents two distinct layers 
of the visceral YS. An outer layer derived from the visceral endoderm and an underlying layer derived from the 
mesoderm. Endodermal layer; Ed, mesodermal layer; Md. White dotted line on neural tube represents outlines of the 
neural tube (scale bar = 10 μm). (G) Immunostaining of cell-cell adjunction proteins on +/+ and UBR4-/- MEFs. 
HEK293 cell was used as a control cell and HEK293 cell (scale bar = 20 μm for MEFs and 10 μm for HEK293). 
N-cadherin signals were more strongly disorganized in the YS and neural tubes that exhibited 
severe null phenotypes. By contrast, the staining appeared normal in tissues that exhibited 
relatively mild null phenotypes, such as mesenchymal cells of the septum transversum which gives 
rise to the thoracic diaphragm and the ventral mesentery of the foregut [134].  
Given the results with N-cadherin, we next examined the expression of other cell adhesion 
proteins such as beta-catenin, delta-catenin, and gamma-catenin in +/+ and UBR4-/- MEFs. 
Immunostaining analyses showed that the expression patterns of all these plasma membrane-
associated proteins were down-regulated or otherwise disorganized in UBR4-/- MEFs in a fashion 
similar to that of N-cadherin (Figure 31G). These results suggest that cell adhesion proteins are 
not properly presented in the plasma membrane, contributing to pleiotropic developmental defects 
observed in UBR4-/- embryos. 
4.3.4 UBR4-loss leads to the depletion of plasma membrane proteins 
Cell adhesion proteins assist growth factor receptors like EGFR (epidermal growth factor receptor) 
and PDGFR (platelet-derived growth factor receptor) and arrange receptor recycling and signaling 
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[135-137]. To assess the impact of UBR4 on the homeostasis of EGFR and PDGFR, we examined 
their levels in +/+ and UBR4-/- MEFs. Immunoblotting analysis showed that UBR4-/- MEFs 
contained a markedly reduced amout of EGFR (Figure 32A). UBR4 knockdown also acutely 
induced the depletion of EGFR in MEFs (Figure 32B). When visualized by immunostaining 
analyses, EGFR+ puncta in UBR4-/- MEFs appeared to be abnormal in size, morphology, and 
intracellular distribution as compared with those in +/+ MEFs (Figure 32C). Consistent with the 
results with EGFR, PDGFR-β was also depleted not only in UBR4-/- MEFs relative to +/+ MEFs 
(Figure 32A) but also by transient knockdown of UBR4 in MEFs (Figure 32B). These results 
suggest that UBR4 is required for the homeostasis of at least some plasma membrane-associated 
receptors, such as EGFR and PDGFR-β.  
To validate these results in the neuronal lineage, we monitored EGFR and PDGFR-β in 
SH-SY5Y cells (Figure 32D). UBR4 knockdown induced a rapid depletion of EGFR and PDGFR-
β in SH-SY5Y cells (Figure 32D). To further characterize the turnover of EGFR in differentiated 
neurons, we induced the axonal growth of SH-SY5Y cells by treating retinoic acid for 5 days. 
When visualized using immunostaining analyses, UBR4 knockdown significantly dampened 
EGFR stainings (Figure 32E). Finally, to extend these findings to animal tissues, we 
immunostained EGFR on the cross sections of +/+ and UBR4-/- mouse YS and embryos at E9.5 
(Figure 32F and G). The EGFR staining was markedly diminished in UBR4-/- embryonic tissues, 
such as the neural tube, paraximal mesoderm, and YS (Figure 32F and G). These results suggest 
that UBR4 has a general role in the homeostasis of at least some plasma membrane-associated 
receptors.  
To further characterize the role of UBR4 in the global turnover of plasma membrane-
associated proteins, we labeled in situ plasma membrane proteins of +/+ and UBR4-/- MEFs with  
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Figure 32: UBR4-loss induces the depletion of EGFR and PDGFR from the plasma membrane.  
(A) Immunoblotting analysis of EGFR and PDGFR-β in +/+ and UBR4-/- MEFs. (B) Immunoblotting analysis of 
EGFR and PDGFR-β in siControl (siCtrl) and siUBR4-treated MEFs. (C) Immunostaining analysis of EGFR using 
+/+ and UBR4-/- MEFs. Solid white lines delineate the cell boundary (scale bar = 40 μm). Enlarged views show the 
areas indicated by yellow rectangles (scale bar = 3 μm). (D) Immunoblotting analysis of EGFR, PDGFR-β, and UBR4 
in siControl (siCtrl) and siUBR4-treated SH-SY5Y cells. (E) Immunostaining of EGFR and UBR4 in siControl (siCtrl) 
and siUBR4-treated differentiated SH-SY5Y. Retinoic acid-derived differentiated SH-SY5Y cells were transiently 
transfected with siRNA for 48 h. Total 12 images were collected using the confocal microscope at 0.36 μm intervals 
to create a stack in the Z axis. The fluorescence intensity of EGFR was significantly down-regulated in UBR4 
knockdown SH-SY5Y cells. White dotted lines delineate the cell boundary (scale bar = 20 μm). Enlarged views show 
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the areas indicated by yellow rectangles and numbers. (F) Immunostaining analysis of EGFR on the cross sections of 
+/+ and UBR4-/- YSs at E9.5. EGFR was significantly down-regulated in the YS of UBR4-/- embryos at E9.5 (scale 
bar = 10 μm). Ed, endodermal layer; Md, mesodermal layer. (G) Immunostaining analysis of EGFR on the cross-
sections of +/+ and UBR4-/- embryos at E9.5. EGFR was markedly down-regulated in various embryonic tissues, such 
as the neural tube, and paraximal mesoderm (scale bar = 5 μm). Panels A, B, and D were conducted by Yoon Jee Lee. 
sulfo-NHS-SS-biotin and partially purified biotinylated proteins using streptavidin-Sepharose 
column. The purified proteins were separated using SDS-PAGE (Figure 33A), followed by in-gel 
trypsinization and LC-MS/MS analysis. The SEQUEST-SORCERER database search platform 
identified a total of 1,024 proteins, of which 253 were plasma membrane-associated proteins. 
Ingenuity Pathway Analysis and PANTHER classification system was used to annotate the 
function of these identified surface proteins (Figure 33B). Amongst the 253 proteins, 71 were 
significantly down-regulated in UBR4-/- MEFs compared to +/+ MEFs (p ≤  0.01) (Table 2; Figure 
33C), and 22 were up-regulated (Table 3; Figure 33C). To validate the results from mass 
spectrometry, we performed immunostaining analyses of a few radomly selected hits, including 
VTI1A, SLC7A1, and VAT1 (Figure 33D). Consistent with the data from mass spectrometric 
analyses, UBR4-/- MEFs contained the reduced levels of VTI1A and SLC7A1 and the increased 
level of VAT1 (Figure 33D and E). Overall, these results suggest that UBR4 has a general role in 
the homeostasis of cell surface proteins. 
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Figure 33: Proteomic analysis of cell surface proteins in MEF cells.  
(A) Coomassie brilliant blue (CBB) staining of purified surface proteins separated using SDS-PAGE. (B) Molecular 
functions of identified cell surface proteins by the Ingenuity Pathway Analysis (IPA) tool. (C) Schematic illustration 
of mass spectrometric data of 93 membrane proteins whose abundance significantly altered in UBR4-/- MEFs as 
compared with +/+ MEFs. (D) Immunostaining analyses of VTI1A, SLC7A1 and VAT1 (scale bar = 10 μm). (E) 
Quantification of D, representing the relative fluorescence intensities for VTI1A, SLC7A1, and VAT1. *p = 0.0325 
vs VTI1A of +/+ (n = 13-14 in each group), ***p < 0.0001 vs SLC7A1 of +/+ (n = 13-23 in each group), and **p = 
0.0070 vs VAT1 of +/+ (n = 16-22 in each group). Data are presented as mean percentage ± SEM of +/+. Statistical 
significance was determined using unpaired t-test. 
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Table 2: The list of 71 membrane proteins down-regulated in UBR4-/- MEF cell compared with +/+ MEF. 
 
Accession Symbol Entrez Gene Name STN p-value Type(s) 
IPI00468633 SLC6A9 solute carrier family 6 (neurotransmitter 
transporter, glycine), member 9 
-1.626  0.010  transporter 
IPI00115117 STOML
2 
stomatin (EPB72)-like 2 -1.626  0.010  other 
IPI00331524 ERLIN1 ER lipid raft associated 1 -1.626  0.010  other 
IPI00408489 DSCAM
L1 
Down syndrome cell adhesion molecule 
like 1 
-1.626  0.010  other 
IPI00323822 RRAS2 related RAS viral (r-ras) oncogene 
homolog 2 
-1.683  0.010  enzyme 
IPI00122971 NCAM1 neural cell adhesion molecule 1 -1.694  0.010  other 
IPI00110588 MSN moesin -1.727  0.009  other 
IPI00648802 EPHB2 EPH receptor B2 -1.727  0.009  kinase 
IPI00123040 PTPRK protein tyrosine phosphatase, receptor 
type, K 
-1.809  0.009  phosphatase 
IPI00230395 ANXA1 annexin A1 -1.822  0.008  other 
IPI00122273 DAG1 dystroglycan 1 (dystrophin-associated 
glycoprotein 1) 
-1.827  0.008  transmembrane 
receptor 
IPI00131540 VTI1A vesicle transport through interaction with 
t-SNAREs homolog 1A (yeast) 
-1.827  0.008  transporter 
IPI00228617 GNAI2 guanine nucleotide binding protein (G 
protein), alpha inhibiting activity 
polypeptide 2 
-1.852  0.008  enzyme 
IPI00312509 AXL AXL receptor tyrosine kinase -1.987  0.007  kinase 
IPI00129298 PALM paralemmin -1.987  0.007  other 
IPI00129220 EPHA2 EPH receptor A2 -2.117  0.006  kinase 
IPI00121827 PDGFR
B 
platelet-derived growth factor receptor, 
beta polypeptide 
-2.190  0.006  kinase 
IPI00664442 SLC4A7 solute carrier family 4, sodium 
bicarbonate cotransporter, member 7 
-2.196  0.006  transporter 
IPI00313884 PODXL podocalyxin-like -2.211  0.006  kinase 
IPI00331175 SLC12A
7 
solute carrier family 12 
(potassium/chloride transporters), 
member 7 
-2.211  0.006  transporter 
IPI00120930 PLSCR1 phospholipid scramblase 1 -2.211  0.006  enzyme 
IPI00270376 CXADR coxsackie virus and adenovirus receptor -2.211  0.006  transmembrane  
receptor 
IPI00123996 NRP1 
(includes 
EG:1818
6) 
neuropilin 1 -2.304  0.005  transmembrane 
receptor 
IPI00123183 AQP1 aquaporin 1 (Colton blood group) -2.304  0.005  transporter 
IPI00124221 ATP1B3 ATPase, Na+/K+ transporting, beta 3 
polypeptide 
-2.366  0.005  transporter 
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Table 2 (continued). 
Accession Symbol Entrez Gene Name STN p-value Type(s) 
IPI00416751 SLC29A
1 
solute carrier family 29 (nucleoside 
transporters), member 1 
-2.413  0.005  transporter 
IPI00137311 PLXNA1 plexin A1 -2.485  0.005  transmembrane 
receptor 
IPI00405742 PLXNB2 plexin B2 -2.550  0.004  transmembrane 
receptor 
IPI00132474 ITGB1 integrin, beta 1 (fibronectin receptor, beta 
polypeptide, antigen CD29 includes 
MDF2, MSK12) 
-2.550  0.004  transmembrane 
receptor 
IPI00121634 SLC7A1 solute carrier family 7 (cationic amino 
acid transporter, y+ system), member 1 
-2.559  0.004  transporter 
IPI00130648 VLDLR very low density lipoprotein receptor -2.575  0.004  transporter 
IPI00117181 FLOT1 flotillin 1 -2.589  0.004  other 
IPI00118569 GNA13 guanine nucleotide binding protein (G 
protein), alpha 13 
-2.589  0.004  enzyme 
IPI00308971 IGF2R insulin-like growth factor 2 receptor -2.608  0.004  transmembrane 
receptor 
IPI00330539 KIRREL kin of IRRE like (Drosophila) -2.708  0.004  other 
IPI00468236 ANO6 anoctamin 6 -2.708  0.004  ion channel 
IPI00135130 SLC1A4 solute carrier family 1 (glutamate/neutral 
amino acid transporter), member 4 
-2.725  0.004  transporter 
IPI00124830 CD47 CD47 molecule -2.728  0.004  other 
IPI00465786 TLN1 talin 1 -2.756  0.004  other 
IPI00754549 FLOT2 flotillin 2 -2.855  0.004  other 
IPI00420589 IGSF3 immunoglobulin superfamily, member 3 -3.256  0.003  other 
IPI00311682 ATP1A1 ATPase, Na+/K+ transporting, alpha 1 
polypeptide 
-3.359  0.003  transporter 
IPI00129253 LY75 lymphocyte antigen 75 -3.406  0.003  other 
IPI00117829 CAV1 caveolin 1, caveolae protein, 22kDa -3.463  0.003  other 
IPI00113798 SNAP23 synaptosomal-associated protein, 23kDa -3.501  0.003  transporter 
IPI00115976 ITGA5 integrin, alpha 5 (fibronectin receptor, 
alpha polypeptide) 
-3.532  0.003  other 
IPI00308691 SLC2A1 solute carrier family 2 (facilitated glucose 
transporter), member 1 
-3.657  0.002  transporter 
IPI00115546 GNAO1 guanine nucleotide binding protein (G 
protein), alpha activating activity 
polypeptide O 
-3.657  0.002  enzyme 
IPI00223769 CD44 CD44 molecule (Indian blood group) -3.706  0.002  enzyme 
IPI00113869 BSG basigin (Ok blood group) -3.720  0.002  transporter 
IPI00125832 CAV2 caveolin 2 -3.720  0.002  other 
IPI00128152 Abcb1b ATP-binding cassette, sub-family B 
(MDR/TAP), member 1B 
-3.735  0.002  transporter 
IPI00138716 RAP2B RAP2B, member of RAS oncogene 
family 
-3.735  0.002  enzyme 
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Table 2 (continued). 
 
 
 
Accession Symbol Entrez Gene Name STN p-value Type(s) 
IPI00875340 SLC1A5 solute carrier family 1 (neutral amino acid 
transporter), member 5 
-4.118 0.002 transporter 
IPI00321753 GPRC5A G protein-coupled receptor, family C, 
group 5, member A 
-4.118 0.002 G-protein 
coupled receptor 
IPI00137194 SLC16A
1 
solute carrier family 16, member 1 
(monocarboxylic acid transporter 1) 
-4.434 0.002 transporter 
IPI00137336 GPC1 glypican 1 -4.581 0.001 transmembrane 
receptor 
IPI00653515 LDLR low density lipoprotein receptor -4.706 0.001 transporter 
IPI00556827 ATP2B1 ATPase, Ca++ transporting, plasma 
membrane 1 
-5.103 0.001 transporter 
IPI00126090 ITGA3 integrin, alpha 3 (antigen CD49C, alpha 3 
subunit of VLA-3 receptor) 
-5.111 0.001 other 
IPI00463589 ATP2B4 ATPase, Ca++ transporting, plasma 
membrane 4 
-5.336 0.001 transporter 
IPI00135324 SLC12A
2 
solute carrier family 12 
(sodium/potassium/chloride transporters), 
member 2 
-5.339 0.001 transporter 
IPI00126834 VCAM1 vascular cell adhesion molecule 1 -5.630 0.001 other 
IPI00129395 SLC7A5 solute carrier family 7 (amino acid 
transporter light chain, L system), 
member 5 
-5.943 0.001 transporter 
IPI00229703 VAMP2 vesicle-associated membrane protein 2 
(synaptobrevin 2) 
-6.411 0.001 other 
IPI00114641 SLC3A2 solute carrier family 3 (activators of 
dibasic and neutral amino acid transport), 
member 2 
-7.015 0.001 transporter 
IPI00153809 CD109 CD109 molecule -7.269 0.000 other 
IPI00923039 ABCC4 
(includes 
EG:1025
7) 
ATP-binding cassette, sub-family C 
(CFTR/MRP), member 4 
-7.505 0.000 transporter 
IPI00129915 ABCC1 ATP-binding cassette, sub-family C 
(CFTR/MRP), member 1 
-8.787 0.000 transporter 
IPI00132276 VAMP3 vesicle-associated membrane protein 3 
(cellubrevin) 
-10.074 0.000 other 
IPI00124700 TFRC transferrin receptor (p90, CD71) -12.33 0.000 transporter 
Footnote: *STN, signal to noise ratio generated by PLGEM analysis (p ≤ 0.01). 
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Table 3: The list of 22 membrane proteins up-regulated in UBR4-/- MEF cell compared with +/+ MEF. 
Accession Symbol Entrez Gene Name STN p-value Type(s) 
IPI00831676 DYSF dysferlin, limb girdle muscular 
dystrophy 2B (autosomal recessive) 
8.224 0.000 other 
IPI00775950 Cald1 caldesmon 1 7.194 0.001 other 
IPI00323885 NPR3 
(includes 
EG:18162) 
natriuretic peptide receptor C/guanylate 
cyclase C (atrionatriuretic peptide 
receptor C) 
6.709 0.001 G-protein 
coupled receptor 
IPI00515360 HSPG2 heparan sulfate proteoglycan 2 5.239 0.001 enzyme 
IPI00623114 FAT1 FAT tumor suppressor homolog 1 
(Drosophila) 
4.494 0.002 other 
IPI00129304 COLEC12 collectin sub-family member 12 3.826 0.003 transmembrane 
receptor 
IPI00227835 Tpm1 tropomyosin 1, alpha 3.258 0.003 other 
IPI00118069 F3 coagulation factor III (thromboplastin, 
tissue factor) 
3.195 0.003 transmembrane 
receptor 
IPI00128915 CSPG4 chondroitin sulfate proteoglycan 4 3.006 0.004 other 
IPI00109727 THY1 Thy-1 cell surface antigen 2.922 0.004 other 
IPI00112963 CTNNA1 catenin (cadherin-associated protein), 
alpha 1, 102kDa 
2.635 0.004 other 
IPI00405227 VCL vinculin 2.613 0.005 enzyme 
IPI00466371 ITGA1 integrin, alpha 1 2.575 0.005 other 
IPI00120716 GNB1 guanine nucleotide binding protein (G 
protein), beta polypeptide 1 
2.213 0.006 enzyme 
IPI00227838 GNG12 guanine nucleotide binding protein (G 
protein), gamma 12 
2.211 0.006 enzyme 
IPI00229534 MARCKS myristoylated alanine-rich protein kinase 
C substrate 
2.169 0.006 other 
IPI00109108 STT3A STT3, subunit of the 
oligosaccharyltransferase complex, 
homolog A (S. cerevisiae) 
2.024 0.007 enzyme 
IPI00762091 MRC2 mannose receptor, C type 2 1.925 0.008 transmembrane 
receptor 
IPI00126072 VAT1 vesicle amine transport protein 1 
homolog (T. californica) 
1.925 0.008 transporter 
IPI00405462 SORBS2 sorbin and SH3 domain containing 2 1.827 0.008 other 
IPI00229475 JUP junction plakoglobin 1.741 0.009 other 
IPI00120245 ITGAV integrin, alpha V 1.708 0.010 ion channel 
Footnote: *STN, signal to noise ratio generated by PLGEM analysis (p ≤ 0.01). 
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4.3.5 UBR4-deficient cells fail to generate MVBs.  
A portion of cell surface proteins and various extracellular materials are endocytosed and degraded 
through the endosome-lysosome pathway [71]. During this process, cargoes carried in endosomes 
are deposited to MVBs, which in turn are fused with autophagosomes to form amphisomes, leading 
to lysosomal degradation [71, 90]. We therefore monitored the formation of MVBs in +/+ and 
UBR4-/- MEFs. Immunostaining analyses of the MVB marker CD63 showed that MVBs were 
enriched in peri-nuclear regions of +/+ MEFs (Figure 34A). By sharp contrast, UBR4-/- MEFs 
contained a drastically reduced level of CD63+ MVBs. The down-regulation of MVBs was  
Figure 34: UBR4 is associated with MVBs and required for the formation of MVBs.  
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(A) Immunostaining of UBR4 and the MVB marker CD63 on siControl- and siUBR4-treated +/+ and UBR4−/− MEFs 
(scale bar = 15 μm and 300 nm, respectively). (B) Transmission electron microscopy (TEM) of HEK293 cells stably 
expressing UBR4V5. Fixed cells were incubated with primary antibody against V5 followed by secondary IgG 
antibody labelled with 12 nm gold beads. Arrows indicate UBR4V5 molecules located at an MVB (scale bar = 100 
nm for left panel and 20 nm for right panel). 
validated by transient silencing of UBR4 with siRNA. Consistent with a previous report [24], 
transmission electron microscopy showed that immunogold labeled UBR4 molecules were 
deposited to MVBs in HEK293 cells stably expressing UBR4V5 (Figure 34B), indicating that 
UBR4 was degraded along the endosome-lysosome pathway. These results suggest that UBR4 is 
required for the formation of MVBs and proteolysis therein, at least in part providing a mechanism 
underlying the depletion of cell surface proteins in the absence of UBR4. 
4.4 DISCUSSION AND CONCLUSION 
We have previously identified UBR4 as an N-recognin of the N-end rule pathway which binds 
type-1 and type-2 N-degrons of short-lived proteins to facilitate their ubiquitination and 
proteasomal degradation [8]. In this study, we characterized the null phenotypes of UBR4-
deficient mice. Our results show that UBR4-deficient embryos die associated with developmental 
defects in various processes such as neurogenesis and cardiovascular development (Figure 28). 
The mutant cells in various tissues do not exhibit tissue-specific morphology as if they cannot 
receive properly external paracrine signals (Figures 29A and 31A). The mutant cells are more 
separated from each other, which is in part attributed to the inability to maintain cell surface 
proteins and, thus, cell adhesion and integrity (Figures 31 and 32). Although the mechanism 
underlying the role of UBR4 in the homeostasis of cell surface proteins should be further 
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investigated, one such mechanism may be relevant to our observation that the MVBs are not 
properly generated in the absence of UBR4 (Figure 34).  
Our results show that UBR4-deficient mouse embryos suffer from multiple abnormalities 
in neurogenesis and other developmental processes. Histological and cytological examinations 
suggest that the cells in mutant embryos fail to maintain their morphology and adhesion, leading 
to failure to communicate with each other and advance into more differentiated stages (Figures 28 
and 31). Consistently, the expression pattern of cell adhesion markers such as N-cadherin is 
significantly disorganized (Figure 31F and G). Indeed, extensive studies have shown that 
neurogenesis in embryos is particularly sensitive to misregulation of intercellular adhesion 
molecules such as immunoglobulins, integrins, cadherins [138, 139].  
Why are cell adhesion molecules down-regulated and disorganized in the absence of UBR4? 
We show that UBR4-loss results in the rapid depletion of other cells surface proteins as well, 
including EGFR and PDGFR (Figure 32). Moreover, mass spectrometric analyses of purified 
biotin-conjugated cell surface proteins indicate that a significant portion, although not all, of 
proteins are depleted from the plasma membrane (Figure 33; Tables 2 and 3). These results 
collectively suggest that UBR4 is required for the turnover of plasma membrane-associated 
proteins. It is known that  cell surface proteins are under constitutive flux into the endosome-
lysosome pathway, in which endocytosed membrane proteins are recycled or degraded through 
endosomal pathways toward lysosomes [71, 90]. As demonstrated in previous chapter, UBR4 is 
associated with early endosomes through its interaction with calmodulin and required for the 
turnover of cell surface proteins (Figures 21 and 27). It is therefore reasonable to speculate that 
the homeostasis of cell surface proteins in UBR4-deficient cells are in part caused by misregulation 
in their endosome-mediated turnover (Figures 15 and 17). We provide evidence that UBR4-
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deficient cells fail to generate the MVBs in which endosome-cargo complexes are temporarily 
stored before degradation by lysosomes (Figure 34). Further mechanistic details are to be 
investigated.  
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5.0  THE FUNCTION OF ARGINYLATION BY ATE1 IN STING-DEPENDENT 
INNATE IMMUNE RESPONSE 
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5.1 RESEARCH BACKGROUND 
In eukaryotes, ATE1-encoded Arg-tRNA transferases (R-transferases; EC 2.3.2) transfer L-
arginine (L-Arg) of Arg-tRNAArg to the N-terminal Asp (Nt-Asp) and Glu (Nt-Glu) of substrates 
including misfolded proteins and endoplasmic reticulum (ER)-residing chaperones [14, 20, 21]. 
The resulting Nt-Arg residue is recognized by N-recognins like UBR box proteins (UBR1, UBR2, 
UBR4/p600, and UBR5/EDD) and the autophagy receptor p62, acting as a bimodal degradational 
signal to UPS or autophagy [8, 9, 20]. Additionally, the Nt-Arg can be generated by 
endoproteolytic cleavages or enzymatically through the modification of Nt-Asn, Nt-Gln, Nt-Cys, 
Nt-Asp, and Nt-Glu [12-15]. The Nt-arginylation of ER chaperones like binding-immunoglobulin 
protein (BiP/GRP78/HSPA5), calreticulin/CRT/CALR, and protein disulfide isomerase (PDI) is 
induced by cytosolic double-stranded DNA (dsDNA), a strong activator of the innate immune 
response [20]. The dsDNA-mediated immune response promotes the accumulation of Nt-
arginylated of BiP (R-BiP) in the cytosol, which binds the selective autophagy receptor p62 
through its binding of the ZZ domain of p62, resulting its self-oligomerization [20]. However, the 
physiological meanings of Nt-arginylation of BiP and the induced interaction of R-BiP with p62 
in the innate immune system are poorly defined.  
Autophagy is cytoprotective system that sequesters damaged cellular organelles, aggregated 
proteins, and foreign pathogens in double membrane vesicles (autophagosome), followed by 
lysosomal degradation [64]. During infection of host cells, the selective autophagy that eliminates 
invading pathogens and foreign particles is called as xenophagy [140]. E3 ubiquitin ligaseses 
contribute to xenophagy by recruitment of Ub to surface proteins of intracellular pathogens, which 
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enables p62 to recognize poly-ubiquitinated bacterial proteins through its UBA (Ub associated) 
domain [141, 142]. p62 deliveries ubiquitinated foreign particles and pathogens as well as 
misfolded proteins to phagophores by binding LC3 using its LC3-interacting region (LIR) [20, 
141]. During cytosolic foreign DNA-mediate innate immune responses, R-BiP is induced and 
associated with cytosolic misfolded proteins, targeted by p62. The inteaction between R-BiP and 
p62 facilitates p62 self-polymerization, autophagosome biogenesis, and lysosomal degradation of 
autophagic protein cargoes [20]. These suggest that co-induced Nt-arginylation and p62 can 
augment host defense system against foreign dsDNA, but its mechanism of regulation is not clearly 
understood. 
Invading of variety pathogens is recognized by the innate immune system through the 
detection of viral nucleic acids (Figure 35) [143]. On the contrary, misregulated recognition of 
self-nucleic acids leads to autoimmune diseases like psoriasis and systemic lupus erythematosus 
[143]. Cytosolic DNA derived from pathogens or host cells activates innate immune response 
through many DNA sensors, which include AIM2 [144], DAI [145], DDX41 [146], IFI16 [147], 
LRRFIP1 [148], RNA polymerase III-RIG-I [149, 150], and cytosolic GMP-AMP (cGAMP) 
synthase (cGAS) [151]. Either these DNA sensors or DNA itself activate TMEM173/STING 
(stimulator of interferon genes), which is identified as a critical adaptor for cytosolic dsDNA-
mediated interferons (IFNs) induction and is a transmembrane protein in the ER and/or 
mitochondria [152-154]. Recent studies showed that activated STING in response to cytoplasmic 
DNA is translocated from the ER to the Golgi compartment, on which it recruits  TANK-binding 
kinase 1 (TBK1) and the transcription factor IFN regulatory factor 3 (IRF3), leading to NF-κB and 
type I IFN gene expression (Figure 36) [155, 156].  
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Figure 35: STING pathway of cytosolic DNA sensing.  
Cytosolic DNA derived from invading pathogens or host cells activates innate immune response through many DNA 
sensors including DDX41, IFI16, RNA polymerase III-RIG-I, and cytosolic cGAS. These DNA sensors activate 
STING, which is a transmembrane protein in the ER. Activated STING in response to cytoplasmic DNA is 
translocated from the ER to the Golgi compartment, on which it recruits TBK1 and IRF3, leading to NF-κB and type 
I IFN gene expression.  
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Figure 36: Translocation of STING. 
Either DNA sensors or DNA itself can bind to STING, resulting its dimerization on the ER membrane. Dimerized 
STING in response to cytoplasmic DNA is translocated from the ER to the Golgi compartment, on which it recruits 
TBK1 and IRF3, leading to NF-κB and type I IFN gene expression. 
Here, we show that cytosolic foreign DNA induces Nt-arginylation of ER chaperons, which 
is required for host defense system for IFN-β mediated gene induction and IRF3 phosphorylation. 
Cytosolic dsDNA facilitates relocation of ATE1 to the ER, on which ATE1 is colocalized with 
STING. Either transient deletion of ATE1 or its pharmaceutical inhibition with tannic acids 
impairs the trafficking of STING from the ER to the Golgi compartment. Activated STING 
complex on the Golgi compartment is eliminated by p62-mediated autophagy. Interference of Nt-
arginylation that is important for host defense induces virion production. Our results suggest that 
Nt-arginylation is essential for cellular immune response against foreign DNA and viral infections.  
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5.2 MATERIALS AND METHODS 
5.2.1 Chemicals and antibodies  
Rabbit polyclonal antibodies specific for the arginylated forms of BiP, CRT and PDI were raised 
using the peptide sequences REEEDKKEDVGC, REPAVYFKEQ and RDAPEEEDHVL, 
corresponding to the N-terminal region of the arginylated mature proteins through a custom service 
at AbFrontier Inc. (Seoul, South Korea), as described previously [20]. Rabbit polyclonal mATE1 
antibody was raised by expressing a 22-kDa fragment corresponding to residues 313 to 516 
through a custom service in AbFrontier Inc. (Seoul, South Korea). The antibodies were purchased: 
rabbit monoclonal anti-BiP (Cell Signaling, 3177), rabbit polyclonal anti-BiP (Abcam, ab21685), 
mouse monoclonal anti-calreticulin/CRT (BD Biosciences, 6121360), rabbit polyclonal anti-PDI 
(Cell Signaling, 2446S), mouse monoclonal anti-ATE1 (Santa Cruz, sc-271220), rabbit polyclonal 
anti-ATE1 (Sigma, HPA038444), mouse monoclonal anti-STING (Abcam, ab131604),  rabbit 
monoclonal anti-IRF-3 (Cell Signaling, 11904P), rabbit polyclonal anti-IRF-3 (Santa Cruz, 
sc9082), rabbit monoclonal anti-phospho-IRF-3 (Ser396) (Cell Signaling, 4947S), rabbit 
polyclonal anti-KDEL (Santa Cruz, sc33806), mouse monoclonal anti-KDEL (Abcam, ab12223), 
mouse monoclonal anti-p62 (Santa Cruz, SC-28359), mouse monoclonal anti-CHOP (Cell 
Signaling, 2895), mouse monoclonal anti-Flag (Sigma, f1804), mouse monoclonal anti-CMV IE1 
(Virusys corporation, CH443), mouse monoclonal anti-HSV-1 anti-ICP0 (Virusys corporation, 
H1A027-100), mouse monoclonal anti-HSV-1 gC-1 (Virusys corporation, H1A022-100), mouse 
monoclonal anti-HSV-1 UL42 (Santa Cruz, sc53331), and rabbit polyclonal anti-GAPDH (Santa 
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Cruz, sc25778). The following secondary antibodies were purchased: Rhodamine Red donkey 
anti-rabbit IgG (Jackson lab, 711-295-152), FITC goat anti-rabbit IgG (Novex, A24532), FITC 
goat anti-mouse IgG (Novex, A24513), anti-rabbit IgG–HRP (Cell Signaling, 7074), and anti-
mouse IgG–HRP (Cell Signaling, 7076). The following secondary antibodies were obtained from 
Invitrogen: Alexa Fluor 488 goat anti-rabbit IgG (A11034, 1:200), and Alexa Fluor 555 goat anti-
mouse IgG (A21424, 1:200). Normal goat serum (ab7481) was obtained from Abcam. Hoechst 
33342 (H21492) was obtained from Invitrogen. 4′,6-Diamidino-2-phenylindole dihydrochloride 
(DAPI; D8417) was obtained from Sigma. Vectashield antifade mounting medium (H1000) was 
from Vector lab. All other chemicals were reagent grades from Sigma or Merck. 
5.2.2 Plasmids and other reagents  
The plasmids encoding ATE11A7A were generated as previously described [20]. pCMV-Sport6-
hSTING (Thermo scientific, 5762441), human STING-Myc-Flag-tagged plasmid (OriGene, 
RC208418), and pRL-SV40-Renilla-luciferase control vector (Promega, E2231) were purchased. 
IgK–IFN-Luciferase reporter vector was a gift from David Baltimore (Addgene, #14886) [157]. 
The mammalian expression plasmids for N-terminal HA-tagged or untagged IE1 (wild-type or 
mutant) were described previously [158]. The wild-type and mutant IE1 DNAs (Towne strain) 
were cloned into pENTR vectors (Invitrogen). Retroviral vectors encoding wild-type or mutant 
IE1 were produced by transferring the IE1 DNAs from pENTR vectors to pMIN-based destination 
vector using LR Clonase (Invitrogen). Other reagents were purchased as follow: poly(dA:dT) 
(InvivoGen, #tlrl-patn), tannic acid (Sigma, 403040),  RNAiMax (Invitrogen, 13778), 
Lipofectamine LTX (Invitrogen, 15338), Lipofectamine 2000 (Invitrogen, 11668), protein A/G 
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plus agarose beads (Santa Cruz, sc2003), Pierce IP lysis buffer (Thermo Scientific, 87788), and 
dual-luciferase reporter assay system (Promega, E1910). 
5.2.3 Cell culture  
HEK293 and CCL2 HeLa cells were purchased from the American Type Culture Collection 
(ATCC). HEK293, HeLa, and MEFs cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Gibco,10566016) supplemented with 10% FBS (HyClone) and 100 U/ml 
penicillin/streptomycin (Gibco, 15140-148). Cells were transfected with the plasmids and 
poly(dA:dT) using Lipofectamine LTX (Invitrogen, 15338). Tannic acid was treated for each time 
indicated in the figure legends. All the cell lines were determined to be negative in a mycoplasma 
test using a MycoAlert detection kit (Lonza, LT07-118). All the culture plates and the cell lines 
were maintained at 37°C and 5% CO2 in a humidified incubator. 
The HCMV Towne virus stocks were prepared as previously described [159]. For 
comparative analysis, the stocks of wild-type virus, IE1-deledeted CR208 virus, and other IE1 
mutant viruses encoding IE1(Δ290–032) or IE1(Δ421–475) were prepared in IE1-expressing HeLa 
cells and the titers of virus stocks were determined as infectious units (IFU) after performing 
infectious center assays in normal HeLa cells (see below). To produce UV-inactivated HCMV 
(UV-HCMV), the virus stock was irradiated with UV light three times at 0.72 J/cm2 using a CL-
1000 cross-linker (UVP). 
5.2.4 Infectious center assays 
The infectious center assays were prepared as previously described [158]. Briefly, the diluted 
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samples were used to inoculate a monolayer of HeLa cells (1 x 105) in a 24-well plate. At 24 h 
post-infection, cells were fixed with 500 μl of cold methanol for 10 min. Cells were then washed 
three times in PBS, incubated with anti-IE1 antibody in PBS at 37°C for 1 h, followed by 
incubation with secondary antibody. Finally, the samples were washed in PBS and treated with 
200 μl of nitro blue tetrazolium/5-bromo-4-chloro-3-indolylphosphate (KPL) for 1 h, according to 
the manufacturer's instructions. The IE1-positive cells were counted in at least three to five 
separate fields per well under a light microscope (200X magnification). 
5.2.5 Immunoblotting and co-immunoprecipitation 
For immunoblotting, cells were lysed in NETN buffer (0.5% Nonidet P-40, 20 mM Tris pH 8.0, 
50 mM NaCl, 50 mM NaF, 100 µM Na3VO4, 1 mM EDTA, and 50 µg/ml PMSF). Cell lysates 
were subjected to SDS-PAGE. Immunoblotting was performed using the antibodies indicated in 
the figure legends. For Co-immunoprecipitation, cells were washed with ice-cold PBS and then 
lysed in Pierce IP lysis buffer (Thermo Scientific, 87787) with cOmplete protease and phosSTOP 
phosphatase inhibitor cocktail tablets (Roche) at 4°C for 10 min. Crude lysates were cleared by 
centrifugation at 14,000 rpm at 4°C for 5 min, and supernatants were incubated with protein A/G 
plus agarose beads with primary antibodies. The immune-complexes were washed three times with 
NETN buffer and subjected to SDS-PAGE. Western blotting was performed using the antibodies 
indicated in the figure legends. 
5.2.6 Immunocytochemistry of cultured cells 
Cells were cultured in chamber slides (Thermo Fisher, 154461PK) or poly-L-lysine coated slides, 
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as described previously [24]. Cells were fixed in 4% PFA in PBS, for 30 min at room temperature. 
After washing twice with PBS, the cells were incubated for 1 h in blocking solution (5% normal 
goat serum and 0.2% Triton X-100 in 0.1 M PBS). After blocking, cells were incubated with 
primary antibodies and subsequently secondary antibodies. Confocal images were taken with a 
Zeiss LSM 700 laser scanning confocal microscope equipped with Zeiss C-Apochromat 60 × (1.2 
NA) and 40 × (1.2 NA) water immersion lens and analyzed using ZEN (black edition) 2012 SP5 
software (Zeiss). Image processing and annotation was done with Adobe Photoshop, Adobe 
Illustrator and Fiji software [103]. ImageJ plugin, interactive 3D surface plot (by Kai Uwe Barthel), 
was used to evaluate localization and expression of fluorescent images. 
5.2.7 Luciferase reporter assays 
Cells were plated on 12-well plates (5 × 105 cells/well) were transiently transfected with 100 ng 
IgK–IFN β-Luc with or without poly(dA:dT) with Lipofectamine 2000. At 24 h after transfection, 
luciferase activities were measured using Dual-luciferase reporter assay system and Wallac 
VICTOR 2 (Perkin Elmer). A Renilla luciferase reporter plasmid (50 ng) was used as an internal 
control.  
5.2.8 RNA interference assay 
Cells in a 6-well plate (1 × 106 cells/well) were transfected with 100 pmol of siRNA using the 
RNAiMax reagent. Pre-designed Silencer Select siRNAs (Invitrogen) were used to knock down 
ATE1 and BiP using the following sequences (Table 4). A negative control oligo (#4390843) was 
purchased from Invitrogen. Approximately 48 h after siRNA silencing, cells were harvested for 
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immunoblotting and immunocytochemical analyses.  
 
Table 4: siRNA nucleotide sequences 
Target mRNA Hairpin siRNA sequences 
ATE1 (HSS117-202) Sense: 5’-GAUUCCUUUGCAGUUCACCCUUGGA-3’ 
Antisense: 5’-UCCAAGGGUGAACUGCAAAGGAAUC-3’ 
ATE1 (HSS117-203) Sense: 5’-GAGAGCCAUGCCUUACGGUGUU-3’ 
Antisense: 5’-AACACCGUAAGGCAUGAUGGCUCUC-3’ 
ATE1 (HSS117-204) Sense: 5’-ACCCACCAUCUUUGUUUCCACCAAA-3’ 
Antisense: 5’-UUUGGUGGAAACAAAGAUGGUGGGU-3’ 
BiP Sense: 5’-CAGAUGAAGCUGUAGCGUATT-3’ 
Antisense: 5’-UACGCUACAGCUUCAUCUGGG-3’ 
5.2.9 Statistical analysis 
All numerical data are presented as means ± SEM or mean percentages ± SEM. Western blots 
shown are representative of three or more independent experiments. Comparisons among 
treatment groups were performed with one-way ANOVA and Tukey test or Dunnett’s multiple 
comparison as a post hoc comparison. Instances involving only two comparisons were evaluated 
with unpaired t-test or two-tailed Mann-Whitney test for non-parametric test. Statistical 
significance was accepted if the null hypothesis was rejected with p < 0.05. All statistical analyses 
were determined using Prism 7.0c software (GraphPad, La Jolla, CA). 
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5.3 EXPERIMENTAL RESULTS 
5.3.1 ATE1 is essential for cytosolic dsDNA-mediated immune response.   
A previous our study reported that cytosolic foreign dsDNA induces arginylation of ER chaperones 
like BiP, CRT, and PDI [20]. Here, we also confirmed that the ATE1-depedent Nt-Arg was 
induced by cytosolic dsDNA. Arginylated forms of BiP (R-BiP), CRT (R-CRT), and PDI (R-PDI) 
were induced by cytoplasmic foreign dsDNA exposure, time- and dose-dependently (Figure 37A 
and B). We further validated whether the transfected poly(dA:dT) leads to cellular immune 
response through the detection of phosphorylated IRF-3 on Ser396. Immunoblotting assay showed 
that cytoplasmic foreign dsDNA exposure facilitated phosphorylation of IRF-3 in a time-
dependent manner (Figure 37B).  
Cytosolic dsDNA causes innate immune response through interaction of cytosolic dsDNA 
sensors and induces production of type I interferon [143, 154]. To characterize a potential link 
between ATE1 and innate immune response, we performed the interferon beta (IFN-β) reporter 
assay. The IFN-β reporter assay revealed that transiently downregulated ATE1 restrained the 
poly(dA:dT)-induced activation of the IFN-β promoter (Figure 37C). Furthermore, the reduced 
IFN-β activation was rescued by overexpression of ATE11A7A, an ATE1 isoform (Figure 37D). 
Consistently, transfection of poly(dA:dT) induced IFN-β-mediated reporter gene activity in +/+ 
MEF cells, but not in ATE1-/- MEFs (Figure 37E). These results suggest that ATE1 is involved in 
cytoplasmic dsDNA-triggered induction of downstream innate immune genes.  
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Figure 37: ATE1 is essential for cytosolic dsDNA-mediated immune response.  
(A) Immunoblotting analysis of R-BiP, R-CRT, and R-PDI in poly(dA:dT)-treated HeLa cells. The Nt-Arg of BiP, 
CRT, and PDI is induced by cytosolic dsDNA in a dose-dependent manner. GAPDH is probed for loading control. 
(B) Immunoblotting analysis of R-BiP, R-CRT, R-PDI, pho-IRF, and IRF in poly(dA:dT)-treated HEK293 cells. The 
Nt-Arg of BiP, CRT, and PDI caused by cytosolic dsDNA is promoted in a time-dependent manner. Cytosolic dsDNA 
facilitates phosphorylation of IRF3 on Ser396. (C) IFN-β reporter assays for untreated or siATE1-treated HeLa cells 
and then transfected with poly(dA:dT) for indicated times. (D) IFN-β reporter assays for siScramble- or siATE1-
treated HeLa cells and then transfected with poly(dA:dT) or ATE11A7A. (E) IFN-β reporter assays for +/+ and ATE1-/- 
MEF cells transfected with 0.5 µg/ml poly(dA:dT) for indicated times. (F) Immunoblotting analysis of pho-IRF3, 
IRF3, R-BiP, BiP, and ATE1 in siScramble- or siATE1-treated HeLa cells followed by transfection with or without 
poly(dA:dT) for 16 h. GAPDH is probed for loading control. Conducted by Kisa Sung.  
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To determine whether ATE1 is required for cytoplasmic dsDNA-triggered immune 
signaling, we examined phosphorylation of IRF3 that is an upstream of IFN-β signlaing induced 
by poly(dA:dT) transfection. RNA interference assays revealed that phosphorylation of IRF3 
induced by poly(dA:dT) transfection was markedly inhibited by transient deletion of ATE1 in 
HeLa cells (Figure 37F, lanes 2 versus 4). Collectively, these suggest that ATE1 can be 
indispensible for efficient indection of genes by cytosolic DNA in cellular immune system.  
5.3.2 Cytosolic dsDNA facilitates relocation of ATE1 to the ER.  
To determine the function of ATE1 on cellular immune response caused by cytosolic DNA, we 
examined the intracellular localization of ATE1. Immunostaining assay showed that transfection 
of poly(dA:dT) induced ATE1 and caused ATE1+ puncta structures, which were accumulated on 
KDEL+ ER in HeLa cells (Figure 38). Additionally, 3D surface plot analysis markedly revealed 
that ATE1+ puncta were translocated to KDEL+ ER by poly(dA:dT) treatment (Figure 38C). 
Tannic acid treatment for 24 h, an ATE1 inhibitor, caused dislocalization of ATE1 puncta from 
the ER (Figure 38B-D). It suggests that the inhibitor did not induce a degradation of ATE1, but it 
may caused conformational changes preventing its attachment to target substrate. Transient 
deletion of ATE1 by RNA interference assay reduced a basal level of ATE1 and its puncta (Figure 
38B). These results suggest that cellular immune response caused by poly(dA:dT) induced the 
translocation of ATE1 to the ER. 
5.3.3 Tannic acid, an ATE1 inhibitor, suppresses the trafficking of STING.  
STING, an ER-associated protein, is a critical signaling molecule in the innate response to cyto- 
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Figure 38: Cytosolic dsDNA facilitates relocation of ATE1 to the ER. 
(A) Immunostaining analysis of ATE1 and KDEL (ER marker) in HeLa cells transfected with or without 1 μg/ml 
poly(dA:dT) for 18 h (scale bar = 10 μm). Enlarged views of areas indicated by rectangles. Colocalized area were 
shown as a central red area, surrounded by yellow ring. (B) Immunostaining analysis of ATE1 and KDEL in tannic 
acid (TA)- and siATE1-treated HeLa cells, follwed by transfection with or without 1 μg/ml poly(dA:dT) for 18 h (scale 
bar = 10 μm). (C) Interactive 3D surface plot assay of B to evaluate the localization of ATE1+ puncta. (D) 
Quantification of B, representing the relative colocalized area between ATE1 and KDEL per cell (*p = 0.0317, n = 6-
16 in each group). Data are presented as mean percentage ± SEM of mock. Statistical significance was determined 
using one-way ANOVA and Tukey test as a post hoc comparison. 
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solic nucleic acids like dsDNA [155]. Because STING trafficking from the ER to Golgi apparatus 
via ERGIC (ER-Golgi intermediate compartment) is essential for its activation mechanism [156], 
we thus determined whether the relocalization of ATE1 from the cytosol to the ER is involved in 
the STING trafficking during the cytoplasmic dsDNA-induced immune response. We transiently 
transfected STING-Myc-Flag plamid in HEK293T cell and performed immunostaining with 
various primary antiobodies against STING, Myc, and Flag respectively. Consistently, all these 
antibodies showed that STING was constituitively located on the ER in HEK293T cells stably 
expressing ER-DsRFP (ER marker) (Figure 39A). Upon poly(dA:dT)-mediated immune response, 
immunostaining assay showed that dsDNA-induced ATE1 were aggregated and colocalized with 
STING, which was located on the ER membrane (Figure 39B).  
Next, we investigated whether the pharmaceutical inhibition of ATE1 using tannic acid 
suppresses the trafficking of STING. Immunostaining assay showed that most of STING were 
aggregated and strongly colocalized with ERGIC53 (ERGIC marker), indicating translocation of 
STING within 8 h from poly(dA:dT) transfection (Figure 40A). We also observed that the 
translocation of STING to Golgi using GM130 antibody, which is a Golgi marker, in a timely 
manner (Figure 40B). Notably, tannic acid treatment inhibited the trafficking of STING to either 
of the ERGIC or the Golgi. These results indicate that the ATE1 can mediate dsDNA-induced 
translocation of STING, which plays a key role in cellular immune reponse against pathegens.  
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Figure 39: ATE1 is co-localized with STING on the ER.  
(A) Immunostaining analysis of STING, Myc, and Flag in transiently STING-Myc-Flag transfected HEK293T cells 
stably expressing ER-DsRFP (ER marker). STING is constitutively located on the ER. Enlarged views show the areas 
indicated by white rectangles (scale bar = 10 μm). (B) Immunostaining analysis of STING and ATE1 in transiently 
STING-Myc-Flag transfected HEK293T cells, follwed by transfection with or without 1 μg/ml poly(dA:dT) for 
indicated times (scale bar = 10 μm). 
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Figure 40: ATE1 is reqired for the STING trafficking.  
(A) Immunostaining analysis of STING and ERGIC53 (ERGIC marker) in untreated or 20 μM tannic acid-treated 
transiently STING-Myc-Flag transfected HeLa cells, follwed by transfection with 2 μg/ml poly(dA:dT) for indicated 
times. White dotted lines delineate the cell boundary. Enlarged views show the areas indicated by white rectangles 
(scale bar = 10 μm). (B) Immunostaining analysis of STING and GM130 (Golgi marker) in untreated or 20 μM tannic 
acid-treated transiently STING-Myc-Flag transfected HeLa cells, follwed by transfection with 2 μg/ml poly(dA:dT) 
for indicated times. White dotted lines delineate the cell boundary. Cyan lines delineate the nucleus. Nu, nucleus. 
Enlarged views show the areas indicated by white rectangles (scale bar = 10 μm). 
5.3.4 Nt-arginylation of BiP is needed for STING-mediated immune response.  
Cytoplasmic dsDNA facilitates Nt-arginylation of BiP, a major substrate of ATE1 (Figure 37A). 
To understand the correlation between induced R-BiP and STING-IRF3 signaling, we perfomed a 
co-immunoprecipitation (co-IP) assay in HeLa cells. The IP of STING co-precipitated BiP (Figure 
41A, lanes 4 versus 5), but the interaction of STING with BiP was not enhanced when the cells 
were transfected with poly(dA:dT) for 16 h (Figure 41A, lanes 5 versus 6). To check whether BiP 
mediates STING-IRF3 immune signaling, we transiently silenced BiP using siRNA. Poly(dA:dT) 
transfection induced pho-IRF3, which was downstream of STING signaling (Figure 41B; lanes 1 
vs. 2), but siBiP transfection interrupted the phosphorylation of IRF3 (Figure 41B; lanes 2 vs. 4).  
We further determined whether R-BiP is a deteminant of STING signaling. 
Immunostaining assay showed that STING was induced at first within a hour and significantly 
colocalized with cytosolic puncta for R-BiP later, which were markedly detected at 8 h from 
poly(dA:dT) transfection (Figure 41C and D). Whereas the colocalization was maximized at 8 h, 
accumulated STING+ puncta were disappreared at 16 h from the dsDNA-induced stress (Figure 
41D). The ATE1 inhibitor tannic acid treatment prevented the co-induction and colocalization of 
STING+ and R-BIP+ puncta (Figure 41C and D). These suggest that ATE1 and R-BiP may be 
necessary for STING translocation in cytoplasmic DNA-mediated response.  
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Figure 41: BiP binds STING and its Nt-arginylation is essential for STING trafficking. 
(A) Co-immunoprecipitation assay in HeLa cells. Cell lysates were immunoprecipitated with anti-STING antibody 
and then immunoblotted with indicated antibodies. (B) Immunoblotting analysis of pho-IRF3, IRF, BiP, CRT, and 
PDI in HeLa cells transfected with the indicated siRNAs. (C) Immunostaining analysis of STING and R-BiP in 
untreated or 20 μM tannic acid-treated transiently STING-Myc-Flag transfected HeLa cells, followed by transfection 
with 2 μg/ml poly(dA:dT) for 8 h. White dotted lines delineate the cell boundary. Orange lines delineate the nucleus. 
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Nu, nucleus (scale bar = 1 μm). (D) Immunostaining analysis of STING and R-BiP in untreated or 20 μM tannic acid-
treated transiently STING-Myc-Flag transfected HeLa cells, followed by transfection with 2 μg/ml poly(dA:dT) for 
indicated times. White dotted lines delineate the cell boundary. Orange lines delineate the nucleus. N, nucleus. 
Enlarged views show the areas indicated by white rectangles (scale bar = 4 μm). Panels A and B were conducted by 
Kisa Sung. 
5.3.5 ATE1 is essential for anti-viral response. 
Collectively, these data imply that ATE1-dependent Nt-arginylation can play a important role in 
host defense system against pathogens. Among various pathogens, we speculated that ATE1 is 
critical for sensing DNA virus beacuase Nt-arginylation was not induced by cytoplasmic ssRNA 
and dsRNA [20]. Therefore, we infected HeLa cells with human cytomegalovirus (HCMV), a 
DNA virus. ATE1-deficient HeLa cells using shATE1 produced 110-fold-more infectious virus, 
compared with that of shScramble transfected cells (Figure 42A and B).  Because the infectivity 
of the virions produced by ATE1 knockdown was hugely increased, we examined the viral protein 
constituents of +/+ and ATE1-/- MEFs cells infected with herpes simplex virus-1 (HSV-1). 
Immunoblotting assay showed that ICP0, gC-1, and UL42 were highly expressed in ATE1-/- MEFs 
(Figure 42C). These data suggest that ATE1 is essential for host defense against virus-infection in 
cultured cell lines.  
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Figure 42: ATE1 is essential for host defense system against DNA virus.   
(A) Immunoblotting analysis of ATE1 in HeLa cells transfected with the indicated shRNAs. (B) Infectious center 
assay of measuring virus titers in shScramble or shATE1-transfected HeLa cells, followed with HCMV infection at a 
multiplicity of infection (MOI) of 0.2 for 10 d. ATE1-deletion in HeLa cells produces 110-fold-more infectious 
progeny than shScramble transfected cells. (C) Immunoblotting analysis of ICP0, gC-1, and UL42 in +/+ and ATE1-/- 
MEFs infected with HSV-1 at a MOI of 1 for the indicated times. Panels A and B were conducted by Jin-Hyun Ahn 
and panel C was conducted by Daeho Kim. 
5.3.6 STING is targeted to p62 for autophagy-lysosomal degradation.  
Because sustained activation of STING can cause autoinflammatory diseases [160, 161], clearing 
of activated STING is necessary for cellular homeostasis, even though it’s beneficial functions to 
detect and promote immune response against pathogens and viral DNA. In addition, we recently 
reported that various Nt-arginylated proteins including ER-residing and cytoplasmic proteins bind 
p62 and induce its self-oligomerization through their binding to ZZ domain of p62, which 
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promotes cargo deliveries for autophagy-lysosomal degradation [9, 20]. According to the co-
induction and colocalization of STING and R-BiP upon dsDNA-induced stress (Figure 41A and 
B), STING/R-BiP complex may enhance autophagy activity and be targeted to p62-LC3-mediated 
autophagic degradation via binding to ZZ domain of p62. We thus determined whether Nt-
arginylation facilitates the interaction of STING with p62 in transiently STING-Myc-Flag 
transfected HeLa cells. The immunostaining analysis showed that most of STING+ puncta 
colocalized with cytosolic puncta postive for p62 as well as LC3 at 16 h from cytoplasmic dsDNA 
exposure (Figure 43A). However, tannic acid treatment impaired co-localization of STING with 
p62 (Figure 43A). Consistent with the previous results, STING was highly co-induced and 
colocalized with the LC3 and p62 at 8 h after poly(dA:dT) transfection, and these STING+-LC3+-
p62+ puncta were disappeared in a time-dependent manner, from 8 to 16 hour (Figure 43B). Thus, 
it suggests that a portion of acivated STING was targeted to p62 for autophagic degradation during 
dsDNA immune response.  
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Figure 43: STING is targeted to p62 for autophagy-lysosomal degradation. 
(a) Immunostaining analysis of STING, LC3, and p62 in untreated or 20 μM tannic acid-treated transiently STING-
Myc-Flag transfected HeLa cells, follwed by transfection with 2 μg/ml poly(dA:dT) for 16 h. White dotted lines 
delineate the cell boundary. Orange lines delineate the nucleus. Nu, nucleus. Enlarged views show the areas indicated 
by white rectangles (scale bar = 1 μm). (b) Immunostaining analysis of STING, LC3, and p62 in untreated or 20 μM 
tannic acid-treated transiently STING-Myc-Flag transfected HeLa cells, follwed by transfection with 2 μg/ml 
poly(dA:dT) for indicated times. White dotted lines delineate the cell boundary. Orange lines delineate the nucleus. 
Nu, nucleus. Enlarged views show the areas indicated by white rectangles (scale bar = 4 μm). 
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5.4 DISCUSSION AND CONCLUSION 
N-terminal Arg (Nt-Arg) is one of the principal degrons that it can be generated through post-
translational conjugation of L-Arg from Arg-tRNAArg to N-terminal Asp or Glu, which is mediated 
by ATE1-encoded Arg-tRNA transferases. Additionally, the Nt-Arg can be generated by 
endoproteolytic cleavages or enzymatically through the modification of Nt-Asn, Nt-Gln, Nt-Cys, 
Nt-Asp, and Nt-Glu [12-15]. The resulting Nt-Arg residue is recognized by N-recognins like UBR 
box proteins (UBR1, UBR2, UBR4/p600, and UBR5/EDD), resulting induced substrate 
ubiquitination and its proteasomal degradation via the N-end rule pathway of the UPS. Recently 
we reported that Nt-Arg residues can modulate proteolytic flux via macroautophagy when 
misfolded proteins accumulate beyond the UPS’s capacity [20]. The Nt-Arg binds and activate the 
autophagic receptor p62, promoting cargo delivery to phagophore/autophagosome [8, 9, 20]. Even 
though it is a universal posttranslational modification in eukaryotes, yet its functions remain poorly 
understood. 
In this chapter, we show that cytosolic foreign DNA induces Nt-arginylation of ER 
chaperons. ATE1-dependent Nt-arginylation is required for STING-mediated cellular immune 
response, which leads to IRF3 phosphorylation and IFN-β mediated gene induction. In addition, 
Cytosolic dsDNA facilitates relocation of ATE1 to the ER, on which ATE1 is colocalized with 
STING. Either transient deletion of ATE1 or its pharmaceutical inhibition with tannic acids 
hinders the trafficking of STING from the ER to the Golgi compartment on which STING makes 
a complex with TBK1 and IRF3. To prevent retained STING activity to cause autoimmune 
response, activated STING complex on the Golgi compartment can be targeted and eliminated by 
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p62-mediated autophagy. Interference of Nt-arginylation that is important for host defense induces 
virion production. Collectively, our results suggest that Nt-arginylation is essential for cellular 
immune response against foreign DNA and viral infections. 
STING can directly recognize cytoplasmic foreign DNA or indirectly through various 
DNA sensors including, cytosolic GMP-AMP (cGAMP) synthase (cGAS) [151]. Recent studies 
showed that activated STING in response to cytoplasmic DNA is translocated from the ER to the 
Golgi compartment, on which it recruits TANK-binding kinase 1 (TBK1) and the transcription 
factor IFN regulatory factor 3 (IRF3), leading to NF-κB and type I IFN gene expression (Figure 
44) [155, 156]. We found that ATE1-dependent Nt-arginylation is essential for translocation of 
STING from the ER and its downstream signaling (Figures 37 and 40). In other way, cytoplasmic 
DNA infection facilitates translocation of the ER-residing chaperone BiP and its Nt-arginylation 
at 8 h from the infection (Figure 41C and D). At that time, most of activated STING already 
aggregated on the Golgi on which STING activates the transcription factor IRF3 for IFN signaling 
(Figure 40). Given that R-BiP still maintains binding affinity to STING as BiP does (Figure 41A), 
R-BiP can bind and accumulate with activated STING complex on the Golgi. R-BiP additionally 
binds the ZZ domain of p62 and induces a conformational change of p62, resulting self-
oligomerization and aggregation of p62. The autophagy receptor p62 interacts with LC3 embedded 
on the phagophore or autophagosome. This can bring the whole complex including STING-R-BiP-
p62 into the phagophore and/or autophagosome, destined to be degraded by lysosomal fusion. 
Through the autophagic degradation of activated STING, it can prevent sustained STING 
activation which can lead to autoimmune diseases.  
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Figure 44: Schematic illustration of the N-end rule pathway in modulation of cytoplasmic DNA-mediated 
STING pathway.  
(A) STING recognizes cytoplasmic foreign DNA and moves from the ER to the Golgi in which activated STING 
recruits TBK1 and IRF3 and activates downstream type I IFN signaling. Because constitutively activated STING leads 
to autoimmune response, p62-mediated autophagic degradation of the complex is needed to maintain cellular 
homeostasis. (B) A model for autophagic degradation of activated STING complex in the N-end rule pathway. 
Palmitation of activated STING complex on the Golgi can lead to its conformational changes and exposure of 
hydrophobic domains of STING, which can be bound by chaperone BiP. As an innate immune reaction, Nt-
arginylation can be facilitated and add Arg to N-termini of BiP. The resulting Nt-Arg of BiP binds to the autophagy 
receptor p62, which promotes autophagic cargo deliveries to phagophore and the formation of autophagosome, 
destined to auto-lysosomal degradation. 
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6.0  CONCLUSION AND FUTURE DIRECTIONS  
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6.1 THE ROLE OF UBR4 IN AUTOPHAGIC MODULATION IN THE YOLK SAC 
We have previously identified UBR4 as an N-recognin of the N-end rule pathway, which can bind 
the N-terminal residues of proteins to facilitate proteolysis via the ubiquitin-proteasome system or 
autophagy. In the current study, we addressed the physiological function of a poorly characterized 
N-recognin, 570-kDa UBR4, in mammalian development. UBR4-deficient mice show severe 
embryonic lethality associated with pleiotropic abnormalities in the YS. In the YS, UBR4 is highly 
enriched in endoderm-derived cell layer that supplies autophagy-generated amino acids during 
early embryogenesis. UBR4 of the YS endoderm is associated with a tissue-specific autophagic 
pathway that mediates autophagy-lysosomal proteolysis of endocytosed maternal proteins into 
amino acids. In cultured cells, UBR4 subpopulation is degraded by autophagy through its 
starvation-induced association with cellular cargoes destined to autophagic double membrane 
structures. UBR4 loss results in multiple misregulations in autophagic induction and flux, 
including synthesis and lipidation of LC3. Our results suggest that UBR4 plays an important role 
in mammalian development, in part through regulation of bulk degradation by lysosomal 
hydrolases in the YS.  
The YS endoderm is a specialized digestive organ wherein maternal proteins from the YS 
cavity are endocytosed and digested into amino acids through the MVB-autophagosome-lysosome 
pathway [57]. The N-end rule pathway has been characterized as a proteolytic system that controls 
the half-lives of cytosolic short-lived proteins through selective proteolysis by the 26S proteasome. 
N-recognin, known to bind to substrates of selective proteasomal degradation, is also associated 
with substrates of bulk lysosomal degradation. Further investigation is needed to understand the 
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mechanism by which UBR4 plays a dual role in selective degradation of short-lived proteins via 
the proteasome and bulk degradation of cellular materials via autophagy-lysosome degradation 
pathway. 
6.2 THE ROLE OF THE N-RECOGNIN UBR4 IN THE BIOGENESIS OF THE 
EARLY ENDOSOME 
Here, we show that the 570 kDa N-recognin UBR4 modulates endosome maturation and the 
trafficking and proteolysis of internalized cargoes. UBR4 is associated with endocytic vesicles 
through the interaction with Ca2+-bound calmodulin. The endosomal recruitment of UBR4 is 
essential for the biogenesis of early endosomes and endosome-related processes such as the 
trafficking of endocytosed protein cargoes. In mouse embryos, UBR4 marks and plays a role in 
the endosome-lysosome pathway that mediates the heterophagic proteolysis of endocytosed 
maternal proteins into amino acids. Our results suggest that UBR4 is an essential modulator in the 
endosome-lysosome system. 
Studies have implicated UBR4 in various biological processes, including 
neurodegeneration [8, 28], auxin transport, trafficking via microvesicles and ectosomes  [51], 
synaptic transmission [47, 48], the interaction with various viral proteins across diverse strains 
[36], proteasomal degradation of short-lived regulators [43, 44] and E7-mediated cellular 
immortalization and transformation activities [39-42]. Despite rather extensive studies, however, 
little is known about the cellular functions of UBR4 that explain these seemingly unrelated 
observations. Given our findings that UBR4 is a key modulator in the biogenesis of early 
endosomes and endosomal proteolysis, the functions of UBR4 in various biological systems may 
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need to be re-evaluated in the light of endosomal processes. 
We have previously identified UBR4 as an N-recognin of the N-end rule pathway, which 
can bind the N-terminal residues of proteins to facilitate proteolysis via the ubiquitin-proteasome 
system or autophagy. Our current finding that UBR4 is associated with maturing endosomes 
through its binding to Ca2+-calmodulin provides a model in which UBR4 modulates its function 
in the biogenesis of early endosomes. In this model, ATE1 R-transferase conjugates L-arginine (L-
Arg) of Arg-tRNAArg to the N-termini of proteins. The resulting N-terminal Arg (Nt-Arg) residue 
acts as a ligand that binds the UBR box of UBR4, enabling UBR4 to bind Ca2+-calmodulin and to 
be associated with EEA1+ early endosomes. We will further investigate the model to verify that 
Nt-arginylation can be a determinant of biogenesis of early endosomes.  
In addition, by screening 11,679 drugs through the DrugBank database, we identify picolinic acid 
as a putative ligand to UBR4, which inhibits the biogenesis of early endosomes. We want to further 
characterize its mechanisms in the endosome-lysosome system.  
6.3 THE FUNCTION OF UBR4 IN NEUROGENESIS AND HOMEOSTASIS OF 
CELL SURFACE PROTEINS 
The N-end rule pathway is a proteolytic system in which single N-terminal amino acids of proteins 
act as a class of degrons (N-degrons) that determine the half-lives of proteins. We have previously 
identified a family of mammals N-recognins (termed UBR1, UBR2, UBR4/p600, and UBR5/EDD) 
whose conserved UBR boxes bind N-degrons to facilitate substrate ubiquitination and proteasomal 
degradation via the UPS. Amongst these N-recognins, UBR1 and UBR2 mediate ubiquitination 
and proteolysis of short-lived regulators and misfolded proteins.  
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Here, we characterized the null phenotypes of UBR4-deficient mice in which the UBR box 
of UBR4 was deleted. We show that the mutant mice die around embryonic days 9.5-10.5 (E9.5-
E10.5) associated with abnormalities in various developmental processes such as neurogenesis and 
cardiovascular development. These developmental defects are significantly attributed to the 
inability to maintain cell integrity and adhesion, which significantly correlates to the severity of 
null phenotypes. UBR4-loss induces the depletion of many, but not all, proteins from the plasma 
membrane, suggesting that UBR4 is involved in proteome-wide turnover of cell surface proteins. 
Indeed, UBR4 is associated with and required to generate the MVBs which transiently store 
endocytosed cell surface proteins before their targeting to autophagosomes and subsequently 
lysosomes. Our results suggest that the N-recognin UBR4 plays a role in the homeostasis of cell 
surface proteins and, thus, cell adhesion and integrity. 
As demonstrated in chapter 3.0, UBR4 is associated with early endosomes through its 
interaction with calmodulin and required for the turnover of cell surface. It is therefore reasonable 
to speculate that the homeostasis of cell surface proteins in UBR4-deficient cells are in part caused 
by misregulation in their endosome-mediated turnover. We provide evidence that UBR4-deficient 
cells fail to generate the MVBs in which endosome-cargo complexes are temporarily stored before 
degradation by lysosomes. Further mechanistic details explaining the correlation between early 
endosomes and cellular surface proteins are to be investigated. 
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6.4 THE FUNCTION OF N-TERMINAL ARGINYLATION BY ATE1 IN INNATE 
IMMUNITY 
The N-end rule pathway has been implicated in Ub-dependent proteolysis of cytosolic short-lived 
proteins in various processes. We recently found that a set of ER-residing proteins, such as BiP, 
calreticulin, and PDI, are re-located to cytoplasm and Nt-arginylated under specific cellular 
stresses including cytoplasmic foreign DNA exposure and proteasomal inhibition [20]. The 
dsDNA-mediated immune response promotes the accumulation of R-BiP in the cytosol, which 
binds the selective autophagy receptor p62 through its binding of the ZZ domain of p62, resulting 
its self-oligomerization [20]. However, the physiological meanings of Nt-arginylation of BiP and 
the induced interaction of R-BiP with p62 in the innate immune system are poorly defined.  
Cytoplasmic DNA derived from pathogens or host cells is recognized by the innate immune 
system through many DNA sensors, which activate STING-mediated innate immune respoonse. 
The activated STING in response to cytoplasmic DNA is translocated from the ER to the Golgi 
compartment, on which it recruits TANK-binding kinase 1 (TBK1) and the transcription factor 
IFN regulatory factor 3 (IRF3), leading to NF-κB and type I IFN gene expression [155, 156].  
Here, we show that cytosolic foreign DNA, a strong inducer of innate immune response, 
facilitates Nt-arginylation of ER chaperons. ATE1-dependent Nt-arginylation is required for host 
defense system for IFN-β mediated gene induction and IRF3 phosphorylation. Cytosolic dsDNA 
induces relocation of ATE1 to the ER, on which ATE1 is colocalized with STING. ATE1 is 
essential for STING-mediated innate immune signaling because either transient deletion of ATE1 
or its pharmaceutical inhibition impairs the trafficking of STING from the ER to the Golgi 
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compartment. Nt-arginylation is essential for maintaining host defense system, thus its interference 
induces virion production. Our results suggest that Nt-arginylation is essential for sustain innate 
immunity against foreign DNA and viral infections. 
We also observed that Nt-arginylation BiP that colocalized with aggregated STING on the 
Golgi compartment is eliminated by p62-mediated autophagy. During infection of host cells, the 
selective autophagy that eliminates invading pathogens and foreign particles is called as 
xenophagy [140]. The autophagic adapter p62 is an N-recognin that binds type-1 and type-2 N-
terminal degrons (N-degrons), including arginine (Nt-Arg). We recently reported that our synthetic 
ZZ ligands targeting Zinc finger of p62 facilitated the self-oligomerization of p62 and induced 
autophagic biogenesis [11, 20]. Through these results, we can expect that ZZ ligands can activate 
p62 and induce selective autophagy for invading pathogens and cytoplasmic foreign DNA. 
Therefore we want to further investigate whether our ZZ ligands efficently induces the clearing of 
cytoplasmic dsDNA or pathogens via p62-mediated selective autophagy system later.  
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